Trulieve Cannabis (TCNNF) S-1 21 Jan 22 IPO registration Financial data

Cover Page

Cover Page	9 Months Ended
	Sep. 30, 2021
Cover [Abstract]
Document Type	S-1
Amendment Flag	false
Entity Registrant Name	TRULIEVE CANNABIS CORP.
Entity Central Index Key	0001754195
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	true

Unaudited Interim Condensed Con

Unaudited Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 213,574	$ 146,713	$ 91,813
Accounts receivable, net	8,487	308
Inventories, net	133,874	98,312	65,981
Income tax receivable, net	3,978	0
Prepaid expenses and other current assets	25,791	16,119	7,678
Total current assets	385,704	261,452	165,471
Property and equipment, net	501,109	314,045	144,748
Right of use assets—operating, net	45,753	30,076	22,045
Right of use assets—finance, net	58,393	36,904	19,088
Intangible assets, net	161,282	93,800	30,036
Goodwill	111,721	74,100	7,316
Other assets	12,077	7,528	949
TOTAL ASSETS	1,276,039	817,905	385,996
Current liabilities:
Accounts payable and accrued liabilities	62,769	41,903	24,308
Income tax payable	0	5,875	8,327
Deferred revenue	4,082	7,178	2,404
Notes payable—current portion	6,000	2,000	2,000
Notes payable—related party—current portion	12,000	12,011	924
Warrant Liability			9,892
Operating lease liabilities—current portion	4,264	3,277	2,541
Finance lease liabilities—current portion	5,354	3,877	2,272
Total current liabilities	94,469	76,121	52,667
Long-term liabilities:
Notes payable	0	4,000	4,000
Notes Payable—Related Party			11,979
Operating lease liabilities	43,657	28,120	20,601
Finance lease liabilities	57,234	35,058	17,168
Private placement notes liabilities, net	119,478	117,165
Other long-term liabilities	6,438	3,915	118,256
Construction finance liabilities	92,021	82,047	22,956
Deferred tax liability	40,099	23,575	5,486
TOTAL LIABILITIES	453,396	370,001	253,114
Common stock, no par value; unlimited shares authorized, 129,531,207 and 119,573,998 issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	0	0	0
Additional paid-in-capital	613,379	328,214	76,192
Warrants		52,570
Accumulated earnings	209,264	119,690	56,691
TOTAL SHAREHOLDERS' EQUITY	822,643	447,904	132,883
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 1,276,039	817,905	385,996
Previously Reported [Member]
Current assets:
Prepaid expenses and other current assets		19,815
Total current assets		265,148
Property and equipment, net		317,701
Right of use assets—operating, net		28,171
Intangible assets, net		90,144	$ 26,380
Other assets		3,944
TOTAL ASSETS		816,112
Current liabilities:
Accounts payable and accrued liabilities		41,902
Operating lease liabilities—current portion		3,154
Total current liabilities		75,998
Long-term liabilities:
Operating lease liabilities		26,450
Other long-term liabilities		121,080
TOTAL LIABILITIES		368,208
Additional paid-in-capital		275,644
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY		$ 816,112

Unaudited Interim Condensed C_2

Unaudited Interim Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Accounts receivable,allowance for doubtful accounts		$ 5,000	$ 5,000
Common stock, no par value	$ 0	$ 0	$ 0
Common stock, shares authorized, unlimited [Fixed List]	Unlimited	Unlimited	Unlimited
Common stock, shares issued	129,531,207	119,573,998	110,346,346
Common stock, shares outstanding	129,531,207	119,573,998	110,346,346

Unaudited Interim Condensed C_3

Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenues, net of discounts	$ 224,092	$ 136,274	$ 633,037	$ 353,096	$ 521,533	$ 252,819	$ 102,817
Cost of goods sold	70,147	34,097	199,345	86,557	135,116	60,982	22,385
Gross profit	153,945	102,177	433,692	266,539	386,418	191,837	80,431
Expenses:
Sales and marketing	51,724	30,890	142,858	80,764	119,395	59,349	25,050
General and administrative	28,218	8,502	55,869	22,696	36,056	14,071	19,156
Depreciation and amortization	7,728	3,314	19,829	8,612	12,600	5,079	1,138
Total expenses	87,670	42,706	218,556	112,072	168,051	78,499	45,344
Income from operations	66,275	59,471	215,136	154,467	218,367	113,338	35,088
Other income (expense):
Interest expense, net	(6,145)	(5,352)	(20,693)	(16,566)	(20,237)	(9,050)	(2,103)
Other (expense) income, net	89	(10,756)	385	(10,827)	(40,680)	(607)	60
Total other expense	(6,056)	(16,108)	(20,308)	(27,393)	(60,917)	(9,658)	(2,044)
Income before provision for income taxes	60,219	43,363	194,828	127,074	157,450	103,680	33,044
Provision for income taxes	41,603	25,948	105,254	67,116	94,451	50,586	22,151
Net income and comprehensive income	$ 18,616	$ 17,415	$ 89,574	$ 59,958	$ 62,999	$ 53,094	$ 10,893
Basic net income per common share	$ 0.15	$ 0.16	$ 0.73	$ 0.54	$ 0.55	$ 0.48	$ 0.11
Diluted net income per common share	$ 0.14	$ 0.15	$ 0.68	$ 0.52	$ 0.53	$ 0.46	$ 0.11
Weighted average number of common shares used in computing net income per common share:
Basic	128,146,298	112,039,640	122,983,729	111,824,816	113,572,379	110,206,103	101,697,002
Diluted	136,909,266	117,949,224	130,927,083	115,998,704	118,325,724	115,317,942	103,201,127

Unaudited Interim Condensed C_4

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Previously Reported [Member]	PurePenn, LLC	Mountaineer Holding, LLC	Keystone Relief Centers LLC	Nature's Remedy of Massachusetts, Inc.	Solevo Wellness West Virginia, LLC	PCMV	Key Stone Shops [Member]	Super Voting Shares	Multiple Voting Shares	Subordinate Voting Shares	Subordinate Voting SharesPurePenn, LLC	Subordinate Voting SharesMountaineer Holding, LLC	Subordinate Voting SharesNature's Remedy of Massachusetts, Inc.	Subordinate Voting SharesSolevo Wellness West Virginia, LLC	Subordinate Voting SharesPCMV	Subordinate Voting SharesKey Stone Shops [Member]	Common Shares	Common SharesPurePenn, LLC	Common SharesMountaineer Holding, LLC	Common SharesNature's Remedy of Massachusetts, Inc.	Common SharesSolevo Wellness West Virginia, LLC	Common SharesPCMV	Common SharesKey Stone Shops [Member]	Additional Paid-in-Capital	Additional Paid-in-CapitalPreviously Reported [Member]	Additional Paid-in-CapitalPurePenn, LLC	Additional Paid-in-CapitalMountaineer Holding, LLC	Additional Paid-in-CapitalKeystone Relief Centers LLC	Additional Paid-in-CapitalNature's Remedy of Massachusetts, Inc.	Additional Paid-in-CapitalSolevo Wellness West Virginia, LLC	Additional Paid-in-CapitalPCMV	Additional Paid-in-CapitalKey Stone Shops [Member]	Warrants	Accumulated Earnings
Beginning Balance at Dec. 31, 2017	$ 4,160																									$ 11,456									$ 0	$ (7,296)
Beginning Balance (in shares) at Dec. 31, 2017										85,246,600	13,436,800	0							98,683,400
Share-based compensation	15,020																									15,020
Shares issued for cash - warrant exercise	1,489																									1,489
Shares issued for cash - warrant exercise (in shares)												321,268							321,268
Conversion of warrants to Subordinate Voting Shares	200
Issuance of Common Stock as Debt Discount	200																									200
Additional Contribution from the Issuance of Below Market Interest Debt	46																									46
Issuance of Shares Subscription Receipt Offering, Net	45,948																									45,948
Issuance of Shares Subscription Receipt Offering, Net (in shares)											3,573,450	7,354,050							10,927,500
Broker Warrants Issued in Reverse Takeover Transaction	1,519																									1,519
Net Consideration Provided in Reverse Takeover Transaction	(460)																									(460)
Net Consideration Provided in Reverse Takeover Transaction (in shares)												200,000							200,000
Conversions of Super and Multiple Voting Shares to Subordinate Voting Shares (in shares)											(3,259,799)	3,259,799
Net income and comprehensive income	10,893																																			10,893
Ending Balance at Dec. 31, 2018	78,814																									75,218									0	3,596
Ending Balance (in shares) at Dec. 31, 2018										85,246,600	13,750,451	11,135,117							110,132,168
Shares issued for cash - warrant exercise	964																									964
Shares issued for cash - warrant exercise (in shares)												214,178							214,178
Additional Contribution from the Issuance of Below Market Interest Debt	10																									10
Conversions of Super and Multiple Voting Shares to Subordinate Voting Shares (in shares)										(17,433,300)	(7,089,077)	24,522,377
Net income and comprehensive income	53,094																																			53,094
Ending Balance at Dec. 31, 2019	132,883																									76,192									0	56,691
Ending Balance (in shares) at Dec. 31, 2019										67,813,300	6,661,374	35,871,672							110,346,346
Share-based compensation	1,222																									1,222
Net income and comprehensive income	23,605																																			23,605
Ending Balance at Mar. 31, 2020	157,710																									77,414										80,296
Ending Balance (in shares) at Mar. 31, 2020										67,813,300	6,661,374	35,871,672							110,346,346
Beginning Balance at Dec. 31, 2019	132,883																									76,192									0	56,691
Beginning Balance (in shares) at Dec. 31, 2019										67,813,300	6,661,374	35,871,672							110,346,346
Net income and comprehensive income	59,958
Ending Balance at Sep. 30, 2020	289,735																									173,086										116,649
Ending Balance (in shares) at Sep. 30, 2020										58,182,500	1,476,959	58,134,478							117,793,937
Beginning Balance at Dec. 31, 2019	132,883																									76,192									0	56,691
Beginning Balance (in shares) at Dec. 31, 2019										67,813,300	6,661,374	35,871,672							110,346,346
Share-based compensation	2,765																									2,765
Shares issued for cash - warrant exercise	11,459																									11,459
Shares issued for cash - warrant exercise (in shares)												2,723,411							2,723,411
Contingent consideration payable in shares	65,000																									65,000
Shares issued for acquisition			$ 37,000																									$ 37,000
Shares issued for acquisition (in shares)													1,780,061							1,780,061
Conversion of Multiple Voting to Subordinate Voting Shares										(9,630,800)	(5,222,337)	14,853,137
Reclassification of Warrants to Equity	$ 52,570																																		52,570
Exercise of Stock Options (in shares)	9,180											9,180							9,180
Issuance of Shares in Private Placement, Net of Issuance Costs (in shares)												4,715,000							4,715,000
Issuance of Shares in Private Placement, Net of Issuance Costs	$ 83,228																									83,228
Net income and comprehensive income	62,999																																			62,999
Ending Balance at Dec. 31, 2020	447,904																									328,214	$ 275,644								52,570	119,690
Ending Balance (in shares) at Dec. 31, 2020										58,182,500	1,439,037	59,952,461							119,573,998
Beginning Balance at Mar. 31, 2020	157,710																									77,414										80,296
Beginning Balance (in shares) at Mar. 31, 2020										67,813,300	6,661,374	35,871,672							110,346,346
Share-based compensation	462																									462
Shares issued for cash - warrant exercise	11,458																									11,458
Shares issued for cash - warrant exercise (in shares)												2,723,311							2,723,311
Net income and comprehensive income	18,938																																			18,938
Ending Balance at Jun. 30, 2020	188,568																									89,334										99,234
Ending Balance (in shares) at Jun. 30, 2020										67,813,300	6,661,374	38,594,983							113,069,657
Share-based compensation	523																									523
Shares issued for cash - warrant exercise	1																									1
Shares issued for cash - warrant exercise (in shares)												100							100
Conversion of Super Voting Shares to Subordinate Voting Shares (in shares)											(5,184,415)	5,184,415
Conversions of Super and Multiple Voting Shares to Subordinate Voting Shares (in shares)										(9,630,800)		9,630,800
Exercise of Stock Options (in shares)												9,180							9,180
Issuance of Shares in Private Placement, Net of Issuance Costs (in shares)												4,715,000							4,715,000
Issuance of Shares in Private Placement, Net of Issuance Costs	83,228																									83,228
Net income and comprehensive income	17,415																																			17,415
Ending Balance at Sep. 30, 2020	289,735																									173,086										116,649
Ending Balance (in shares) at Sep. 30, 2020										58,182,500	1,476,959	58,134,478							117,793,937
Beginning Balance at Dec. 31, 2020	447,904																									328,214	275,644								52,570	119,690
Beginning Balance (in shares) at Dec. 31, 2020										58,182,500	1,439,037	59,952,461							119,573,998
Share-based compensation	741																									741
Shares issued for cash - warrant exercise	6,861																									6,861
Shares issued for cash - warrant exercise (in shares)												469,133							469,133
Conversion of warrants to subordinate voting shares (in shares)												133,408							133,408
Conversion of Multiple Voting to Subordinate Voting Shares											(117,668)	117,668
Conversion of Super Voting Shares to Subordinate Voting Shares (in shares)										(3,021,100)		3,021,100
Conversion of Super Voting Shares to Multiple Voting Shares (in shares)										(55,161,400)	55,161,400
Net income and comprehensive income	30,078																																			30,078
Ending Balance at Mar. 31, 2021	485,584																									335,816										149,768
Ending Balance (in shares) at Mar. 31, 2021											56,482,769	63,693,770							120,176,539
Beginning Balance at Dec. 31, 2020	$ 447,904																									328,214	$ 275,644								$ 52,570	119,690
Beginning Balance (in shares) at Dec. 31, 2020										58,182,500	1,439,037	59,952,461							119,573,998
Exercise of Stock Options (in shares)	36,787
Net income and comprehensive income	$ 89,574
Ending Balance at Sep. 30, 2021	822,643																									613,379										209,264
Ending Balance (in shares) at Sep. 30, 2021											54,919,596	74,611,611							129,531,207
Beginning Balance at Mar. 31, 2021	485,584																									335,816										149,768
Beginning Balance (in shares) at Mar. 31, 2021											56,482,769	63,693,770							120,176,539
Share-based compensation	744																									744
Shares issued for cash - warrant exercise	811																									811
Shares issued for cash - warrant exercise (in shares)												100,400							100,400
Common stock issued upon cashless warrant exercise (in shares)												661,614							661,614
Tax withholding related to net share settlement of equity awards	(595)																									(595)
Tax withholding related to net share settlement of equity awards (in shares)												(15,734)							(15,734)
Issuance of shares in offering, net of issuance costs	217,896																									217,896
Issuance of shares in offering, net of issuance costs (in shares)												5,750,000							5,750,000
Contingent consideration payable in shares	(2,800)																									(2,800)
Adjustment of fair value of equity consideration			$ 2,711		$ 1,004																							$ 2,711		$ 1,004
Shares issued for acquisition				$ 2,470		$ 9,140	$ 445																						$ 2,470		$ 9,140	$ 445
Shares issued for acquisition (in shares)														60,342	237,881	11,658					60,342	237,881	11,658
Conversion of warrants to Subordinate Voting Shares																																				0
Conversion of warrants to subordinate voting shares (in shares)											(21,673)	21,673
Net income and comprehensive income	40,880																																			40,880
Ending Balance at Jun. 30, 2021	758,290	$ 756,235																								567,642										190,648
Ending Balance (in shares) at Jun. 30, 2021											56,461,096	70,521,604							126,982,700
Share-based compensation	732																									732
Common stock issued upon cashless warrant exercise (in shares)												1,280,965							1,280,965
Tax withholding related to net share settlement of equity awards	(392)																									(392)
Tax withholding related to net share settlement of equity awards (in shares)												(21,151)							(21,151)
Shares issued for acquisition								$ 10,012	$ 35,385																								$ 10,012	$ 35,385
Shares issued for acquisition (in shares)																	258,383	1,009,336						258,383	1,009,336
Conversions of Super and Multiple Voting Shares to Subordinate Voting Shares (in shares)											(1,541,500)	1,541,500
Exercise of Stock Options (in shares)												20,974							20,974
Net income and comprehensive income	18,616																																			18,616
Ending Balance at Sep. 30, 2021	$ 822,643																									$ 613,379										$ 209,264
Ending Balance (in shares) at Sep. 30, 2021											54,919,596	74,611,611							129,531,207

Unaudited Interim Condensed C_5

Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flow from operating activities
Net income and comprehensive income	$ 89,574	$ 59,958	$ 62,999	$ 53,094	$ 10,893
Adjustments to reconcile net income and comprehensive income to net cash provided by operating activities:
Depreciation and amortization	19,829	8,612	12,600	5,079	1,138
Depreciation and amortization included in cost of goods sold	14,396	7,424	11,542	7,992	1,968
Non-cash interest expense	2,313	2,142	2,889	849
Loss from Sale of Property and Equipment	(5)	63	63	67	46
Amortization of operating lease right of use assets	3,216	2,383	6,045	2,733
Share-based compensation	2,217	2,208	2,765		15,020
Accretion of construction finance liability	1,097	617
Loss on fair value of warrants		12,782	42,679	806
Deferred income tax expense	(2,111)	(2,324)	(4,887)	(908)	(546)
Changes in operating assets and liabilities:
Inventories	(33,796)	(11,687)	(22,534)	(54,481)	(18,751)
Accounts receivable	(8,179)		1,109
Prepaid expenses and other current assets	(9,412)	(6,915)	(11,670)	(5,224)	(2,271)
Other assets	(4,509)	(5,790)	(2,517)	147	(1,096)
Income tax payable / receivable	(12,745)	1,911	(2,452)	(6,735)	13,926
Accounts payable and accrued liabilities	17,853	1,303	1,002	13,587	1,056
Operating lease liabilities	(1,906)	(2,054)	(4,764)	(2,825)
Deferred revenue	(3,096)	2,207	4,774	977	1,412
Other long-term liabilities	344			3,915	723
Net cash provided by operating activities	75,080	72,840	99,643	19,073	23,517
Cash flow from investing activities
Purchases of property and equipment	(190,907)	(61,359)	(99,941)	(71,834)	(42,561)
Purchases of property and equipment related to construction finance liability	(8,877)	(27,381)
Purchases of Property and Equipment from Construction			(41,116)	(2,571)
Cash paid for internal use software	(3,587)		(887)
Acquisitions, net of cash acquired	(29,924)		(27,923)	(19,825)	(7,644)
Capitalized interest	(4,355)	(2,090)	(4,803)	(471)	(980)
Proceeds from Sale of Property and Equipment	8	16	16	29	129
Net cash used in investing activities	(237,642)	(90,814)	(174,654)	(94,673)	(51,055)
Cash flow from financing activities
Proceeds from Issuance of Notes Payable					6,040
Proceeds from Issuance of Notes Payable—Related Party					11,357
Proceeds from Debt Financings, Net of Discounts and Accrued Interest				122,215
Proceeds from share warrant exercise	7,672	11,459	11,459	964	1,289
Proceeds from construction finance liability	8,877	28,582	41,116	23,071
Payments on Construction Finance Liability			(4,951)	(115)
Payments on Issuance of Shares for Reverse Transaction					(460)
Payments on Notes Payable					(6,000)
Proceeds from shares issued pursuant to private placement	217,896	83,228	83,228		47,467
Payments on finance lease obligations	(4,024)	(2,824)		(1,633)	(454)
Payments on notes payable - related party	(11)	(907)	(941)	(1,520)	(8,677)
Payments for taxes related to net share settlement of equity awards	(987)
Net cash provided by financing activities	229,423	119,538	129,911	142,982	50,561
Net increase in cash and cash equivalents	66,861	101,564	54,900	67,383	23,023
Cash and cash equivalents, beginning of period	146,713	91,813	91,813	24,430	1,407
Cash and cash equivalents, end of period	213,574	193,377	146,713	91,813	24,430
Supplemental disclosure of cash flow information
Interest	22,653	12,798	22,135	7,417	2,948
Income taxes	120,365	70,996	105,248	43,658	8,195
Other noncash investing and financing activities
Shares Issued for PurePenn and Solevo Acquisition	57,452		37,000
Shares Reserved for PurePenn and Solevo Acquisition			65,000
Purchase of Property and Equipment Financed with Notes Payable - Related Party				257	3,095
Adjustment to PurePenn, LLC and Keystone Relief Centers, LLC contingent consideration	2,800
ASC 842 lease additions - operating and finance leases	43,748	23,096
Shares issued for acquisitions	57,452		37,000
Purchase of property and equipment financed with accounts payable	$ 16,148	$ 7,167	13,613	6,516	4,697
Property and Equipment Acquired via Finance Leases			$ 24,165	19,883	1,406
Transfer of Shares Treated as a Debt Discount					200
Debt Discount related to Below Market Interest Debt				$ 10	$ 46

The Company

The Company	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
The Company	NOTE 1. THE COMPANY Trulieve Cannabis Corp. (together with its subsidiaries, “Trulieve” or the “Company”) was incorporated in British Columbia, Canada. Trulieve (through its wholly-owned subsidiaries) is a vertically integrated cannabis company which, as of September 30, 2021, held licenses to operate in Florida, Massachusetts, California, Connecticut, Pennsylvania and West Virginia, to cultivate, produce, and sell medicinal-use adult-use adult-use In July 2018, Trulieve, Inc. entered into a non-binding The Company’s head office is located Tallahassee, Florida. The Company’s registered office is located in British Columbia. The Company is listed on the Canadian Securities Exchange (the “CSE”) and began trading on September 24, 2018 under the ticker symbol “TRUL”, and trades on the OTCQX market under the symbol “TCNNF”.	1. NATURE OF OPERATIONS Trulieve Cannabis Corp. (“Trulieve” or the “Company”) together with its subsidiaries was incorporated in British Columbia, Canada. Trulieve (through its wholly-owned licensed subsidiary, Trulieve, Inc.) is a vertically integrated cannabis company which currently operates under licenses in six states Florida, Massachusetts, California, Connecticut and Pennsylvania to cultivate, produce, and sell medicinal-use In July 2018, Trulieve, Inc. entered into a non-binding See “Note 3—Acquisitions” th The Company’s head office and principal address is located at 6749 Ben Bostic Road, Quincy, Florida 32351.The Company’s registered office is located at Suite 2800, Park Place, 666 Burrard Street, Vancouver, British Columbia, V6C 2Z7. The Company is listed on the Canadian Securities Exchange (the “CSE”) and began trading on September 24, 2018 under the ticker symbol “TRUL”.

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	NOTE 2. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP” or “GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, comprehensive income, statement of shareholders’ equity, and cash flows of the Company for the interim periods presented. Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the current year ending December 31, 2021. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2020 and 2019 (“2020 audited consolidated financial statements”). The preparation of these unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q. Revision of Previously Issued Financial Statements During the quarter ended September 30, 2021, the Company identified an error in its accounting for leases which was due to the lack of a complete lease population and the conclusions reached for the commencement date for leases not aligning with the possession date of the associated right of use asset. This resulted in an understatement of the associated right of use assets and the associated lease liabilities. The Company also identified a misstatement related to the accounting for asset acquisitions that were consummated during the three months ended June 30, 2021, which was due to the Company initially valuing the equity consideration transferred using the contract value whereas the fair value as of the closing date should have been used. This resulted in an understatement of intangible assets, an understatement of the associated deferred tax liabilities and an understatement of additional paid-in-capital. To correct the immaterial misstatements, during the quarter ended September 30, 2021, the Company elected to revise its previously issued interim unaudited condensed consolidated balance sheet as of June 30, 2021 and March 31, 2021 as well as the previously issued 2020 condensed consolidated balance sheet. The revision of the historical interim unaudited condensed consolidated balance sheet includes the correction of these immaterial misstatements as well as other previously identified balance sheet misclassifications. Accordingly, the accompanying interim unaudited condensed consolidated balance sheet and relevant footnotes in this Quarterly Report on Form 10-Q 10-Q. The The impact of the revision on the Company’s interim unaudited condensed consolidated balance sheet as of June 30, 2021 is reflected in the following table: Balance Sheet as of June 30, 2021 (unaudited) As Previously Adjustment As Revised Prepaid expenses and other current assets $ 28,313 $ (4,249 ) $ 24,064 Total current assets 442,090 (4,249 ) 437,841 Property and equipment, net 427,666 258 427,924 Right of use assets—operating, net 31,254 8,768 40,022 Right of use assets—finance, net 41,521 6,371 47,892 Intangible assets, net 123,106 (621 ) 122,485 Other assets 9,547 4,246 13,793 Total assets 1,146,307 14,773 1,161,080 Operating lease liabilities, current portion 3,583 432 4,015 Finance lease liabilities, current portion 4,723 281 5,004 Total current liabilities 76,738 713 77,451 Operating lease liabilities 29,381 8,396 37,777 Finance lease liabilities 39,694 5,822 45,516 Deferred tax liability 29,845 (2,213 ) 27,632 Total liabilities 390,072 12,718 402,790 Additional paid-in-capital 522,898 2,055 524,953 Total shareholders equity $ 756,235 $ 2,055 $ 758,290 Balance Sheet as of March 31, 2021 (unaudited) As Previously Adjustment As Revised Prepaid expenses and other current assets $ 25,180 $ (3,728 ) $ 21,452 Total current assets 294,157 (3,728 ) 290,429 Right of use assets—operating, net 30,051 2,830 32,881 Right of use assets—finance, net 38,380 1,838 40,218 Other assets 7,549 3,693 11,242 Total assets 897,455 4,633 902,088 Operating lease liabilities, current portion 3,324 173 3,497 Finance lease liabilities, current portion 4,344 70 4,414 Total current liabilities 100,900 243 101,143 Operating lease liabilities 28,326 2,581 30,907 Finance lease liabilities 36,294 1,809 38,103 Total liabilities $ 411,871 $ 4,633 $ 416,504 Balance Sheet as of December 31, 2020 As Previously Adjustment As Revised Prepaid expenses and other current assets $ 19,815 $ (3,696 ) $ 16,119 Total current assets 265,148 (3,696 ) 261,452 Right of use assets—operating, net 28,171 1,905 30,076 Other assets 3,944 3,584 7,528 Total assets 816,112 1,793 817,905 Operating lease liabilities, current portion 3,154 123 3,277 Total current liabilities 75,998 123 76,121 Operating lease liabilities 26,450 1,670 28,120 Total liabilities $ 368,208 $ 1,793 $ 370,001 The Company recorded operating lease expense, depreciation, and interest expense totaling $0.3 million in the income statement for the three months ended September 30, 2021 that related to these expenses from prior periods. This had . Significant Accounting Policies The Company’s significant accounting policies are described in Note 2 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K 10-K”). 2019-12 In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes 2019-12 ASU 2019-12 COVID-19 The global outbreak of the novel strain of the coronavirus known as COVID-19 non-essential shelters-in-place COVID-19, COVID-19

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (a) Basis of Presentation The accompanying consolidated financial statements present the consolidated financial position and operations of Trulieve Cannabis Corp. and its subsidiaries as of and for the years ended December 31, 2020 and 2019 (the “consolidated financial statements”) in accordance with accounting principles generally accepted in the United States of America (“GAAP”). (b) Functional Currency The functional currency of the Company and its subsidiaries, as determined by management, is the United States (“U.S.”) dollar. These consolidated financial statements are presented in U.S. dollars. (c) Basis of Consolidation These consolidated financial statements include the financial information of the Company and its subsidiaries, Trulieve, Inc., Life Essence, Inc., Leef Industries, LLC, Trulieve Bristol, Inc. “Healing Corner”, PurePenn LLC, and Keystone Relief Centers “Solevo”. The accounts of the subsidiaries are prepared for the same reporting period using consistent accounting policies. All of the consolidated entities were under common control during the entirety of the periods for which their respective results of operations were included in the consolidated financial statements (i.e., from the date of their acquisition). See “Note 3—Acquisitions” (d) Cash and Cash Equivalents The Company considers cash deposits and all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include cash deposits in financial institutions plus cash held at retail locations. Cash held in money market investments are carried at fair value, cash held in financial institutions and cash held at retail locations, have carrying values that approximate fair value. (e) Inventory Inventories are primarily comprised of raw materials, internally produced work in process, finished goods and packaging materials. Costs incurred during the growing and production process are capitalized as incurred to the extent that cost is less than net realizable value. These costs include materials, labor and manufacturing overhead used in the growing and production processes. The Company capitalizes pre-harvest Inventories of purchased finished goods and packing materials are initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion, disposal and transportation for inventories in process. The Company periodically reviews its inventory and identifies that which is excess, slow moving and obsolete by considering factors such as inventory levels, expected product life and forecasted sales demand. Any identified excess, slow moving and obsolete inventory is written down to its net realizable value through a charge to cost of goods sold. The Company did not recognize any inventory reserves as of December 31, 2020 and 2019. (f) Property and Equipment Property and equipment are measured at cost less accumulated depreciation and impairment losses. Depreciation is recognized on a straight-line basis over the following terms: Land Not Depreciated Buildings & Improvements 7 to 40 Years Furniture & Equipment 3 to 10 Years Vehicles 3 to 5 Years Construction in Progress Not Depreciated Leasehold Improvements The lesser of the life of the lease or the estimated useful life of the asset An asset’s residual value, useful life and depreciation method are reviewed during each financial year and adjusted if appropriate. Property and equipment, as well as right-of-use An impairment charge is recorded for the excess of the asset’s carrying value over its fair value, if any. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. The Company did not record any impairment charges on these long-lived assets during the years ended December 31, 2020 and 2019. Gains or losses on disposal of an item are determined by comparing the proceeds from disposal with the carrying amount of the item and recognized in the statement of operations and comprehensive income. Construction in progress is transferred when available f o The Company capitalizes interest on debt financing invested in projects under construction. Upon the asset becoming available for use, capitalized interest costs, as a portion of the total cost of the asset, are depreciated over the estimated useful life of the related asset. (g) Intangible Assets Intangible assets are recorded at cost, less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Intangible assets that have indefinite useful lives are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. The estimated useful lives, residual values and amortization methods are reviewed at each year-end, Intangible assets are amortized using the straight-line method over estimated useful lives as follows: Dispensary License 15 Tradenames 2 to 10 Customer Relationship 5 Years Moxie Brand 3 Years Non-Compete 2 Years Trademarks 6 months to 1 Year (h) Goodwill Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill is either assigned to a specific reporting unit or allocated between reporting units based on the relative fair value of each reporting unit. Goodwill is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. The Company reviews indefinite lived assets, including goodwill, annually at fiscal year-end The Company assesses the fair values of its intangible assets, and its reporting unit for goodwill testing purposes, as necessary, using an income-based approach. Under the income approach, fair value is based on the present value of estimated future cash flows. The Company operates as one operating segment and reporting unit and therefore, evaluates goodwill and other intangible assets with indefinite lives for impairment annually as one singular reporting unit once a year or more often when an event occurs or circumstances indicate the carrying value may not be recoverable The Company’s policy is to first perform a qualitative assessment to determine if it was more-likely-than-not that The Company did not identify any impairment of its goodwill at December 31, 2020 and 2019. (i) Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consist of: Year Ended December 31, 2020 2019 (dollars in thousands) Trade Accounts Payable $ 9,247 $ 9,954 Trade Accounts Payable—Related Party 10,403 6,463 Accrued Payroll 11,030 5,822 Other Payables and Accrued Liabilities 11,222 2,069 Total Accounts Payable and Accrued Liabilities $ 41,902 $ 24,308 (j) Leases In February 2016, the FASB issued ASU 2016-02, Leases (ASC The new standard was effective for the Company beginning January 1, 2019 and the standard was adopted using the modified retrospective transition approach, which allows the Company to recognize a cumulative effect adjustment to the opening balance of accumulated earnings in the period of adoption rather than restate comparative prior year periods. The cumulative effect adjustment to the opening balance of accumulated earnings is zero because (i) the Company does not have any unamortized initial direct costs as of January 1, 2019 that need to be written off; and (ii) the Company does not have any deferred gain or loss from our previous sale and operating leaseback transactions that need to be recognized. See “ Note 10—Leases (k) Revenue Recognition Revenue is recognized by the Company in accordance with ASU 2014-09, Revenue In order to recognize revenue under ASU 2014-09, the • Identify a customer along with a corresponding contract; • Identify the performance obligation(s) in the contract to transfer goods or provide distinct services to a customer; • Determine the transaction price the Company expects to be entitled to in exchange for transferring promised goods or services to a customer; • Allocate the transaction price to the performance obligation(s) in the contract; and • Recognize revenue when or as the Company satisfies the performance obligation(s). The Company’s contracts with customers for the sale of dried cannabis, cannabis oil and other cannabis related products consist of multiple performance obligations. Revenue from the direct sale of cannabis to customers for a fixed price is recognized when the Company transfers control of the goods to the customer at the point of sale and the customer has paid for the goods. The Company has a loyalty rewards program that allows customers to earn reward credits to be used on future purchases. Loyalty reward credit issued as part of a sales transaction results in revenue being deferred until the loyalty reward is redeemed by the customer. The loyalty rewards are shown as reductions to ‘revenue, net of discounts’ line on the accompanying consolidated statements of operations and comprehensive income and included as deferred revenue on the consolidated balance sheet. Contract assets are defined in the standard to include amounts that represent the right to receive payment for goods and services that have been transferred to the customer with rights conditional upon something other than the passage of time. Contract liabilities are defined in the standard to include amounts that reflect obligations to provide goods and services for which payment has been received. There are no contract assets on unsatisfied performance obligations as of December 31, 2020 and 2019. For some of its locations, the Company offers a loyalty reward program to its dispensary customers. A portion of the revenue generated in a sale must be allocated to the loyalty points earned. The amount allocated to the points earned is deferred until the loyalty points are redeemed or expire. As of December 31, 2020 and 2019, the loyalty liability totaled $5.3 million and $2.4 million, respectively, that is included in deferred revenue on the consolidated balance sheet. (l) Income Taxes The Company uses the asset and liability method to account for income taxes. Deferred income tax assets and liabilities are determined based on enacted tax rates and laws for the years in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As the Company operates in the cannabis industry, it is subject to the limits of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production. The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not (m) Financial Instruments The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk. Classification of financial instruments The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices in active markets, that are observable for the asset or liability, either directly or indirectly; and Level 3 – Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions. (n) Warrant Liability The Company has issued subordinate voting share purchase warrants for the June and November debt, see “Note 9—Debt”. The June and November Warrants related to the June and November debt are governed by a warrant indenture date June 18, 2019 as supplemented pursuant to a supplement dated November 7, 2019. Each Warrant entitled the holder thereof to purchase one Subordinate Voting Share at an exercise price of C$17.25 per share at any time prior to June 18, 2022, subject to adjustment in certain events. The Warrant indenture provides that the share ratio and exercise price of the Note Warrants will be subject to adjustment in the event of a subdivision or consolidation of the Subordinate Voting Shares. On December 10, 2020, the Company entered into a Supplemental Warrant Indenture with Odyssey Trust Company pursuant to which it amended the terms of the issued and outstanding subordinate voting share purchase warrants of the Company (the “Public Warrants”) to convert the exercise price of the Public Warrants to $13.47 per share, the U.S. dollar equivalent of the Canadian dollar exercise price of the Public Warrants of C$17.25. The U.S. dollar exercise price was determined using the U.S. dollar exchange rate published by the Bank of Canada at the close of business on December 9, 2020 of C$1.00 = $0.781. See “ Note 9—Debt (o) Share Capital Common shares are classified as equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the vesting periods are recorded as share capital. Incremental costs directly attributable to the issuance of shares are recognized as a deduction from equity. (p) Earnings Per Share The Company computes basic earnings attributable to common shareholders per share by dividing net income attributable to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted earnings per share attributable to shareholders gives effect to all potential dilutive shares outstanding during the period. The number of dilutive shares is calculated using the treasury stock method which reduces the effective number of shares by the amount of shares the Company could purchase with the proceeds of assumed exercises. (q) Advertising Costs Advertising costs which are expensed as incurred and are included in sales and marketing expenses were $2.1 million, $1.9 million and $0.3 million for the years ended December 31, 2020 2019, and 2018, respectively. (r) Net Income and Comprehensive Income The Company does not have any elements of other comprehensive income, therefore net income and comprehensive income are the same. (s) Critical accounting estimates and judgments The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. Significant judgments, estimates and assumptions that have the most significant effect on the amounts recognized in the consolidated financial statements are described below. Accounting for acquisitions and business combinations The Company has treated the acquisitions described in Note 3 (a) (b) and (c) The Company has treated the acquisitions described in Note 3 (d) and (e) Inventories The net realizable value of inventories represents the estimated selling price for inventories in the ordinary course of business, less all estimated costs of completion and costs necessary to make the sale. The determination of net realizable value requires significant judgment, including consideration of factors such as shrinkage, the aging of and future demand for inventory, expected future selling price, what we expect to realize by selling the inventory and the contractual arrangements with customers. Reserves for excess and obsolete inventory are based upon quantities on hand, projected volumes from demand forecasts and net realizable value. The estimates are judgmental in nature and are made at a point in time, using available information, expected business plans and expected market conditions. As a result, the actual amount received on sale could differ from the estimated value of inventory. Periodic reviews are performed on the inventory balance. The impact of changes in inventory reserves is reflected in cost of goods sold. Goodwill impairment Goodwill is tested for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of goodwill may have been impaired. In order to determine that the value of goodwill may have been impaired, the Company performs a qualitative assessment to determine that it was more-likely-than-not if Leases—(ASU 842) Leases requires lessees to discount lease payments using the rate implicit in the lease if that rate is readily available in accordance with ASU 842. If that rate cannot be readily determined, the lessee is required to use its incremental borrowing rate. The Company generally uses the incremental borrowing rate when initially recording real estate leases. Information from the lessor regarding the fair value of underlying assets and initial direct costs incurred by the lessor related to the leased assets is not available. The Company determines the incremental borrowing rate as the interest rate the Company would pay to borrow over a similar term the funds necessary to obtain an asset of a similar value to the right-of-use non-cancellable Estimated useful lives and depreciation and amortization of property and equipment and intangible assets Depreciation and amortization of property and equipment and intangible assets are dependent upon estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets. Share-based payment arrangements The Company uses the Black-Scholes pricing model to determine the fair value of warrants granted to employees and directors under share-based payment arrangements, where appropriate. In estimating fair value, management is required to make certain assumptions and estimates such as the expected life of units, volatility of the Company’s future share price, risk free rates, and future dividend yields at the initial grant date. Changes in assumptions used to estimate fair value could result in materially different results. The Company classified its stock warrants as either liability or equity instruments in accordance with ASC 480, “Distinguishing Liabilities from Equity” (ASC 480) and ASC 815, “Derivatives and Hedging” (ASC 815), depending on the specific terms of the warrant agreement. Because of the Canadian denominated exercise price, the June and November Warrants did not qualify to be classified within equity and were therefore classified as derivative liabilities at fair value with changes to earnings in the statements of operations. On December 10, 2020, the Company amended the terms of the Warrants to convert the exercise price of the Warrants to U.S. Dollar which were then classified as equity on the consolidated Balance Sheet. The fair value of all warrants issued are determined by using the Black-Scholes valuation technique and were assigned based on the relative fair value of both the debt and the warrants issued. (t) Recently Issued Accounting Pronouncements Recent accounting pronouncements, other than those below, issued by the FASB, the AICPA and the SEC did not or are not believed by management to have a material effect on the Company’s present or future financial statements. In February 2016, the FASB issued ASU No. 2016-02, Note 10—Leases In June 2016, the FASB issued ASU 2016-13, 2016-13 ASU 2016-13 will 2016-13 In August 2018, the FASB issued ASU 2018-13, 2018-13 2018-13 2018-13 In December 2019, the FASB issued ASU 2019-12, 2019-12 2019-12

Acquisitions

Acquisitions	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Business Combination and Asset Acquisition [Abstract]
Acquisitions	NOTE 3. ACQUISITIONS (a) Keystone Shops On July 8, 2021, the Company acquired 100% of the membership interests of Anna Holdings, LLC, the sole member of Chamounix Ventures, LLC which holds a permit to operate dispensaries under Keystone Shops (“Keystone Shops”) with locations in Philadelphia, Devon and King of Prussia, Pennsylvania. Total consideration was $55.6 million consisting of $20.3 million in cash, inclusive of net working capital adjustments, and 1,009,336 in Trulieve Subordinate Voting Shares (“Trulieve Shares”) with a fair value of $35.4 million. The agreement provides for an additional $5.0 million in consideration which is contingent on the enactment, adoption or approval of laws allowing for adult-use (dollars in thousands) Consideration: Cash $ 20,251 Shares issued upon acquisition 35,385 Fair value of consideration exchanged $ 55,636 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 500 Inventories 1,766 Prepaid expenses and other current assets 240 Property and equipment 1,144 Right of use asset—finance 1,340 Intangible assets Dispensary license 27,000 Tradename 100 Favorable leasehold interests, net 86 Goodwill 40,072 Other assets 40 Accounts payable and accrued liabilities (878 ) Income tax payable (2,892 ) Operating lease liabilities (1,340 ) Other long-term liabilities (2,179 ) Deferred tax liability (9,363 ) Total net assets acquired $ 55,636 The acquired intangible assets include a dispensary license which is treated as a definite-lived intangible asset amortized over a 15-year period (b) Patient Centric of Martha’s Vineyard On July 2, 2021, the Company acquired certain assets of Patient Centric of Martha’s Vineyard (“PCMV”) including the rights to a Provisional Marijuana Retailers License from the Massachusetts Cannabis Control Commission, the right to exercise an option held by PCMV to lease real property in Framingham, Massachusetts for use as a marijuana retailer, and necessary municipal entitlements to operate as a marijuana retailer at the property. Total consideration was 258,383 in Trulieve Shares, of which 10,879 are subject to a holdback for six months as security for any indemnity claims by the Company under the asset purchase agreement. The fair value of the equity exchange was $10.0 million. The Company analyzed the acquisition under ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, (dollars in thousands) Consideration: Shares issued upon acquisition $ 10,012 Transaction costs 18 Fair value of consideration exchanged $ 10,030 Recognized amounts of identifiable assets acquired and liabilities assumed: Right of use asset—finance $ 1,756 Intangible assets Dispensary license 13,298 Finance lease liabilities (2,321 ) Deferred tax liability (2,703 ) Total net assets acquired $ 10,030 The acquired intangible asset is represented by the adult-use 15-year (c) Nature’s Remedy of Massachusetts, Inc. On June 30, 2021, the Company completed an asset purchase agreement whereby Trulieve acquired a licensed, but not yet operating, adult-use 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, Note 2. Basis of Presentation Revisions of Previously Issued Financial Statements (dollars in thousands) Consideration: Cash $ 7,000 Shares issued upon acquisition 9,139 Transaction costs 23 Fair value of consideration exchanged $ 16,162 Recognized amounts of identifiable assets acquired and liabilities assumed: Prepaid expenses and other current assets $ 12 Property and equipment 1,006 Right of use asset—finance 799 Intangible assets Dispensary license 19,630 Accounts payable and accrued liabilities (335 ) Finance lease liability (594 ) Deferred tax liability (4,356 ) Total net assets acquired $ 16,162 The acquired intangible asset is represented by the adult-use 15 (d) Solevo Wellness West Virginia, LLC On June 8, 2021, the Company acquired 100% of the membership interests of Solevo Wellness West Virginia, LLC (“Solevo WV”) which holds three West Virginia dispensary licenses. The Company analyzed the acquisition under ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, 15-year Note 2. Basis of Presentation Revisions of Previously Issued Financial Statements (e) Mountaineer Holding, LLC On May 6, 2021, the Company acquired 100% of the membership interests of Mountaineer Holding LLC (“Mountaineer”) which holds a cultivation permit and two dispensary permits in West Virginia. The Company analyzed the acquisition under ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, 15-year Note 2. Basis of Presentation Revisions of Previously Issued Financial Statements (f) PurePenn, LLC and Pioneer Leasing & Consulting, LLC On November 12, 2020, the Company acquired 100% of the membership interests of both PurePenn, LLC, which holds a permit to cultivate and process medical marijuana in Pennsylvania, and Pioneer Leasing & Consulting, LLC (collectively “PurePenn”). The purpose of this acquisition was to operate the cultivation and manufacturing facility located in McKeesport, Pennsylvania. Trulieve acquired PurePenn for an upfront payment valued at $48.7 million, comprised of 1,298,964 in Trulieve Shares with a fair value of $29.7 million and $19.0 million in cash, plus a potential earn-out earn-out For the three months ended June 30, 2021, the Company recorded an adjustment to the initial valuation of shares issued upon acquisition, which increased the fair value of the consideration exchanged and the estimated purchase price by $2.7 million and increased goodwill by $2.7 million and we recorded an adjustment to the initial valuation of contingent consideration payable in shares, which reduced contingent consideration payable in shares and the estimated purchase price by $3.0 million and decreased goodwill by $3.0 million. For the three months ended September 30, 2021, the Company recorded an adjustment to the deferred tax liability decreasing goodwill and the associated deferred tax liability by $0.6 million. The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 19,000 Shares issued upon acquisition 29,711 Contingent consideration payable in shares 46,951 Fair value of consideration exchanged $ 95,662 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 563 Accounts receivable 1,300 Prepaid expenses and other current assets 376 Inventories 7,461 Property and equipment, net 26,233 Intangible assets, net: State license 45,310 Moxie license 2,960 Tradename 580 Goodwill 46,349 Other assets 478 Accounts payable and accrued liabilities (2,189 ) Construction finance liability (17,413 ) Deferred tax liability (16,346 ) Total net assets acquired $ 95,662 (g) Keystone Relief Centers, LLC On November 12, 2020, the Company acquired 100% of the membership interests of Keystone Relief Centers, LLC (referred to herein as “Solevo Wellness”), which holds a permit to operate three medical marijuana dispensaries in the Pittsburgh, Pennsylvania area. Trulieve acquired Solevo for an upfront purchase price of $21.0 million, comprised of $10.0 million in cash and 481,097 in Trulieve Shares with a fair value of $11.0 million, plus a potential earn-out earn-out September 30, 2021, total transaction costs related to the acquisition were approximately $0.9 million. Goodwill arose because the consideration paid for the business acquisition reflected the benefit of expected revenue growth and future market development. These benefits were not recognized separately from goodwill because they do not meet the recognition criteria for identifiable intangible assets. Goodwill is subject to the limits of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to the cost of production, therefore goodwill is not deductible. During 2021, the purchase price allocations were adjusted, primarily to net working capital, goodwill and intangible assets. For the three mo nths ended March 31, 2021, we recorded an adjustment of $3.8 million to the initial valuation amount of intangible assets for the dispensary license, increasing The following table summarizes the final allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 10,000 Shares issued upon acquisition 11,004 Contingent consideration payable in shares 15,249 Net working capital adjustment 624 Fair value of consideration exchanged $ 36,877 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 1,229 Accounts receivable 117 Prepaid expenses and other current assets 91 Inventories 2,337 Property and equipment, net 2,245 Right of use asset 2,156 Intangible assets, net: Dispensary license 19,890 Tradename 930 Goodwill 17,985 Accounts payable and accrued liabilities (790 ) Lease liability (2,156 ) Deferred tax liability (7,157 ) Total net assets acquired $ 36,877	3. ACQUISITIONS (a) PurePenn, LLC and Pioneer Leasing & Consulting, LLC On November 12, 2020, the Company acquired 100% of the membership interests of both PurePenn, LLC and Pioneer Leasing & Consulting, LLC (collectively “PurePenn”). The purpose of this acquisition was to acquire the cultivation and manufacturing facility located in McKeesport, Pennsylvania. Trulieve acquired PurePenn for an upfront payment of $46 million, comprised of $27 million or 1,780,061 in Trulieve subordinate voting shares (“Trulieve Shares”) and $19 million in cash, plus a potential earn-out payment earn-out The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 19,000 Shares issued upon issuance 27,000 Contingent consideration payable in shares 50,000 Fair value of consideration exchanged $ 96,000 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 563 Accounts receivable 1,300 Prepaids and other current assets 376 Inventory 7,461 Property and equipment, net 26,233 Intangible assets: Tradename 580 Moxie license 2,960 State license 45,310 Goodwill 47,311 Other assets 478 Accounts payable and accrued expenses (2,189 ) Construction liability (17,413 ) Deferred tax liability (16,970 ) Total net assets acquired 96,000 (b) Keystone Relief Centers, LLC On November 12, 2020, the Company acquired 100% of the membership interests of Keystone Relief Centers, LLC (referred to herein as “Solevo Wellness”). The purpose of this acquisition was to acquire the licenses to operate three medical marijuana dispensaries in the Pittsburgh, Pennsylvania area. Trulieve acquired Solevo for an upfront purchase price of $20 million, comprised of $10 million in cash and $10 million or 481,097 in Trulieve Shares, plus a potential earn-out payment earn-out The preliminary valuation was based on Management’s estimates and assumptions which are subject to change within the purchase price allocation period (generally one year from the acquisition date). The primary areas of the purchase price allocation that are not yet finalized relate to the valuation of the tangible and intangible assets acquired and the residual goodwill. The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 10,000 Shares issued upon issuance 10,000 Contingent consideration payable in shares 15,000 Net working capital adjustment 715 Fair value of consideration exchanged $ 35,715 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 1,229 Accounts receivable 117 Prepaids and other current assets 91 Inventory 2,337 Property and equipment, net 2,245 Right of use asset 2,156 Intangible assets: Dispensary License 16,090 Tradename 930 Goodwill 19,473 Accounts payable and accrued expenses (790 ) Lease liability (2,156 ) Deferred tax liability (6,007 ) Total net assets acquired $ 35,715 The consolidated unaudited proforma revenue and net income, which includes our acquisition of PurePenn and Solevo Wellness, assuming the acquisition occurred on January 1, 2020 through December 31, 2020 were approximately $575.2 million and $75.7 million. Financial information is not available for the years ended December 31, 2019 and 2018. (c) The Healing Corner, Inc. On May 21, 2019, the Company acquired all of the issued and outstanding shares of The Healing Corner, Inc. The purpose of this acquisition was to acquire the medical marijuana license in the State of Connecticut. The acquisition was financed with cash on hand and borrowings. The acquisition was accounted for as a business combination in accordance with Accounting Standards Codification (ASC) 805, Business Combinations, and related operating results are included in the accompanying consolidated statements of operations and comprehensive income, changes in shareholders’ equity, and statements of cash flows for periods subsequent to the acquisition date. Total transaction costs related to the acquisition were approximately $0.3 million and has been included in the year ended December 31, 2019 consolidated statements of operations and comprehensive income. Goodwill arose because the consideration paid for the business acquisition reflected the benefit of expected revenue growth and future market development. These benefits were not recognized separately from goodwill because they do not meet the recognition criteria for identifiable intangible assets. Goodwill is subject to the limits of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to the cost of production. The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 19,900 Fair value of consideration exchanged $ 19,900 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 2 Inventory 73 Prepaids 4 Property and equipment, net 203 Intangible assets: Dispensary License 14,300 Trademark 321 Customer Relationship 1,000 Non-Compete 35 Goodwill 7,316 Accrued expenses (4 ) Deferred tax liability (3,350 ) Total net assets acquired $ 19,900 (d) Life Essence, Inc. On December 13, 2018, the Company acquired all of the issued and outstanding shares of Life Essence, Inc. The purpose of this acquisition was to acquire the licenses to operate three medical marijuana dispensaries and a marijuana cultivation and processing facility. The acquisition was financed with cash on hand. The Company determined that the net assets acquired did not meet the definition of a business in accordance with ASC 805, Business Combinations, and was therefore accounted for as an asset acquisition. Operating results of the acquired entity are included in the accompanying consolidated statement of operations and comprehensive income, changes in shareholders’ equity, and cash flows for periods subsequent to the acquisition date. The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 4,125 Transaction costs 270 Fair value of consideration exchanged $ 4,395 Recognized amounts of identifiable assets acquired and liabilities assumed: Intangible asset—dispensary license $ 6,144 Accrued expenses (121 ) Deferred tax liability (1,628 ) Total net assets acquired $ 4,395 (e) Leef Industries, LLC On November 30, 2018, the Company acquired 80% of the issued and outstanding membership interests of Leef Industries, LLC. Payment for 19% occurred in 2019 and payment for the remaining 1% was made in 2020. The purpose of this acquisition was to acquire the recreational marijuana license. The Company deterred that the net assets acquired did not meet the definition of a business in accordance with ASC 805, Business Combinations, and was therefore accounted for as an asset acquisition. Operating results of the acquired entity are included in the accompanying consolidated statement of operations and comprehensive income, changes in shareholders’ equity, and cash flows for periods subsequent to the acquisition date. The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 3,250 Balance of Purchase Price Payable 750 Transaction costs 25 Fair value of consideration exchanged $ 4,025 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 7 Inventory 19 Property and equipment, net 8 Intangible assets: Dispensary License 5,470 Tradename 10 Accrued expenses (38 ) Deferred tax liability (1,452 ) Total net assets acquired $ 4,025 (f) Patient Centric of Martha’s Vineyard Ltd. In October 2020, Life Essence, entered into an asset purchase agreement with Patient Centric of Martha’s Vineyard Ltd. or PCMV, pursuant to which Life Essence agreed to purchase certain assets of PCMV including the rights to a Provisional Marijuana Retailer License from the Massachusetts Cannabis Control Commission, the right to exercise an option held by PCMV to lease real property in Framingham, Massachusetts for use as a marijuana retailer, and necessary municipal entitlements to operate as a marijuana retailer at the property. Life Essence has agreed to acquire these assets for an aggregate purchase price of $4.7 million payable in Subordinate Voting Shares totaling 258,383, of which 10,881 are subject to a holdback for six months as security for any indemnity claims by us under the asset purchase agreement. The asset purchase agreement includes customary representations, warranties, and indemnities. We expect the closing of the transaction to occur promptly following receipt of applicable state and local regulatory approvals. The issuance of the Subordinate Voting Shares at the closing will have a dilutive impact on our existing shareholders. The closing of the asset acquisition is subject to customary closing conditions including necessary regulatory approvals.

Inventory

Inventory	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory	NOTE 4. INVENTORY The Company’s inventory includes the following at September 30, 2021 and December 31, 2020: September 30, December 31, (dollars in thousands) Raw material Cannabis plants $ 19,419 $ 10,661 Harvested cannabis and packaging 23,529 11,233 Total raw material 42,948 21,894 Work in process 63,952 54,780 Finished goods-unmedicated 3,473 3,908 Finished goods-medicated 23,501 17,730 Total inventories $ 133,874 $ 98,312	4. INVENTORIES Inventories are comprised of the following items at December 31: 2020 2019 (dollars in thousands) Raw Material Cannabis plants 10,661 $ 10,835 Harvested Cannabis and Packaging 11,233 8,132 Total Raw Material 21,894 18,967 Work in Process 54,781 34,212 Finished Goods-Unmedicated 3,908 5,263 Finished Goods-Medicated 17,730 7,538 Total Inventories 98,312 $ 65,981

Property and Equipment

Property and Equipment	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	NOTE 5. PROPERTY & EQUIPMENT At September 30, 2021 and December 31, 2020, Property and Equipment consisted of the following: September 30, 2021 December 31, 2020 (dollars in thousands) Land $ 7,468 $ 5,878 Buildings and improvements 288,133 156,372 Construction in progress 162,528 129,588 Furniture and equipment 93,485 51,714 Vehicles 349 351 Total 551,963 343,903 Less: accumulated depreciation (50,854 ) (29,858 ) Total property and equipment, net $ 501,109 $ 314,045 Capitalized interest for the three and nine months ended September 30, 2021 totaled $2.2 million and $4.4 million, respectively. Capitalized interest for the three and nine months ended September 30, 2020 totaled $1.3 million and $2.1 million, respectively. Depreciation expense for the three and nine months ended September 30, 2021 totaled $8.1 million and $21.0 million, respectively. Depreciation expense for the three and nine months ended September 30, 2020 totaled $3.9 million and $10.7 million respectively. Certain prior period amounts have been reclassified to conform to the current period presentation. Internal use software with a net book value of $3.7 million was reclassified from “Property and equipment, net” to “Intangible assets, net” in the consolidated balance sheet as of December 31, 2020. Property and equipment with a net book value of $50.0 million was reclassified from construction in progress to land, buildings and improvements, and furniture and equipment as , 2020	5. PROPERTY AND EQUIPMENT At December 31, 2020 and 2019, Property and Equipment consisted of the following: 2020 2019 (dollars in thousands) Land $ 5,022 $ 4,479 Buildings & Improvements 112,692 89,542 Construction in Progress 182,962 24,732 Furniture & Equipment 46,532 38,659 Vehicles 351 288 Total 347,559 157,701 Less: accumulated depreciation (29,858 ) (12,953 ) Total property and equipment, net $ 317,701 $ 144,748 For the years ended December 31, 2020, 2019 and 2018, the Company capitalized interest of $4.8 million, $0.5 million and $1.0 million, respectively. For the years ended December 31, 2020, 2019 and 2018, there was depreciation expense of $16.9 million, $9.3 million and $3.0 million, respectively. J.T. Burnette, the spouse of Kim Rivers, the Chief Executive Officer and Chair of the board of directors of the Company, is a minority owner of a company (the “Supplier”) that provides construction and related services to the Company. The Supplier is responsible for the construction of the Company’s cultivation and processing facilities, and provides labor, materials and equipment on a cost-plus basis. For the years ended December 31, 2020, 2019 and 2018, property and equipment purchases from the Supplier totaled $96.7 million, $46.4 million and $12.1 million, respectively. As of December 31, 2020 and 2019, $10.4 million and $6.5 million was included in accounts payable. The use of the Supplier was reviewed and approved by the independent members of the Company’s board of directors, and all invoices of the Supplier are reviewed by the office of the Company’s general counsel.

Intangible Assets & Goodwill

Intangible Assets & Goodwill	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets & Goodwill	NOTE 6. INTANGIBLE ASSETS & GOODWILL At September 30, 2021 and December 31, 2020, definite-lived intangible assets consisted of the following: September 30, 2021 (dollars in thousands) Net Adjustments to Additions Amortization Net Licenses $ 84,517 $ 3,061 $ 68,493 $ (5,593 ) $ 150,478 Internal use software 3,656 — 3,589 (529 ) 6,716 Moxie brand 2,828 — — (740 ) 2,088 Tradenames 2,109 — 100 (741 ) 1,468 Customer relationship 683 — — (151 ) 532 Miscellaneous 7 — 86 (93 ) — $ 93,800 $ 3,061 $ 72,268 $ (7,847 ) $ 161,282 December 31, 2020 (dollars in thousands) Net Acquired Additions Amortization Net Licenses $ 24,538 $ 887 $ 61,400 $ (2,308 ) $ 84,517 Internal use software 3,656 — — — 3,656 Moxie brand — — 2,960 (132 ) 2,828 Tradenames 800 — 1,510 (201 ) 2,109 Customer relationship 883 — — (200 ) 683 Miscellaneous 25 — — (18 ) 7 Trademarks 134 — — (134 ) — $ 30,036 $ 887 $ 65,870 $ (2,993 ) $ 93,800 Amortization expense for the three and nine months ended September 30, 2021 was $3.3 million and $7.8 million, respectively. Amortization expense for the three and nine months ended September 30, 2020 was $0.5 million and $1.7 million, respectively. The following table outlines the estimated future annual amortization expense related to all intangible assets as of September 30, 2021: Estimated (dollars in thousands) Remaining 2021 $ 3,326 2022 13,887 2023 13,320 2024 12,349 2025 11,895 Thereafter 106,505 $ 161,282 Goodwill arose from the acquisition of PurePenn, LLC, Pioneer Leasing & Consulting, Solevo Wellness, and Keystone Shops, see “Note 3—Acquisitions” At September 30, 2021, Goodwill consisted of the following: (dollars in thousands) At January 1, 2020 7,316 Acquisition of PurePenn, LLC and Pioneer Leasing & Consulting, LLC 47,311 Acquisition of Solevo Wellness 19,473 At December 31, 2020 74,100 Measurement period purchase price allocation adjustments of Solevo Wellness (2,639 ) Measurement period purchase price allocation adjustments of PurePenn, LLC and Pioneer Leasing & Consulting, LLC (338 ) At June 30, 2021 71,123 Acquisition of Keystone Shops 40,072 Measurement period purchase price allocation adjustments of Solevo Wellness 1,150 Measurement period purchase price allocation adjustments of PurePenn, LLC and Pioneer Leasing & Consulting, LLC (624 ) At September 30, 2021 $ 111,721	6. INTANGIBLE ASSETS & GOODWILL At December 31, 2020 and 2019, definite-lived intangible assets consisted of the following: December 31, 2020 (dollars in thousands) Net amount Acquired license agreements Additions from acquisitions Amortization expense Net amount Licenses $ 24,538 $ 887 $ 61,400 $ 2,308 84,517 Moxie brand — — 2,960 132 2,828 Tradenames 800 — 1,510 201 2,109 Customer relationship 883 — — 200 683 Non-compete 25 — — 18 7 Trademarks 134 — — 134 — $ 26,380 $ 887 $ 65,870 $ 2,992 90,144 December 31, 2019 (dollars in thousands) Net amount Acquired license agreements Additions from acquisitions Amortization expense Net amount Licenses $ 11,568 $ — $ 14,300 $ 1,330 $ 24,538 Moxie brand — — — — — Tradenames 900 — — 100 800 Customer relationship — — 1,000 117 883 Non-compete — — 35 10 25 Trademarks 9 — 321 196 134 $ 12,477 $ — $ 15,656 $ 1,753 $ 26,380 Amortization expense for the years ended December 31, 2020 and 2019 was $3.0 million and $1.8 million, respectively. The following table outlines the estimated future annual amortization expense related to intangible assets as of December 31, 2020: Year Ended December 31, Estimated Amortization (dollars in thousands) 2021 $ 7,914 2022 7,823 2023 7,038 2024 6,066 2025 5,982 Thereafter 55,321 $ 90,144 Goodwill arose from the acquisition of PurePenn, LLC, Pioneer Leasing & Consulting and Solevo Wellness, and The Healing Corner, Inc. see “Note 3—Acquisitions” At December 31, 2020, Goodwill consisted of the following: (dollars in thousands) At January 1, 2019 $ — Acquisition of The Healing Corner, Inc. 7,316 At of December 31, 2019 $ 7,316 Acquisition of PurePenn, LLC and Pioneer Leasing & Consulting, LLC 47,311 Acquisition of Solevo Wellness 19,473 At December 31, 2020 $ 74,100

Notes Payable

Notes Payable	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Notes Payable	NOTE 7. NOTES PAYABLE At September 30, 2021 and December 31, 2020, notes payable consisted of the following : September 30, December 31, (dollars in thousands) Promissory note dated April 10, 2017, with annual interest at 12%, due between April $ 4,000 $ 4,000 Promissory note dated December 7, 2017, with annual interest at 12%, secured by certain property located in Miami, FL due December 2021 2,000 2,000 Total notes payable 6,000 6,000 Less current portion (6,000 ) (2,000 ) Long-term notes payable $ — $ 4,000 Stated maturities of notes payable are as follows: As of September 30, (dollars in thousands) 2021 $ 2,000 2022 4,000 $ 6,000 All notes payable were fully paid off during the fourth quarter of 2021.	7. NOTES PAYABLE At December 31, 2020 and 2019, 2020 2019 (dollars in thousands) Promissory note dated April 10, 2017, with annual interest at 12%, due between April $ 4,000 $ 4,000 Promissory note dated December 7, 2017, with annual interest at 12%, secured by certain property located in Miami, FL, due December 2021 2,000 2,000 Less current portion (2,000 ) (2,000 ) Long Term Notes Payable $ 4,000 $ 4,000 The unsecured promissory note dated April 10, 2017, was amended in January 2019 to extend the maturity date by three years to 2022 The promissory note dated December 7, 2017, has terms allowing the lender to request prepayment at any time once the Company had raised in excess of $24.0 million. In conjunction with the close of the SR Offering, the promissory note became due on demand. Stated maturities of notes payables are as follows: Year Ended December 31, (dollars in thousands) 2020 $ — 2021 2,000 2022 4,000 $ 6,000

Notes Payable Related Party

Notes Payable Related Party	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Notes Payable Related Party [Abstract]
Notes Payable Related Party	NOTE 8. NOTES PAYABLE RELATED PARTY At September 30, 2021 and December 31, 2020, notes payable related party consisted of the following: September 30, December 31, (dollars in thousands) Notes payable due to related parties, with varying interest rates between 8% to 12% annual, with varying maturity dates $ 12,000 $ 12,011 Less current portion (12,000 ) (12,011 ) Non-current $ — $ — Stated maturities of notes payable to related parties are as follows: (dollars in 2022 $ 12,000 $ 12,000 In March 2021, the two unsecured promissory notes (the “Traunch Four Note” and the “Rivers Note”) were amended to extend the maturity one year to May 2022, all other terms remain unchanged. In the fourth quarter of 2021, the unsecured promissory notes were fully paid.	8. NOTES PAYABLE RELATED PARTY At December 31, 2020 and 2019, 2020 2019 2018 (dollars in thousands) Notes payable due to related parties, with varying interest rates between 8% to 12% annual, with varying maturity dates $ 12,011 $ 12,952 $ 14,215 Less debt discount — (49 ) (141 ) Less current portion (12,011 ) (924 ) (1,427 ) Non-current $ — $ 11,979 $ 12,647 In February 2019, the Company entered into a 24-month In March 2018, the Company entered into a 24-month In April 2018, the Company entered into a $6.0 million unsecured promissory note with Clearwater GPC, an entity controlled by members of management and shareholders with a 24-month In May 2018, the Company entered into two separate unsecured promissory notes (the “Traunch Four Note” and the “Rivers Note”) for a total of $12.0 million. The Traunch Four Note is held by Traunch Four, LLC, an entity whose direct and indirect owners include Kim Rivers, the Chief Executive Officer and Chair of the Board, as well as Thad Beshears, Richard May, George Hackney, all of whom are directors of Trulieve, and certain of Richard May’s family members. The Rivers Note is held by Kim Rivers. Each promissory note has a 24-month In June 2018, the Company entered into a 24-month In November 2018, the Company entered into two separate 24-month As disclosed in the consolidated statements of cash flows, under other noncash investing and financing activities, the noncash portion of the notes for the years ended December 31, 2019 and 2018 was $0.3 million and $3.1 million, respectively, and was used to finance acquisition of property and equipment. The lenders paid for the property and equipment directly while issuing the Company promissory notes and the Company took custody of the property and equipment. Stated maturities of notes payable to related parties are as follows: Year Ended December 31, (dollars in thousands) 2021 $ 12,011 $ 12,011

Private Placement Notes

Private Placement Notes	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Instruments [Abstract]
Private Placement Notes	NOTE 9. PRIVATE PLACEMENT NOTES In 2019, the Company completed two private placement arrangements (the “June Notes” and the “November Notes”), each comprised of 5-year The fair value of the June Notes was determined to be $63.9 million using an interest rate of 13.32% which the Company estimates would have been the coupon rate required to issue the June Notes had the financing not included the June Warrants. The fair value of the June Warrants was determined to be $4.7 million using the Black-Scholes option pricing model and the following assumptions: share price: C$14.48; exercise price: C$17.25; expected life: 3 years; annualized volatility: 49.96%; dividend yield: 0%; discount rate: 1.92%; C$ exchange rate: 1.34. The fair value of the November Notes was determined to be $54.5 million using an interest rate of 13.43% which the Company estimates would have been the coupon rate required to issue the notes had the financing not included the November Warrants. The fair value of the November Warrants was determined to be $4.4 million using the Black-Scholes option pricing model and the following assumptions: share price: C$14.29; exercise price: C$17.25; expected life: 2.6 years; annualized volatility: 48.57%; dividend yield: 0%; discount rate: 1.92%; C$ exchange rate: 1.32. For the three and nine months ended September 30, 2021 accretion expense was $0.8 million and $2.3 million respectively. For the three and nine months ended September 30, 2020, accretion expense was $0.7 million and $2.1 million, respectively. Accretion expense is included in general and administrative expenses in the condensed consolidated statements of operations and comprehensive income. Because of the Canadian denominated exercise price, the June and November Warrants did not qualify to be classified within equity and were therefore classified as derivative liabilities at fair value with changes in fair value charged or credited to earnings in the condensed consolidated statements of operations and comprehensive income prior to December 10, 2020. On December 10, 2020, the Company entered into a Supplemental Warrant Indenture with Odyssey Trust Company pursuant to which it amended the terms of the issued and outstanding subordinate voting share purchase warrants of the Company (the “Public Warrants”) to convert the exercise price of the Public Warrants to $13.47 per share, the U.S. dollar equivalent of the Canadian dollar exercise price of the Public Warrants of C$17.25. The U.S. dollar exercise price was determined using the U.S. dollar exchange rate published by the Bank of Canada as at the close of business on December 9, 2020 of C$1.00 = $0.781. The June Warrants and November Warrants converted to equity as per ASC 815-40, The $130.0 million principal amount of the June and November Notes are due in June 2024. Scheduled annual maturities of the principal portion of long-term debt outstanding at September 30, 2021 in the successive five-year period and thereafter are summarized below: Private (dollars in 2021 $ — 2022 — 2023 — 2024 130,000 2025 — Thereafter — Total debt 130,000 Less: unamortized debt issuance costs (10,522 ) Net debt $ 119,478	9. DEBT On May 16, 2019, the Company completed a private offering of an aggregate principal amount of $17.8 million of 9.75% unsecured notes of the Company maturing on August 14, 2019 (the “Bridge Notes”). In connection with the closing of the June Units (defined below), the Company repaid the Bridge Notes. On June 18, 2019, the Company completed a private placement financing comprising 5-year The fair value of the June Notes was determined to be $63.9 million using an interest rate of 13.32% which the Company estimates would have been the coupon rate required to issue the notes had the financing not included the June Warrants. The fair value of the June Warrants was determined to be $4.7 million using the Black-Scholes option pricing model and the following assumptions: Share Price: C$14.48; Exercise Price: C$17.25; Expected Life: 3 years; Annualized Volatility: 49.96%; Dividend yield: 0%; Discount Rate: 1.92%; C$ Exchange Rate: 1.34. Issuance costs totaling $3.1 million were allocated between the June Notes and the June Warrants based on their relative fair values with $2.9 million allocated to the June Notes and $0.2 million expensed as incurred. The June Notes will accrete from their carrying value on June 18, 2019 of $60.1 million to $70.0 million at maturity in 5 years Because of the Canadian denominated exercise price, the June Warrants did not qualify to be classified within equity and were therefore classified as derivative liabilities at fair value with changes in fair value charged or credited to earnings in the consolidated statements of operations and comprehensive income prior to December 10, 2020. On December 10, 2020, the Company entered into a Supplemental Warrant Indenture with Odyssey Trust Company pursuant to which it amended the terms of the issued and outstanding subordinate voting share purchase warrants of the Company (the “Public Warrants”) to convert the exercise price of the Public Warrants to $13.47 per share, the U.S. dollar equivalent of the Canadian dollar exercise price of the Public Warrants of C$17.25. The U.S. dollar exercise price was determined using the U.S. dollar exchange rate published by the Bank of Canada as at the close of business on December 9, 2020 of C$1.00 = $0.781. As of December 10, 2020, the June Notes converted to equity as per ASC 815-40, On November 7, 2019, the Company completed a prospectus offering of 60,000 units of the Company (the “November Units”), comprised of an aggregate principal amount of $60.0 million of 9.75% senior secured notes of the Company maturing in 2024 (the “November Notes”) and an aggregate amount of 1,560,000 Subordinate Voting Share warrants of the Company (each individual warrant being a “November Warrant”) at a price of $980 per Unit for a gross proceeds of $61.1 million. Each Unit was comprised of one Note issued in denominations of $1,000 and 26 Warrants. The fair value of the November Notes was determined to be $56.7 million using an interest rate of 13.43% which the Company estimates would have been the coupon rate required to issue the notes had the financing not included the November Warrants. The fair value of the November Warrants was determined to be $4.4 million using the Black-Scholes option pricing model and the following assumptions: Share Price: C$14.29; Exercise Price: C$17.25; Expected Life: 2.6 years; Annualized Volatility: 48.57%; Dividend yield: 0%; Discount Rate: 1.92%; C$ Exchange Rate: 1.32 Issuance costs totaling $2.1 million were allocated between the November Notes and the November Warrants based on their relative fair values with $2.0 million allocated to the November Notes and $0.2 million expensed in the consolidated statements of operations and comprehensive income. The November Notes will accrete from their carrying value on November 7, 2019 of $54.7 million to $60.0 million at maturity in 4.6 years using an effective interest rate of 13.43%. For the years ended December 31, 2020 and 2019, the Company incurred accretion expense of $1.3 million and $0.1 million which is included in general and administrative in the consolidated statements of operations and comprehensive income. Because of the Canadian denominated exercise price, the November Warrants did not qualify to be classified within equity and were therefore classified as derivative liabilities at fair value with changes in fair value charged or credited to earnings in the consolidated statements of operations and comprehensive income prior to December 10, 2020. On December 10, 2020, the Company entered into a Supplemental Warrant Indenture with Odyssey Trust Company pursuant to which it amended the terms of the issued and outstanding subordinate voting share purchase warrants of the Company (the “Public Warrants”) to convert the exercise price of the Public Warrants to $13.47 per share, the U.S. dollar equivalent of the Canadian dollar exercise price of the Public Warrants of C$17.25. The U.S. dollar exercise price was determined using the U.S. dollar exchange rate published by the Bank of Canada as at the close of business on December 9, 2020 of C$1.00 = $0.781. As of December 10, 2020, the November Notes converted to equity as per ASC 815-40, The $130.0 million principal amount of the June and November Notes are due in June 2024. Scheduled annual maturities of the principal portion of long-term debt outstanding at December 31, 2020 in the successive five-year period and thereafter are summarized below: Year Ended December 31, Other Long-term Liabilities (dollars in thousands) 2021 $ — 2022 — 2023 — 2024 130,000 2025 Thereafter — Total Debt 130,000 Less: Unamortized debt issuance costs (12,835 ) Net Debt $ 117,165 The net debt of $117.2 million is recorded as other long-term liabilities in our consolidated balance sheet as of December 31, 2020

Leases

Leases	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Leases	NOTE 10. LEASES The following table provides the components of lease cost recognized in the condensed consolidated statement of operations and comprehensive income for the three and nine months ended September 30, 2021 and 2020: For the Three Months For the Nine Months Lease Cost 2021 2020 2021 2020 (dollars in thousands) Operating lease cost 2,483 1,545 5,751 4,087 Finance lease cost: Amortization of lease assets 1,990 1,496 5,357 3,688 Interest on lease liabilities 1,177 782 2,914 1,801 Finance lease cost 3,167 2,278 8,271 5,489 Variable lease cost 2,529 28 3,139 310 Total lease cost $ 8,179 $ 3,851 $ 17,161 $ 9,886 Weighted average discount rate and remaining lease term for the nine months ended September 30, 2021 are as follows: Operating Finance Weighted average discount rate 8.75 % 8.46 % Weighted average remaining lease term (in years) 8.67 8.20 The maturity of the contractual undiscounted lease liabilities as of September 30, 2021 is as follows: Operating Finance (dollars in thousands) Remainder of 2021 $ 1,991 $ 2,494 2022 8,173 10,509 2023 7,886 13,246 2024 7,759 9,395 2025 7,800 9,069 Thereafter 35,893 43,875 Total undiscounted lease liabilities 69,502 88,588 Interest on lease liabilities (21,581 ) (26,000 ) Total present value of minimum lease payments 47,921 62,588 Lease liability—current portion (4,264 ) (5,354 ) Lease liability $ 43,657 $ 57,234 During the third quarter of 2021, the Company identified a misstatement in its accounting for leases in prior periods, primarily the second quarter of 2021. Refer to “ Note 2. Basis of Presentation Revisions of Previously Issued Financial Statements	10. LEASES On January 1, 2019, the Company adopted ASC 842, Leases (“Topic 842”) using the modified retrospective transition method. Topic 842 requires the recognition of lease assets and liabilities for operating and finance leases. Beginning on January 1, 2019, the Company’s consolidated financial statements are presented in accordance with the revised policies. Management elected to utilize the practical expedients permitted under the transition guidance within Topic 842, which allowed the Company to carry forward prior conclusions about lease identification, classification and initial direct costs for leases entered prior to adoption of Topic 842. Additionally, management elected not to separate lease and non-lease right-of-use The Company leases real estate used for dispensaries, production plants, and corporate offices. Lease terms for real estate generally range from 5 to 10 years. Most leases include options to renew for varying terms at the Company’s sole discretion. Other leased assets include passenger vehicles and trucks and equipment. Lease terms for these assets generally range from 3 to 5 years. Certain leases include escalation clauses or payment of executory costs such as property taxes, utilities, or insurance and maintenance. Rent expense for leases with escalation clauses is accounted for on a straight-line basis over the lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. As a result of the adoption of ASU 2016-02, right-of-use 2016-02, 2016-02, The following table provides the components of lease cost recognized in the consolidated statement of operations and comprehensive income for the year ended December 31, 2020 and 2019. Year Ended December 31, Lease Cost 2020 2019 Operating lease cost 5,700 5,542 Finance lease cost: Amortization of lease assets 4,956 1,984 Interest on lease liabilities 2,133 960 Finance lease cost 7,089 2,944 Variable lease cost 222 192 Total lease cost $ 13,010 $ 8,678 Other information related to operating and finance leases as of and for the year ended December 31, 2020 are as follows: Finance Lease Operating Lease Weighted average discount rate 8.36 % 8.64 % Weighted average remaining lease term (in years) 8.51 7.49 The maturity of the contractual undiscounted lease liabilities as of December 31, 2020 is as follows: Year Ended December 31, Finance Lease Operating Lease (dollars in thousands) 2021 $ 6,964 $ 5,480 2022 6,642 5,405 2023 6,257 5,276 2024 5,787 4,921 2025 5,588 4,843 Thereafter 24,669 14,225 Total undiscounted lease liabilities 55,907 40,150 Interest on lease liabilities (16,972 ) (10,545 ) Total present value of minimum lease payments 38,935 29,605 Lease liability—current portion 3,877 3,154 Lease liability $ 35,058 $ 26,450

Construction Finance Liabilitie

Construction Finance Liabilities	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Construction Finance Liability [Abstract]
CConstruction Finance Liabilities	NOTE 11. CONSTRUCTION FINANCE LIABILITIES In July 2019, the Company sold property it had recently acquired in Massachusetts for $3.5 million, which was the cost to the Company. In connection with the sale of this location, the Company agreed to lease the location back for cultivation. The landlord has agreed to provide a tenant improvement allowance (“TI Allowance”) of $40.0 million, which was dispensed in its entirety as of December 31, 2020. The initial term of the agreement is ten years, with two options to extend the term for five years each. The initial payments are equal to 11% of the sum of the purchase price for the property and will increase when a draw is made on the TI Allowance. In addition, a 3% increase in payments will be applied annually after the first year. As of September 30, 2021, the total finance liability associated with this transaction is $44.4 million. In October 2019, the Company sold property in Florida in exchange for cash of $17.0 million. Concurrent with the closing of the purchase, the buyer entered into a lease agreement with the Company for continued operation as a licensed medical cannabis cultivation facility. The initial term of the agreement is ten years, with two options to extend the term for five years each. The initial annualized payments are equal to 11% of the purchase price for the property. A 3% increase in payments will be applied annually after the first year. As of September 30, 2021, the total finance liability associated with this transaction is $17.4 million. In October 2019, prior to its acquisition by the Company, PurePenn, LLC (“PurePenn”) sold their cannabis cultivation facility in Pennsylvania for $5.0 million. Simultaneously with the closing of the sale, PurePenn agreed to lease the cultivation facility back. The initial term of the lease is fifteen years, with two five-year options to renew. The landlord has agreed to provide a TI allowance of $21.0 million as an additional component of base rent. Payments are made based on one twelfth (1/12) of the TI allowance dispersed with 12.75% due for the first $5.0 million and 13.75% thereafter. On March 8, 2021, the Company entered into a lease amendment with the landlord to increase the tenant improvement allowance to $36.5 million at a rate of 10.75% on the additional allowance in excess of $21.0 million. As of September 30, 2021, $25.6 million of the TI allowance has been provided. As of September 30, 2021, the total finance liability associated with this transaction is $30.2 million. Under the failed-sales-leaseback accounting model, the Company is deemed under U.S. GAAP to own the above mentioned real estate properties as financing arrangements since control was never transferred to the buyer-lessor. These agreements are presented on our condensed consolidated balance sheet within property and equipment, net and depreciated	11. CONSTRUCTION FINANCE LIABILITY In July 2019, the Company sold property it had recently acquired in Massachusetts for $3.5 million, which was the cost to the Company. In connection with the sale of this location, the Company agreed to lease the location back for cultivation. This transaction was determined to be a finance lease, and therefore did not meet the definition of a sale because control was never transferred to the buyer-lessor. The transaction was treated as a failed sale-leaseback financing arrangement. Included in the agreement, the Company completed the tenant improvements related to the property, for which the landlord has provided a tenant improvement allowance (“TI Allowance”) for $40.0 million. As of December 31, 2020, and December 31, 2019 $40.0 million and $2.5 million, respectively, of the TI Allowance has been provided respectively. The initial term of the agreement is ten years, with two options to extend the term for five years each. The initial payments are equal to 11% of the sum of the purchase price for the property and will increase when a draw is made on the TI Allowance. In addition, a 3% increase in payments will be applied annually after the first year. As of December 31, 2020 and 2019, the total finance liability associated with this transaction is $43.9 million and $6.1 million, respectively. In October 2019, the Company sold property in Florida in exchange for cash of $17.0 million. Concurrent with the closing of the purchase, the buyer entered into a lease agreement with the Company, for continued operation as a licensed medical cannabis cultivation facility. Control was never transferred to the buyer-lessor because the transaction was determined to be a finance lease and did not meet the requirements of a sale. The transaction was treated as a failed sale-leaseback financing arrangement. The initial term of the agreement is ten years, with two options to extend the term for five years each. The initial annualized payments are equal to 11% of the purchase price for the property. A 3% increase in payments will be applied annually after the first year. As of December 31, 2020 and 2019, the total finance liability associated with this transaction is $17.2 million and $16.9 million, respectively. Under the failed-sale-leaseback accounting model, the Company is deemed under GAAP to own this real estate and will reflect the properties on our consolidated balance sheet and depreciate over the assets’ remaining useful life. The Company is making interest only payments through 2024 with the entire balance of $ 23.0 In October 2019, prior to acquisition by the Company, PurePenn, LLC (“PurePenn”) sold their cannabis cultivation facility in Pennsylvania for $5.0 million. Simultaneously with the closing of the sale, PurePenn agreed to lease the cultivation facility back. The initial term of the lease is fifteen years, with two five-year options to renew. The landlord has agreed to provide a tenant improvement allowance of $21.0 million as an additional component of base rent. Payments are made based on one twelfth (1/12) of the TI allowance dispersed with 12.75% due for the first $5.0 million and 13.75% thereafter. As of December 31, 2020, $16.7 million of the TI allowance has been provided. Subsequent to December 31, 2020, the Company entered into an amendment with the landlord to increase the tenant improvement allowance to $36.5 million at a rate of 10.75% on the additional allowance in excess of $21.0

Share Capital

Share Capital	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Equity [Abstract]
Share Capital	NOTE 12. SHARE CAPITAL The authorized share capital of the Company is comprised of the following: (i) Unlimite Holders of the Subordinate Voting Shares are entitled to notice of and to attend any meeting of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company shall have the right to vote. At each such meeting holders of Subordinate Voting Shares shall be entitled to one vote in respect of each Subordinate Voting Share held. Holders of Subordinate Voting Shares are entitled to receive as and when declared by the directors, dividends in cash or property of the Company. No dividend will be declared or paid on the Subordinate Voting Shares unless the Company simultaneously declares or pays, as applicable, equivalent dividends (on an as-converted As of September 30, 2021 and 2020, there were 74,611,611 and 58,134,478 Subordinate Voting Shares issued and outstanding, respectively. (ii) Unlimite Holders of Multiple Voting shares are entitled to notice of and to attend any meetings of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company have the right to vote. At each such meeting, holders of Multiple Voting Shares are entitled to one vote in respect of each Subordinate Voting Share into which such Multiple Voting Share could ultimately then be converted (initially, 100 votes per Multiple Voting Share). The initial “Conversation Ratio” for Multiple Voting Shares is 100 Subordinate Voting shares for each Multiple Voting Share, subject to adjustment in certain events. Holders of Multiple Voting Shares have the right to receive dividends, out of any cash or other assets legally available therefore, pari passu (on an as converted basis, assuming conversion of all Multiple Voting Shares into Subordinate Voting Shares at the Conversion Ratio) as to dividends and any declaration or payment of any dividend on the Subordinate Voting Shares. No dividend may be declared or paid on the Multiple Voting Shares unless the Company simultaneously declares or pays, as applicable, equivalent dividends (on an as-converted As of September 30, 2021 and 2020, there were 549,196, and 14,770 Multiple Voting Shares issued and outstanding, respectively, which were equal to 54,919,596, and 1,476,959 Subordinate Voting Shares, respectively, if converted. (iii) Unlimite Holders of Super Voting Shares are entitled to notice of and to attend at any meeting of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company shall have the right to vote. At each such meeting, holders of Super Voting Shares are be entitled to two votes in respect of each Subordinate Voting Share into which such Super Voting Share could ultimately then be converted (initially, 200 votes per Super Voting Share). Holders of Super Voting Shares have the right to receive dividends, out of any cash or other assets legally available therefore, pari passu (on an as converted to Subordinated Voting Share basis) as to dividends and any declaration or payment of any dividend on the Subordinate Voting Shares. No dividend is to be declared or paid on the Super Voting Shares unless the Company simultaneously declares or pays, as applicable, equivalent dividends (on an as-converted On March 21, 2021, in accordance with the terms of the Company’s Articles, all of the outstanding Super Voting Shares converted automatically, without any action by the holders of such Super Voting Shares, into Multiple Voting Shares and, following that conversion, the Company may not issue additional Super Voting Shares. As of September 30, 2021, there were no Super Voting Shares issued or outstanding. As of September 30, 2020, there were 581,825 Super Voting Shares issued or outstanding which were equal to 58,182,500 Super Voting Shares if converted.	12. SHARE CAPITAL The authorized share capital of the Company is comprised of the following: (i) Unlimi Holders of the Subordinate Voting Shares are entitled to notice of and to attend any meeting of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company shall have the right to vote. At each such meeting holders of Subordinate Voting Shares shall be entitled to one vote in respect of each Subordinate Voting Share held. Holders of Subordinate Voting Shares are entitled to receive as and when declared by the directors, dividends in cash or property of the Company. No dividend will be declared or paid on the Subordinate Voting Shares unless the Company simultaneously declares or pays, as applicable, equivalent dividends (on an as-converted As of December 31, 2020, 2019 and 2018, there were 59,952,461 and 35,871,672 and 11,135,117 Subordinate Voting Shares issued and outstanding, respectively. (ii) Unlimited Holders of Multiple Voting shares are entitled to notice of and to attend any meetings of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company have the right to vote. At each such meeting, holders of Multiple Voting Shares are entitled to one vote in respect of each Subordinate Voting Share into which such Multiple Voting Share could ultimately then be converted (initially, 100 votes per Multiple Voting Share). The initial “Conversation Ratio” for Multiple Voting Shares is 100 Subordinate Voting shares for each Multiple Voting Share, subject to adjustment in certain event. Holders of Multiple Voting Shares have the right to receive dividends, out of any cash or other assets legally available therefor, pari passu (on an as converted basis, assuming conversion of all Multiple Voting Shares into Subordinate Voting Shares at the Conversion Ratio) as to dividends and any declaration or payment of any dividend on the Subordinate Voting Shares. No dividend may be declared or paid on the Multiple Voting Shares unless the Company simultaneously declares or pays, as applicable, equivalent dividends (on an as-converted As of December 31, 2020, 2019 and 2018, there were 14,390, 66,614 and 137,505 Multiple Voting Shares issued and outstanding, respectively, which were equal to 1,439,037, 6,661,374 and 13,750,451 Subordinate Voting Shares, respectively, if converted. During the year ended December 31, 2019, 70,891 Multiple Voting Shares were converted into 7,089,077 Subordinate Voting Shares. There were no (iii) Unlimited number of Super Voting Shares Holders of Super Voting Shares are entitled to notice of and to attend at any meeting of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company shall have the right to vote. At each such meeting, holders of Super Voting Shares are be entitled to two votes in respect of each Subordinate Voting Share into which such Super Voting Share could ultimately then be converted (initially, 200 votes per Super Voting Share). Holders of Super Voting Shares have the right to receive dividends, out of any cash or other assets legally available therefor, pari passu (on an as converted to Subordinated Voting Share basis) as to dividends and any declaration or payment of any dividend on the Subordinate Voting Shares. No dividend is to be declared or paid on the Super Voting Shares unless the Company simultaneously declares or pays, as applicable, equivalent dividends (on an as-converted As of December 31, 2020, 2019 and 2018 there were 581,825, 678,133 and 852,466 Super Voting Shares issued and outstanding, respectively, which were equal to 58,182,500, 67,813,300 and 85,246,600 Subordinate Voting Shares, respectively, if converted. During the year ended December 31, 2019, 174,333 Super Voting Shares were converted into 17,433,300 Subordinate Voting Shares. There were no Super Voting Shares converted during the year ended December 31, 2018. During the year ended December 31, 2018, the Company entered into four separate $6.0 million promissory notes see “Note 7—Notes Payable and Note 8—Notes Payable Related Party” On August 27, 2018, concurrent with the Transaction, the Company completed a brokered private placement (the “SR Offering”) of 10,927,500 subscription receipts for gross proceeds of $50.6 million, which after transaction costs resulted in net proceeds of $47.5 million. The 10,927,500 issued and outstanding subscription receipts were exchanged for 10,927,500 Subordinate Voting Shares of the Company (3,573,450 of those Subordinate Voting Shares were immediately converted into 35,734.50 Multiple Voting Shares). In connection with the SR Offering, Trulieve paid a cash fee to the Agents equal to 6.0% of the gross proceeds of the SR Offering, provided that the cash fee payable to the Agents was reduced to 3.0% in respect of sales to subscribers on a president’s list. As additional consideration, the Agents were granted an aggregate of 535,446 broker warrants (the “Broker Warrants”) on closing of the SR Offering. The Broker Warrants are exercisable at any time prior to the date that is 24 months following the date that the Escrow Release Conditions are satisfied to acquire one Trulieve Share at the SR Offering Price, see “ Note 14—Reverse Takeover Transaction”. Number of Warrants Weighted average exercise price ($CAD) Weighted Average Remaining Contractual Life (Yrs) Outstanding and exercisable at December 31, 2017 — — — Granted 535,446 6.00 2.00 Exercised (321,268 ) 6.00 — Outstanding and exercisable at December 31, 2018 214,178 6.00 1.66 Granted — — — Exercised (214,178 ) 6.00 — Outstanding and exercisable at December 31, 2019 — — — Granted — — — Exercised — — — Outstanding and exercisable at December 31, 2020 — — — On September 11, 2018, Trulieve approved a reclassification of the issued and outstanding share capital of Trulieve whereby each issued and outstanding Trulieve Share was split and became 150

Share Based Compensation

Share Based Compensation	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Share Based Compensation	NOTE 13. SHARE-BASED COMPENSATION Equity Incentive Plans The Company’s 2021 Omnibus Incentive Plan (the “2021 Plan”) was adopted at the annual meeting of shareholders. The 2021 Plan reserves 4,000,000 Subordinate Voting Shares for issuance thereunder and replaced the Schyan Exploration Inc. Stock Option Plan (the “Prior Plan”). Awards previously granted under the Prior Plan, including equity awards granted in the first quarter of 2021 for performance in 2020, remain subject to the terms of the Prior Plan. No further grants of awards shall be made under the Prior Plan. The Prior Plan is administered by the Board of Directors of the Company and the 2021 Plan is administered by the Compensation Committee. The 2021 Plan provides for the grant of Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Share Units, and Other Awards. As of September 30, 2021 a total of 895,877 awards were granted under the 2021 Plan between the date of its adoption by shareholders on June 10, 2021 and September 30, 2021. Options The fair value of stock options granted by the Company during 2021 and 2020, under the Prior Plan, were estimated on the date of the grant using the Black-Scholes option-pricing model with the relevant assumptions outlined in the table below. The expected volatility was estimated by using the historical volatility of other companies that the Company considers comparable that have trading and volatility history prior to the Company becoming public. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate was based on the United States three-year bond yield rate at the time of grant of the award. Expected annual rate of dividends is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. On January 3, 2020, under the Prior Plan, the Board awarded options to purchase shares to directors, officers, and key employees of the Company. In accordance with the Prior Plan’s policy, the vesting period for employees is 15% as of the date of issuance, 25% vested on December 31, 2020, and 60% vest on December 31, 2021. For founding members of the Board of Directors, the options were fully vested on the date of grant. For non-founding On January 4, 2021, under the Prior Plan, the Board awarded options to purchase shares to directors, officers, and key employees of the Company. In accordance with the Prior Plan’s policy, the vesting period for employees is 15% vest on December 31, 2021, 25% vest on December 31, 2022, and 60% vest on December 31, 2023. For founding and non-founding On September 29, 2021, under the 2021 Plan, the Board awarded options to purchase shares to officers and other select employees of the Company. The options vest over three years and have a contractual term between six 33 1/3 33 1/3 33 1/3 For the Nine Months For the Nine Months Fair value at grant date $10.58-$11.20 $3.11-$3.26 Stock price at grant date $26.88-$33.42 $11.52-$12.50 Exercise price at grant date $26.88-$33.42 $11.52-$12.50 Expected life in years 3.00 - 3.50 1.58 - 2.00 Expected volatility 49.88% - 53.75% 49.10% - 50.15% Expected annual rate of dividends 0% 0% Risk free annual interest rate 0.16% - 0.79% 1.40 - 1.58% For the nine months ended September 30, 2021, the Company recorded share-based compensation for all stock options in the amount of $2.2 million. This is recognized as $0.2 million cost of goods sold, net, $1.6 million general and administrative and $0.4 million sales and marketing in the condensed consolidated statements of operations and comprehensive income. The number and weighted-average exercise prices and remaining contractual life of options at September 30, 2021 were as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2021 1,129,774 11.72 4.01 — Granted 877,509 29.32 3.55 — Exercised (36,787 ) 11.52 — — Forfeited — — — — Outstanding, September 30, 2021 1,970,496 $ 19.56 4.52 $ 8.43 Exercisable, September 30, 2021 517,672 $ 11.71 3.34 $ 15.20 Total unvested options as of September 30, 2021, are 1,452,824 which are expected to vest over time and have an aggregate unrecognized compensation expense of $8.5 million. The unrecognized compensation expense will be recognized over a weighted average period of 2.09 years. As noted above, following shareholder approval of the 2021 Plan, no further grants of awards shall be made under the Prior Plan. Restricted Stock Units Restricted stock units (“RSUs”) represent a right to receive a single Subordinate Voting Share that is both non-transferable two two Number of Weighted average Balance as of January 1, 2021 — — Granted 3,249,319 25.45 Vested (2,904,079 ) 25.28 Forfeited — — Balance as of September 30, 2021 345,240 $ 26.88 No share-based compensation expense was recorded for RSUs during the three months ended September 30, 2021. In September 2021, the Board of Directors approved grants of RSUs for two executive officers who previously held warrants. The previously held warrants were cancelled on September 15, 2021 with the new RSUs granted on September 15, 2021 as a replacement of the previously held warrants. The two officers were awarded a total premium of $3.1 million, allocated between the two officers, to incentivize the cancellation and replacement. No share-based compensation expense was recorded related to the cancellation and replacement of the previous warrants with the new RSUs during the three months ended September 30, 2021. Warrants During the year ended December 31, 2018, the Company issued 8,784,872 warrants to certain employees and directors of the Company for past services provided. The warrants had no vesting conditions and are exercisable at any time for three years after the issuance, subject to certain lock-up 19-24 The following table summarizes the warrants issued and outstanding to certain employees and directors of the Company as of December 31, 2020 and the changes during the nine months ended September 30, 2021: Number of Weighted Weighted Outstanding as of January 1, 2021 6,061,561 6.00 0.72 Granted — — — Exercised (2,075,990 ) 6.00 — Exchanged in cashless exercise (413,057 ) — — Cancelled (3,572,514 ) — — Outstanding as of September 30, 2021 — — — Refer to the restricted stock unit disclosure above for additional information regarding the issuance of RSU’s in exchange for the cancelled warrants held by two executive officers.	13. SHARE BASED COMPENSATION Options The Company has a Stock Option Plan (the “Plan”) as administered by the board of directors of the Company. The aggregate number of Subordinate Voting Shares which may be reserved for issue under the Plan shall not exceed 10% of the issued and outstanding number of Subordinate Voting Shares. In determining the amount of share-based compensation related to options issued during the twelve months ended December 31, 2020, the Company used the Black-Scholes pricing model to establish the fair value of the options granted with the following assumptions: Year Ended December 31, 2020 Fair Value at Grant Date $ 3.11 – $3.26 Stock Price at Grant Date $ 11.52 – $12.50 Exercise Price at Grant Date $ 11.52 – $12.50 Expected Life in Years 1.58 – 2.00 Expected Volatility 49.10% –50.15 % Expected Annual Rate of Dividends 0 % Risk Free Annual Interest Rate 1.40% – 1.58 % The expected volatility was estimated by using the historical volatility of other companies that the Company considers comparable that have trading and volatility history prior to the Company becoming public. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate was based on the United States two-year bond On January 3, 2020, under the Plan, the Board awarded options to purchase shares to directors, officers, and key employees of the Company. In accordance with the Plan’s policy, the vesting period for employees is 15% as of the date of issuance, 25% vest on December 31, 2020, and 60% vest on December 31, 2021. For founding members of the board of directors, the options were fully vested on the date of grant. For non-founding For the twelve months ended December 31, 2020, the Company recorded share-based compensation in the amount of $2.8 million. This is recognized as $0.2 million Cost of Goods Sold, Net, $2.1 million General and Administrative and $0.5 million Sales and Marketing in the condensed consolidated interim statements of operations and comprehensive income. The number and weighted-average exercise prices and remaining contractual life of options at December 31, 2020 were as follows: Number of Options Weighted average exercise price Weighted Average Remaining Contractual Life (Yrs) Outstanding at January 1, 2020 — $ — — Granted 1,252,403 11.70 1.93 Exercised (9,180 ) 11.52 — Forfeited (113,444 ) 11.52 — Outstanding, December 31, 2020 1,129,779 11.72 1.92 Exercisable, December 31, 2020 554,456 $ 11.70 — Warrants During the year ended December 31, 2018, the Company issued 8,784,872 warrants to certain employees and directors of the Company for past services provided. The warrants had no vesting conditions and are exercisable at any time for three years after the issuance, subject to certain lock-up 19-24 The following table summarizes the warrants issued and outstanding to certain employees and directors of the Company as of December 31, 2020 and 2019 and the changes during the year ended December 31, 2020: Number of Warrants Weighted average exercise price ($CAD) Weighted Average Remaining Contractual Life (Yrs) Outstanding as of December 31, 2018 8,784,872 6.00 2.72 Granted — — — Exercised — — — Outstanding as of December 31, 2019 8,784,872 6.00 1.72 Granted — — — Exercised 2,723,311 — — Outstanding as of December 31, 2020 6,061,561 6.00 0.72 In determining the amount of share-based compensation related to warrants issued during the year, the Company used the Black-Scholes pricing model to establish the fair value of the warrants granted. The weighted-average grant date fair value was $1.71. The following were the assumptions utilized in the model during the year ended December 31, 2020 December 31, 2020 Stock Price ($CAD) $ 6.00 Exercise Price ($CAD) $ 6.00 Expected Life in Years 3.00 Annualized Volatility 51 % Annual Rate of Quarterly Dividends 0 % Discount Rate—Bond Equivalent Yield 3 % Volatility was estimated by using the historical volatility of other companies that the Company considers comparable that have trading and volatility history prior to the Company becoming public. The expected life in years represents the life of the warrants. The risk-free rate was based on the 3-year

Reverse Takeover Transaction

Reverse Takeover Transaction	12 Months Ended
	Dec. 31, 2020
Business Combinations [Abstract]
Business Combination Disclosure	14. REVERSE TAKEOVER TRANSACTION In July 2018, Trulieve, Inc. entered into a non-binding Pursuant to the reverse merger, the historical financial statements of Trulieve, Inc. (the accounting acquirer) become the historical financial statements of Schyan (legal acquirer) on a go forward basis. As a result, Trulieve, Inc. has retroactively restated its share capital on a per share basis pursuant to Accounting Standards Codification (ASC) 805, Business Combinations to reflect that of the legal acquirer. In consideration for the acquisition of Schyan, Trulieve is deemed to have issued 200,000 shares of Trulieve common stock representing $0.1 million total value based on the concurrent financing subscription price of $4.6328 “Note 13—Share Capital”. The excess of the purchase price over net assets acquired was charged to the consolidated balance sheet as a reduction in share capital. Schyan equity was eliminated. There were no identifiable assets of Schyan on the date of acquisition. The amounts below are accounted for as an offset to Additional Paid in Capital on the consolidated balance sheet as the transaction was accounted for as a recapitalization. The acquisition costs have been allocated as follows: Fair value of 200,000 shares issued $ 927 Transaction costs 460 Total purchase price $ 1,387

Prospectus Offering

Prospectus Offering	12 Months Ended
	Dec. 31, 2020
Prospectus Offering [Abstract]
Prospectus Offering	15. PROSPECTUS OFFERING On September 21, 2020, the Company concluded the offer and sale of 4,715,000 Subordinate Voting Shares pursuant to an agreement with Canaccord Genuity Corp. (the “Underwriter”) at a price of $18.56 per share. After paying the Underwriter a commission of approximately $4.1 million and issuance costs of $0.1 million, the Company received aggregate consideration of approximately $83.2 million. Net proceeds from the offering are expected to be used primarily to fund Trulieve’s business development and for general working capital purposes. The Company has made the required filings to list the offered securities on the Canadian Securities Exchange.

Earnings Per Share

Earnings Per Share	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	NOTE 14. EARNINGS PER SHARE The following is a reconciliation for the calculation of basic and diluted earnings per share for the three and nine months ended September 30, 2021 and 2020: For the Three Months Ended For the Nine Months Ended 2021 2020 2021 2020 (dollars in thousands) (dollars in thousands) Net income $ 18,616 $ 17,415 $ 89,574 $ 59,958 Weighted average number of common shares outstanding 128,146,298 112,039,640 122,983,729 111,824,816 Dilutive effect of warrants and options outstanding 8,762,968 5,909,584 7,943,354 4,173,888 Diluted weighted average number of common shares outstanding 136,909,266 117,949,224 130,927,083 115,998,704 Basic earnings per share $ 0.15 $ 0.16 $ 0.73 $ 0.54 Diluted earnings per share $ 0.14 $ 0.15 $ 0.68 $ 0.52	16. EARNINGS PER SHARE The following is a reconciliation for the calculation of basic and diluted earnings per share for the years ended December 31, 2020, 2019 and 2018: 2020 2019 2018 (dollars in thousands) Net Income $ 62,999 $ 53,094 $ 10,893 Weighted average number of common shares outstanding 113,572,379 110,206,103 101,697,002 Dilutive effect of warrants and options outstanding 4,753,345 5,111,839 1,504,125 Diluted weighted average number of common shares outstanding 118,325,724 115,317,942 103,201,127 Basic earnings per share $ 0.55 $ 0.48 $ 0.11 Diluted earnings per share $ 0.53 $ 0.46 $ 0.11

Income Taxes

Income Taxes	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 15. INCOME TAXES The following table summarizes the Company’s income tax expense and effective tax rate for the three and nine months ended September 30, 2021 and 2020 For the Three Months For the Nine Months 2021 2020 2021 2020 (dollars in thousands) (dollars in thousands) Income before provision for income taxes $ 60,219 $ 43,363 $ 194,828 $ 127,074 Provision for income taxes 41,603 25,948 105,254 67,116 Effective tax rate 69 % 60 % 54 % 53 %	17. INCOME TAXES The components of the income tax provision include: Year Ended December 31, 2020 2019 2018 (dollars in thousands) Current $ 99,338 $ 51,494 $ 22,697 Deferred (4,887 ) (908 ) (546 ) $ 94,451 $ 50,586 $ 22,151 A reconciliation of the Federal statutory income tax rate percentage to the effective tax rate is as follows: Year Ended December 31, 2020 2019 2018 (dollars in thousands) Income before income taxes $ 157,450 $ 103,680 $ 33,044 Federal statutory rate 21.0 % 21.0 % 21.0 % Theoretical tax expense 33,064 21,773 6,939 State taxes 12,406 9,477 4,366 Other (1,666 ) 1,310 1,176 Tax effect of non-deductible Nondeductible share based compensation — — 3,154 Section 280E permanent differences 50,646 18,026 6,517 61,386 28,813 15,212 Tax expense $ 94,451 $ 50,586 $ 22,151 Deferred income taxes consist of the following at December 31, 2020 and 2019, and 2018: Year Ended December 31, 2020 2019 2018 (dollars in thousands) Deferred tax assets Lease liability $ 1,219 $ 1,020 $ — Other deferred tax assets 7,025 969 570 Deferred tax liabilities Right of use assets (1,210 ) (1,099 ) — Intangible assets (26,446 ) (6,144 ) (3,080 ) Property and equipment (3,153 ) (233 ) (534 ) Lease payments (1,010 ) — — Net deferred tax liability $ (23,575 ) $ (5,486 ) $ (3,044 ) The Company has an income tax filing obligation in Canada as well, but as there is not expected to be any income for the parent Company, there is no associated tax liability related to the Canadian filing, and any deferred tax asset is not being recognized because it is unlikely the Company will generate sufficient taxable income in Canada to utilize these assets. The impact of an uncertain income tax position taken in our income tax return is recognized at the largest amount that is more-likely-than-not Uncertain tax positions of $3.9 million are recorded as other long-term liabilities in our consolidated balance sheet as of December 31, 2020 and 2019. No liability was recorded as of December 31, 2018. No interest and penalties were accrued based on the amount of estimated tax payments made through December 31, 2020.

Related Parties

Related Parties	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Parties	NOTE 16. RELATED PARTIES The Company had raised funds by issuing notes to various related parties including directors, officers, and shareholders and the balance at September 30, 2021 and December 31, 2020 was $12.0 million and $12.0 million, respectively, as discussed in “Note 8 – Notes Payable Related Party” J.T. Burnette, the spouse of Kim Rivers, the Chief Executive Officer and Chair of the board of directors of the Company, is a minority owner of a company (the “Supplier”) that provides construction and related services to the Company. The Supplier is responsible for the construction of the Company’s cultivation and processing facilities, and provides labor, materials and equipment on a cost-plus basis. For the nine months ended September 30, 2021 and 2020, property and equipment purchases totaled $119.6 million, and $65.0 million, respectively. As of September 30, 2021 and December 31, 2020, $14.7 million and $10.4 million, respectively, of property and equipment purchases was included in accounts payable in the condensed consolidated balance sheets. The use of the Supplier was reviewed and approved by the independent members of the Company’s board of directors, and all invoices of the Supplier are reviewed by the office of the Company’s Chief Legal Officer. The Company has many leases from various real estate holding companies that are managed by various related parties including Benjamin Atkins, a former director and current shareholder of the Company, and the Supplier. As of September 30, 2021 and December 31, 2020, under ASC 842, the Company had the following in the condensed consolidated balance sheet: As of September 30, 2021 As of December 31, 2020 Operating Finance Operating Finance (dollars in thousands) (dollars in thousands) Right-of-use $ 6,116 $ 2,080 $ 12,003 $ 3,425 Lease liabilities: Lease liabilities—current portion 725 207 1,539 281 Lease liabilities 5,790 2,184 11,083 3,500 Total related parties lease liabilities $ 6,515 $ 2,391 $ 12,622 $ 3,781 Expenses recognized for related party leases were $0.9 million and $2.4 million for the three and nine months ended September 30, 2021, respectively. Expenses recognized for related party leases were $0.9 million and $2.6 million for the three and nine months ended September 30, 2020, respectively.	18. RELATED PARTIES The Company had raised funds by issuing notes to various related parties including directors, officers, and shareholders and the balance at December 31, 2020 and 2019 was $12.0 million and $13.0 million, respectively, as discussed in “Note 8—Notes Payable Related Party” J.T. Burnette, the spouse of Kim Rivers, the Chief Executive Officer and Chair of the board of directors of the Company, is a minority owner of a company (the “Supplier”) that provides construction and related services to the Company. The Supplier is responsible for the construction of the Company’s cultivation and processing facilities, and provides labor, materials and equipment on a cost-plus basis. For the years ended December 31, 2020 and 2019 and 2018, property and equipment purchases totaled $96.7 million, $46.4 million and $12.1 million, respectively. As of December 31, 2020, and 2019, $10.4 million and $6.5 million was included in accounts payable in the consolidated balance sheets, as discussed in “ Note 5—Property and Equipment The Company has many leases from various real estate holding companies that are managed by various related parties including Benjamin Atkins, a former director and current shareholder of the Company, and the Supplier. As of December 31, 2020, and 2019, under ASC 842, the Company had $15.4 million and $18.9 million of right-of-use

Contingencies

Contingencies	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Contingencies	NOTE 17. CONTINGENCIES (a) Operating Licenses Although the possession, cultivation and distribution of cannabis for medical use is permitted in Florida, Massachusetts, California, Connecticut, Pennsylvania and West Virginia, cannabis is a Schedule-I (b) Claims and Litigation From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. Except as disclosed below, at September 30, 2021, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s condensed consolidated statements of operations and comprehensive income. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest. On December 30, 2019, a securities class-action complaint, David McNear v. Trulieve Cannabis Corp. et al. 1:19-cv-07289, Monica Acerra v. Trulieve Cannabis Corp. et al. 1:20-cv-00775, 10b-5 In re Trulieve Cannabis Corp. Securities Litigation 1:19-cv-07289,	19. CONTINGENCIES (a) Operating Licenses Although the possession, cultivation and distribution of cannabis for medical use is permitted in Florida, California, Connecticut, Pennsylvania and West Virginia cannabis is a Schedule-I (b) Claims and Litigation From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. Except as disclosed below, at December 31, 2020, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s consolidated statements of operations and comprehensive income. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest. On December 30, 2019, a securities class-action complaint, David McNear v. Trulieve Cannabis Corp. et al. 1:19-cv-07289, Monica Acerra v. Trulieve Cannabis Corp. et al. 1:20-cv-00775, 10b-5 In re Trulieve Cannabis Corp. Securities Litigation 1:19-cv-07289,

Financial Instruments and Finan

Financial Instruments and Financial Risk Management	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Financial Instruments and Financial Risk Management	20. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (a) Financial Instruments The Company’s financial instruments consist of money market funds and warrant liability, to the point at which the warrants were converted to equity. Our financial instruments where carrying value approximates the fair value include cash, accounts payable and accrued liabilities, notes payable, notes payable related party, operating lease liability, finance lease liability, other long-term liabilities and construction finance liability. Excluding the money market funds and warrant liability classified at fair value, the carrying values of these financial instruments approximate their fair values at December 31, 2020 and 2019 due to their short-term nature or because the effective interest rate applied to the balance approximates the market rate. Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs to fair value measurements. The three levels of hierarchy are: Level 1 – Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices in active markets, that are observable for the asset or liability, either directly or indirectly; and Level 3 – Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions. The warrants liability is classified within level 2 of the fair value hierarchy. There have been no transfers between hierarchy levels during the years ended December 31, 2020 and 2019, respectively. The following tables present information about the Company’s financial instruments and their classifications as of December 31, 2020 and 2019 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: Fair Value Measurements at December 31, 2020 using: Level 1 Level 2 Level 3 Total (dollars in thousands) Financial Assets: Money Market Funds(1) $ 65,516 $ — $ — $ 65,516 Financial Liabilities: Warrant Liability(3) $ — $ — $ — $ — Fair Value Measurements at December 31, 2019 using: Level 1 Level 2 Level 3 Total (dollars in thousands) Financial Assets: Money Market Funds(1) $ 77,993 $ — $ — $ 77,993 Financial Liabilities: Warrant Liability(2) $ — $ 9,892 $ — $ 9,892 (1) Money market funds are included within cash and cash equivalents in the Company’s consolidated balance sheets. As a short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that is fair value. (2) During the year ended December 31, 2020, the Company converted subordinate voting purchase warrants for the June and November debt to equity. (3) During the year ended December 31, 2019, the Company issued subordinate voting purchase warrants with the June and November debt see “Note 9—Debt” (b) Liquidity Risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages its liquidity risk by reviewing on an ongoing basis its capital requirements. During the year ended December 31, 2020, the Company completed several Debt financings see “ Note 9—Debt”. The following table summarizes the Company’s contractual cash flows: <1 Year 1 to 3 Years 3 to 5 Years >5 Years Total Accounts Payable and Accrued Liabilities $ 41,902 $ — $ — $ — $ 41,902 Notes Payable 2,000 4,000 — — 6,000 Notes Payable—Related Party 12,011 — — — 12,011 Other Long-Term Liabilities — — 130,000 — 130,000 Operating Lease Liability 5,480 10,681 9,764 14,225 40,150 Finance Lease Liability 6,964 12,899 11,375 24,669 55,907 Construction Finance Liability $ — $ — $ 61,071 $ 20,977 $ 82,047 A summary for future minimum lease payments due under our Lease Liability has been disclosed in “ Note 10—Leases (c) Credit Risk Management does not believe that the Company has credit risk related to its customers, as the Company’s revenue is generated primarily through cash transactions. The Company deals almost entirely with on demand sales and does not have any material wholesale agreements as of December 31, 2020. Concentrations of credit risk with respect to our cash and cash equivalents are limited primarily to amounts held with financial institutions. (d) Market Risk (i) Interest Rate Risk Interest rate risk is the risk that the fair value or the future cash flows of a financial instrument will fluctuate as a result of changes in market interest rates. Interest rates have a direct impact on the valuation of the Company’s debt warrants whose value is calculated by using the Black-Scholes method for fair value calculation, for which interest rates are a key assumption used in the Black-Scholes valuation model. (ii) Concentration Risk The Company operates substantially in Florida. Should economic conditions deteriorate within that region, its results of operations and financial position would be negatively impacted. (e) Banking risk Notwithstanding that a majority of states have legalized medical marijuana, there has been no change in U.S. federal banking laws related to the deposit and holding of funds derived from activities related to the marijuana industry. Given that U.S. federal law provides that the production and possession of cannabis is illegal, there is a strong argument that banks cannot accept for deposit funds from businesses involved with the marijuana industry. Consequently, businesses involved in the marijuana industry often have difficulty accessing the U.S. banking system and traditional financing sources. The inability to open bank accounts with certain institutions may make it difficult to operate the businesses of the Company, its subsidiaries and investee companies, and leaves their cash holdings vulnerable. The Company has banking relationships in all jurisdictions in which it operates. In addition, the Company has cash balances in excess of Federal Deposit Insurance Corporation (the “FDIC”) limits, which results in the cash in excess of the FDIC limits being at risk if the financial institutions with which it does business fail. (f) COVID-19 The Company’s business could be materially and adversely affected by the outbreak of a widespread epidemic or pandemic or other public health crisis, including arising from the novel strain of the coronavirus known as COVID-19. This of COVID-19 could

Subsequent Events

Subsequent Events	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 18. SUBSEQUENT EVENTS Harvest Health & Recreation On October 1, 2021 (the “Closing Date”), the Company completed its previously announced acquisition of Harvest Health & Recreation Inc. (“Harvest”) pursuant to an Arrangement Agreement, dated May 10, 2021 (“the Arrangement Agreement”). On the Closing Date, the Company acquired all of the issued and outstanding subordinate voting shares, multiple voting shares and super voting shares (collectively the “Harvest Shares”) of Harvest. Pursuant to the terms of the Arrangement Agreement, holders of Harvest Shares received 0.1170 of a Subordinate Voting Share of the Company for each subordinate voting share of Harvest held. In total, the Company issued an aggregate of 50,874,175 Trulieve Shares, representing a value of $1.4 billion, in connection with the exchange for all of the issued and outstanding Harvest shares. The acquisition will be accounted for as a business combination in accordance with the Accounting Standards Codification (ASC) 805, Business Combinations. The Company has begun the process to determine the purchase price allocation for the assets acquired and liabilities assumed including estimating the fair values of intangible and tangible assets. Due to the limited time since the acquisition, these estimates and the initial accounting for the business combination have not been completed. As a result, the Company is unable to provide the amounts recognized as of the acquisition date for the major classes of assets acquired and liabilities assumed. Senior Secured Notes Due 2026 On October 6, 2021, the Company closed its previously announced private placement of 8% Senior Secured Notes (the “Notes”) for aggregate gross proceeds of $350.0 million and net proceeds of $342.6 million. The Notes were issued at 100% face value, bear an interest rate of 8% per annum payable semi-annually in equal installments until the maturity date, unless earlier redeemed or repurchased. The Notes will mature on October 6, 2026 and may be redeemed in whole or in part, at any time from time to time, on or after October 6, 2023 at the application redemption price set forth in the Indenture. The Company used a portion of the net proceeds to redeem certain outstanding indebtedness of Harvest, and intends to use the remaining net proceeds for capital expenditures and other general corporate purposes.	21. SUBSEQUENT EVENTS The Company has evaluated subsequent events through March 22, 2021, which is the date these consolidated financial statements were approved by the board of directors of the Company. On March 22, 2021, we entered into a membership interest purchase agreement with Mountaineer Holding, LLC (“Mountaineer”). Mountaineer holds a West Virginia cultivation license and two dispensary licenses. We expected the transaction to close promptly following regulatory approval. On March 21, 2021, in accordance with the terms of our Articles, an aggregate of 551,614 outstanding Super Voting Shares converted automatically, without any action by the holders of such Super Voting Shares, into an aggregate of 551,614 Multiple Voting Shares.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Revision of Previously Issued Financial Statements	Revision of Previously Issued Financial Statements During the quarter ended September 30, 2021, the Company identified an error in its accounting for leases which was due to the lack of a complete lease population and the conclusions reached for the commencement date for leases not aligning with the possession date of the associated right of use asset. This resulted in an understatement of the associated right of use assets and the associated lease liabilities. The Company also identified a misstatement related to the accounting for asset acquisitions that were consummated during the three months ended June 30, 2021, which was due to the Company initially valuing the equity consideration transferred using the contract value whereas the fair value as of the closing date should have been used. This resulted in an understatement of intangible assets, an understatement of the associated deferred tax liabilities and an understatement of additional paid-in-capital. To correct the immaterial misstatements, during the quarter ended September 30, 2021, the Company elected to revise its previously issued interim unaudited condensed consolidated balance sheet as of June 30, 2021 and March 31, 2021 as well as the previously issued 2020 condensed consolidated balance sheet. The revision of the historical interim unaudited condensed consolidated balance sheet includes the correction of these immaterial misstatements as well as other previously identified balance sheet misclassifications. Accordingly, the accompanying interim unaudited condensed consolidated balance sheet and relevant footnotes in this Quarterly Report on Form 10-Q 10-Q. The The impact of the revision on the Company’s interim unaudited condensed consolidated balance sheet as of June 30, 2021 is reflected in the following table: Balance Sheet as of June 30, 2021 (unaudited) As Previously Adjustment As Revised Prepaid expenses and other current assets $ 28,313 $ (4,249 ) $ 24,064 Total current assets 442,090 (4,249 ) 437,841 Property and equipment, net 427,666 258 427,924 Right of use assets—operating, net 31,254 8,768 40,022 Right of use assets—finance, net 41,521 6,371 47,892 Intangible assets, net 123,106 (621 ) 122,485 Other assets 9,547 4,246 13,793 Total assets 1,146,307 14,773 1,161,080 Operating lease liabilities, current portion 3,583 432 4,015 Finance lease liabilities, current portion 4,723 281 5,004 Total current liabilities 76,738 713 77,451 Operating lease liabilities 29,381 8,396 37,777 Finance lease liabilities 39,694 5,822 45,516 Deferred tax liability 29,845 (2,213 ) 27,632 Total liabilities 390,072 12,718 402,790 Additional paid-in-capital 522,898 2,055 524,953 Total shareholders equity $ 756,235 $ 2,055 $ 758,290 Balance Sheet as of March 31, 2021 (unaudited) As Previously Adjustment As Revised Prepaid expenses and other current assets $ 25,180 $ (3,728 ) $ 21,452 Total current assets 294,157 (3,728 ) 290,429 Right of use assets—operating, net 30,051 2,830 32,881 Right of use assets—finance, net 38,380 1,838 40,218 Other assets 7,549 3,693 11,242 Total assets 897,455 4,633 902,088 Operating lease liabilities, current portion 3,324 173 3,497 Finance lease liabilities, current portion 4,344 70 4,414 Total current liabilities 100,900 243 101,143 Operating lease liabilities 28,326 2,581 30,907 Finance lease liabilities 36,294 1,809 38,103 Total liabilities $ 411,871 $ 4,633 $ 416,504 Balance Sheet as of December 31, 2020 As Previously Adjustment As Revised Prepaid expenses and other current assets $ 19,815 $ (3,696 ) $ 16,119 Total current assets 265,148 (3,696 ) 261,452 Right of use assets—operating, net 28,171 1,905 30,076 Other assets 3,944 3,584 7,528 Total assets 816,112 1,793 817,905 Operating lease liabilities, current portion 3,154 123 3,277 Total current liabilities 75,998 123 76,121 Operating lease liabilities 26,450 1,670 28,120 Total liabilities $ 368,208 $ 1,793 $ 370,001 The Company recorded operating lease expense, depreciation, and interest expense totaling $0.3 million in the income statement for the three months ended September 30, 2021 that related to these expenses from prior periods. This had .
Significant Accounting Policies	Significant Accounting Policies The Company’s significant accounting policies are described in Note 2 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K 10-K”). 2019-12 In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes 2019-12 ASU 2019-12
COVID-19 Pandemic	COVID-19 The global outbreak of the novel strain of the coronavirus known as COVID-19 non-essential shelters-in-place COVID-19, COVID-19

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	(a) Basis of Presentation The accompanying consolidated financial statements present the consolidated financial position and operations of Trulieve Cannabis Corp. and its subsidiaries as of and for the years ended December 31, 2020 and 2019 (the “consolidated financial statements”) in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
Functional Currency	(b) Functional Currency The functional currency of the Company and its subsidiaries, as determined by management, is the United States (“U.S.”) dollar. These consolidated financial statements are presented in U.S. dollars.
Basis of Consolidation	(c) Basis of Consolidation These consolidated financial statements include the financial information of the Company and its subsidiaries, Trulieve, Inc., Life Essence, Inc., Leef Industries, LLC, Trulieve Bristol, Inc. “Healing Corner”, PurePenn LLC, and Keystone Relief Centers “Solevo”. The accounts of the subsidiaries are prepared for the same reporting period using consistent accounting policies. All of the consolidated entities were under common control during the entirety of the periods for which their respective results of operations were included in the consolidated financial statements (i.e., from the date of their acquisition). See “Note 3—Acquisitions”
Cash and Cash Equivalents	(d) Cash and Cash Equivalents The Company considers cash deposits and all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include cash deposits in financial institutions plus cash held at retail locations. Cash held in money market investments are carried at fair value, cash held in financial institutions and cash held at retail locations, have carrying values that approximate fair value.
Inventory	(e) Inventory Inventories are primarily comprised of raw materials, internally produced work in process, finished goods and packaging materials. Costs incurred during the growing and production process are capitalized as incurred to the extent that cost is less than net realizable value. These costs include materials, labor and manufacturing overhead used in the growing and production processes. The Company capitalizes pre-harvest Inventories of purchased finished goods and packing materials are initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion, disposal and transportation for inventories in process. The Company periodically reviews its inventory and identifies that which is excess, slow moving and obsolete by considering factors such as inventory levels, expected product life and forecasted sales demand. Any identified excess, slow moving and obsolete inventory is written down to its net realizable value through a charge to cost of goods sold. The Company did not recognize any inventory reserves as of December 31, 2020 and 2019.
Property and Equipment	(f) Property and Equipment Property and equipment are measured at cost less accumulated depreciation and impairment losses. Depreciation is recognized on a straight-line basis over the following terms: Land Not Depreciated Buildings & Improvements 7 to 40 Years Furniture & Equipment 3 to 10 Years Vehicles 3 to 5 Years Construction in Progress Not Depreciated Leasehold Improvements The lesser of the life of the lease or the estimated useful life of the asset An asset’s residual value, useful life and depreciation method are reviewed during each financial year and adjusted if appropriate. Property and equipment, as well as right-of-use An impairment charge is recorded for the excess of the asset’s carrying value over its fair value, if any. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. The Company did not record any impairment charges on these long-lived assets during the years ended December 31, 2020 and 2019. Gains or losses on disposal of an item are determined by comparing the proceeds from disposal with the carrying amount of the item and recognized in the statement of operations and comprehensive income. Construction in progress is transferred when available f o The Company capitalizes interest on debt financing invested in projects under construction. Upon the asset becoming available for use, capitalized interest costs, as a portion of the total cost of the asset, are depreciated over the estimated useful life of the related asset.
Intangible Assets	(g) Intangible Assets Intangible assets are recorded at cost, less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Intangible assets that have indefinite useful lives are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. The estimated useful lives, residual values and amortization methods are reviewed at each year-end, Intangible assets are amortized using the straight-line method over estimated useful lives as follows: Dispensary License 15 Tradenames 2 to 10 Customer Relationship 5 Years Moxie Brand 3 Years Non-Compete 2 Years Trademarks 6 months to 1 Year
Goodwill	(h) Goodwill Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill is either assigned to a specific reporting unit or allocated between reporting units based on the relative fair value of each reporting unit. Goodwill is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. The Company reviews indefinite lived assets, including goodwill, annually at fiscal year-end The Company assesses the fair values of its intangible assets, and its reporting unit for goodwill testing purposes, as necessary, using an income-based approach. Under the income approach, fair value is based on the present value of estimated future cash flows. The Company operates as one operating segment and reporting unit and therefore, evaluates goodwill and other intangible assets with indefinite lives for impairment annually as one singular reporting unit once a year or more often when an event occurs or circumstances indicate the carrying value may not be recoverable The Company’s policy is to first perform a qualitative assessment to determine if it was more-likely-than-not that The Company did not identify any impairment of its goodwill at December 31, 2020 and 2019.
Accounts Payable and Accrued Liabilities	(i) Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consist of: Year Ended December 31, 2020 2019 (dollars in thousands) Trade Accounts Payable $ 9,247 $ 9,954 Trade Accounts Payable—Related Party 10,403 6,463 Accrued Payroll 11,030 5,822 Other Payables and Accrued Liabilities 11,222 2,069 Total Accounts Payable and Accrued Liabilities $ 41,902 $ 24,308
Leases	(j) Leases In February 2016, the FASB issued ASU 2016-02, Leases (ASC The new standard was effective for the Company beginning January 1, 2019 and the standard was adopted using the modified retrospective transition approach, which allows the Company to recognize a cumulative effect adjustment to the opening balance of accumulated earnings in the period of adoption rather than restate comparative prior year periods. The cumulative effect adjustment to the opening balance of accumulated earnings is zero because (i) the Company does not have any unamortized initial direct costs as of January 1, 2019 that need to be written off; and (ii) the Company does not have any deferred gain or loss from our previous sale and operating leaseback transactions that need to be recognized. See “ Note 10—Leases
Revenue Recognition	(k) Revenue Recognition Revenue is recognized by the Company in accordance with ASU 2014-09, Revenue In order to recognize revenue under ASU 2014-09, the • Identify a customer along with a corresponding contract; • Identify the performance obligation(s) in the contract to transfer goods or provide distinct services to a customer; • Determine the transaction price the Company expects to be entitled to in exchange for transferring promised goods or services to a customer; • Allocate the transaction price to the performance obligation(s) in the contract; and • Recognize revenue when or as the Company satisfies the performance obligation(s). The Company’s contracts with customers for the sale of dried cannabis, cannabis oil and other cannabis related products consist of multiple performance obligations. Revenue from the direct sale of cannabis to customers for a fixed price is recognized when the Company transfers control of the goods to the customer at the point of sale and the customer has paid for the goods. The Company has a loyalty rewards program that allows customers to earn reward credits to be used on future purchases. Loyalty reward credit issued as part of a sales transaction results in revenue being deferred until the loyalty reward is redeemed by the customer. The loyalty rewards are shown as reductions to ‘revenue, net of discounts’ line on the accompanying consolidated statements of operations and comprehensive income and included as deferred revenue on the consolidated balance sheet. Contract assets are defined in the standard to include amounts that represent the right to receive payment for goods and services that have been transferred to the customer with rights conditional upon something other than the passage of time. Contract liabilities are defined in the standard to include amounts that reflect obligations to provide goods and services for which payment has been received. There are no contract assets on unsatisfied performance obligations as of December 31, 2020 and 2019. For some of its locations, the Company offers a loyalty reward program to its dispensary customers. A portion of the revenue generated in a sale must be allocated to the loyalty points earned. The amount allocated to the points earned is deferred until the loyalty points are redeemed or expire. As of December 31, 2020 and 2019, the loyalty liability totaled $5.3 million and $2.4 million, respectively, that is included in deferred revenue on the consolidated balance sheet.
Income Taxes	(l) Income Taxes The Company uses the asset and liability method to account for income taxes. Deferred income tax assets and liabilities are determined based on enacted tax rates and laws for the years in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As the Company operates in the cannabis industry, it is subject to the limits of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production. The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not
Financial Instruments	(m) Financial Instruments The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk. Classification of financial instruments The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices in active markets, that are observable for the asset or liability, either directly or indirectly; and Level 3 – Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.
Warrant Liability	(n) Warrant Liability The Company has issued subordinate voting share purchase warrants for the June and November debt, see “Note 9—Debt”. The June and November Warrants related to the June and November debt are governed by a warrant indenture date June 18, 2019 as supplemented pursuant to a supplement dated November 7, 2019. Each Warrant entitled the holder thereof to purchase one Subordinate Voting Share at an exercise price of C$17.25 per share at any time prior to June 18, 2022, subject to adjustment in certain events. The Warrant indenture provides that the share ratio and exercise price of the Note Warrants will be subject to adjustment in the event of a subdivision or consolidation of the Subordinate Voting Shares. On December 10, 2020, the Company entered into a Supplemental Warrant Indenture with Odyssey Trust Company pursuant to which it amended the terms of the issued and outstanding subordinate voting share purchase warrants of the Company (the “Public Warrants”) to convert the exercise price of the Public Warrants to $13.47 per share, the U.S. dollar equivalent of the Canadian dollar exercise price of the Public Warrants of C$17.25. The U.S. dollar exercise price was determined using the U.S. dollar exchange rate published by the Bank of Canada at the close of business on December 9, 2020 of C$1.00 = $0.781. See “ Note 9—Debt
Share Capital	(o) Share Capital Common shares are classified as equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the vesting periods are recorded as share capital. Incremental costs directly attributable to the issuance of shares are recognized as a deduction from equity.
Earnings Per Share	(p) Earnings Per Share The Company computes basic earnings attributable to common shareholders per share by dividing net income attributable to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted earnings per share attributable to shareholders gives effect to all potential dilutive shares outstanding during the period. The number of dilutive shares is calculated using the treasury stock method which reduces the effective number of shares by the amount of shares the Company could purchase with the proceeds of assumed exercises.
Advertising Costs	(q) Advertising Costs Advertising costs which are expensed as incurred and are included in sales and marketing expenses were $2.1 million, $1.9 million and $0.3 million for the years ended December 31, 2020 2019, and 2018, respectively.
Net Income and Comprehensive Income	(r) Net Income and Comprehensive Income The Company does not have any elements of other comprehensive income, therefore net income and comprehensive income are the same.
Critical accounting estimates and judgments	(s) Critical accounting estimates and judgments The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. Significant judgments, estimates and assumptions that have the most significant effect on the amounts recognized in the consolidated financial statements are described below. Accounting for acquisitions and business combinations The Company has treated the acquisitions described in Note 3 (a) (b) and (c) The Company has treated the acquisitions described in Note 3 (d) and (e) Inventories The net realizable value of inventories represents the estimated selling price for inventories in the ordinary course of business, less all estimated costs of completion and costs necessary to make the sale. The determination of net realizable value requires significant judgment, including consideration of factors such as shrinkage, the aging of and future demand for inventory, expected future selling price, what we expect to realize by selling the inventory and the contractual arrangements with customers. Reserves for excess and obsolete inventory are based upon quantities on hand, projected volumes from demand forecasts and net realizable value. The estimates are judgmental in nature and are made at a point in time, using available information, expected business plans and expected market conditions. As a result, the actual amount received on sale could differ from the estimated value of inventory. Periodic reviews are performed on the inventory balance. The impact of changes in inventory reserves is reflected in cost of goods sold. Goodwill impairment Goodwill is tested for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of goodwill may have been impaired. In order to determine that the value of goodwill may have been impaired, the Company performs a qualitative assessment to determine that it was more-likely-than-not if Leases—(ASU 842) Leases requires lessees to discount lease payments using the rate implicit in the lease if that rate is readily available in accordance with ASU 842. If that rate cannot be readily determined, the lessee is required to use its incremental borrowing rate. The Company generally uses the incremental borrowing rate when initially recording real estate leases. Information from the lessor regarding the fair value of underlying assets and initial direct costs incurred by the lessor related to the leased assets is not available. The Company determines the incremental borrowing rate as the interest rate the Company would pay to borrow over a similar term the funds necessary to obtain an asset of a similar value to the right-of-use non-cancellable Estimated useful lives and depreciation and amortization of property and equipment and intangible assets Depreciation and amortization of property and equipment and intangible assets are dependent upon estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets. Share-based payment arrangements The Company uses the Black-Scholes pricing model to determine the fair value of warrants granted to employees and directors under share-based payment arrangements, where appropriate. In estimating fair value, management is required to make certain assumptions and estimates such as the expected life of units, volatility of the Company’s future share price, risk free rates, and future dividend yields at the initial grant date. Changes in assumptions used to estimate fair value could result in materially different results. The Company classified its stock warrants as either liability or equity instruments in accordance with ASC 480, “Distinguishing Liabilities from Equity” (ASC 480) and ASC 815, “Derivatives and Hedging” (ASC 815), depending on the specific terms of the warrant agreement. Because of the Canadian denominated exercise price, the June and November Warrants did not qualify to be classified within equity and were therefore classified as derivative liabilities at fair value with changes to earnings in the statements of operations. On December 10, 2020, the Company amended the terms of the Warrants to convert the exercise price of the Warrants to U.S. Dollar which were then classified as equity on the consolidated Balance Sheet. The fair value of all warrants issued are determined by using the Black-Scholes valuation technique and were assigned based on the relative fair value of both the debt and the warrants issued.
Recently Issued Accounting Pronouncements	(t) Recently Issued Accounting Pronouncements Recent accounting pronouncements, other than those below, issued by the FASB, the AICPA and the SEC did not or are not believed by management to have a material effect on the Company’s present or future financial statements. In February 2016, the FASB issued ASU No. 2016-02, Note 10—Leases In June 2016, the FASB issued ASU 2016-13, 2016-13 ASU 2016-13 will 2016-13 In August 2018, the FASB issued ASU 2018-13, 2018-13 2018-13 2018-13 In December 2019, the FASB issued ASU 2019-12, 2019-12 2019-12

Basis of Presentation (Tables)

Basis of Presentation (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Impact of Revision on Interim Unaudited Condensed Consolidated Balance Sheet	The impact of the revision on the Company’s interim unaudited condensed consolidated balance sheet as of June 30, 2021 is reflected in the following table: Balance Sheet as of June 30, 2021 (unaudited) As Previously Adjustment As Revised Prepaid expenses and other current assets $ 28,313 $ (4,249 ) $ 24,064 Total current assets 442,090 (4,249 ) 437,841 Property and equipment, net 427,666 258 427,924 Right of use assets—operating, net 31,254 8,768 40,022 Right of use assets—finance, net 41,521 6,371 47,892 Intangible assets, net 123,106 (621 ) 122,485 Other assets 9,547 4,246 13,793 Total assets 1,146,307 14,773 1,161,080 Operating lease liabilities, current portion 3,583 432 4,015 Finance lease liabilities, current portion 4,723 281 5,004 Total current liabilities 76,738 713 77,451 Operating lease liabilities 29,381 8,396 37,777 Finance lease liabilities 39,694 5,822 45,516 Deferred tax liability 29,845 (2,213 ) 27,632 Total liabilities 390,072 12,718 402,790 Additional paid-in-capital 522,898 2,055 524,953 Total shareholders equity $ 756,235 $ 2,055 $ 758,290 Balance Sheet as of March 31, 2021 (unaudited) As Previously Adjustment As Revised Prepaid expenses and other current assets $ 25,180 $ (3,728 ) $ 21,452 Total current assets 294,157 (3,728 ) 290,429 Right of use assets—operating, net 30,051 2,830 32,881 Right of use assets—finance, net 38,380 1,838 40,218 Other assets 7,549 3,693 11,242 Total assets 897,455 4,633 902,088 Operating lease liabilities, current portion 3,324 173 3,497 Finance lease liabilities, current portion 4,344 70 4,414 Total current liabilities 100,900 243 101,143 Operating lease liabilities 28,326 2,581 30,907 Finance lease liabilities 36,294 1,809 38,103 Total liabilities $ 411,871 $ 4,633 $ 416,504 Balance Sheet as of December 31, 2020 As Previously Adjustment As Revised Prepaid expenses and other current assets $ 19,815 $ (3,696 ) $ 16,119 Total current assets 265,148 (3,696 ) 261,452 Right of use assets—operating, net 28,171 1,905 30,076 Other assets 3,944 3,584 7,528 Total assets 816,112 1,793 817,905 Operating lease liabilities, current portion 3,154 123 3,277 Total current liabilities 75,998 123 76,121 Operating lease liabilities 26,450 1,670 28,120 Total liabilities $ 368,208 $ 1,793 $ 370,001

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of Property Plant and Equipment Useful Life	Property and equipment are measured at cost less accumulated depreciation and impairment losses. Depreciation is recognized on a straight-line basis over the following terms: Land Not Depreciated Buildings & Improvements 7 to 40 Years Furniture & Equipment 3 to 10 Years Vehicles 3 to 5 Years Construction in Progress Not Depreciated Leasehold Improvements The lesser of the life of the lease or the estimated useful life of the asset
Schedule of Intangible Assets are Amortized using Straight Line Method Over Estimated Useful Lives	Intangible assets are amortized using the straight-line method over estimated useful lives as follows: Dispensary License 15 Tradenames 2 to 10 Customer Relationship 5 Years Moxie Brand 3 Years Non-Compete 2 Years Trademarks 6 months to 1 Year
Summary Of Accounts Payable and Accrued Liabilities	Accounts payable and accrued liabilities consist of: Year Ended December 31, 2020 2019 (dollars in thousands) Trade Accounts Payable $ 9,247 $ 9,954 Trade Accounts Payable—Related Party 10,403 6,463 Accrued Payroll 11,030 5,822 Other Payables and Accrued Liabilities 11,222 2,069 Total Accounts Payable and Accrued Liabilities $ 41,902 $ 24,308

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
PurePenn, LLC and Pioneer Leasing & Consulting, LLC
Summary of Allocation of Consideration Exchanged for Estimated/Final Fair Value of Tangible and Identifiable Intangible Assets Acquired and Liabilities Assumed	The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 19,000 Shares issued upon acquisition 29,711 Contingent consideration payable in shares 46,951 Fair value of consideration exchanged $ 95,662 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 563 Accounts receivable 1,300 Prepaid expenses and other current assets 376 Inventories 7,461 Property and equipment, net 26,233 Intangible assets, net: State license 45,310 Moxie license 2,960 Tradename 580 Goodwill 46,349 Other assets 478 Accounts payable and accrued liabilities (2,189 ) Construction finance liability (17,413 ) Deferred tax liability (16,346 ) Total net assets acquired $ 95,662	The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 19,000 Shares issued upon issuance 27,000 Contingent consideration payable in shares 50,000 Fair value of consideration exchanged $ 96,000 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 563 Accounts receivable 1,300 Prepaids and other current assets 376 Inventory 7,461 Property and equipment, net 26,233 Intangible assets: Tradename 580 Moxie license 2,960 State license 45,310 Goodwill 47,311 Other assets 478 Accounts payable and accrued expenses (2,189 ) Construction liability (17,413 ) Deferred tax liability (16,970 ) Total net assets acquired 96,000
Keystone Relief Centers LLC
Summary of Allocation of Consideration Exchanged for Estimated/Final Fair Value of Tangible and Identifiable Intangible Assets Acquired and Liabilities Assumed	The following table summarizes the final allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 10,000 Shares issued upon acquisition 11,004 Contingent consideration payable in shares 15,249 Net working capital adjustment 624 Fair value of consideration exchanged $ 36,877 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 1,229 Accounts receivable 117 Prepaid expenses and other current assets 91 Inventories 2,337 Property and equipment, net 2,245 Right of use asset 2,156 Intangible assets, net: Dispensary license 19,890 Tradename 930 Goodwill 17,985 Accounts payable and accrued liabilities (790 ) Lease liability (2,156 ) Deferred tax liability (7,157 ) Total net assets acquired $ 36,877	The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 10,000 Shares issued upon issuance 10,000 Contingent consideration payable in shares 15,000 Net working capital adjustment 715 Fair value of consideration exchanged $ 35,715 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 1,229 Accounts receivable 117 Prepaids and other current assets 91 Inventory 2,337 Property and equipment, net 2,245 Right of use asset 2,156 Intangible assets: Dispensary License 16,090 Tradename 930 Goodwill 19,473 Accounts payable and accrued expenses (790 ) Lease liability (2,156 ) Deferred tax liability (6,007 ) Total net assets acquired $ 35,715
The Healing Corner, Inc [Member]
Summary of Allocation of Consideration Exchanged for Estimated/Final Fair Value of Tangible and Identifiable Intangible Assets Acquired and Liabilities Assumed		The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 19,900 Fair value of consideration exchanged $ 19,900 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 2 Inventory 73 Prepaids 4 Property and equipment, net 203 Intangible assets: Dispensary License 14,300 Trademark 321 Customer Relationship 1,000 Non-Compete 35 Goodwill 7,316 Accrued expenses (4 ) Deferred tax liability (3,350 ) Total net assets acquired $ 19,900
Life Essence Inc [Member]
Summary of Allocation of Consideration Exchanged for Estimated/Final Fair Value of Tangible and Identifiable Intangible Assets Acquired and Liabilities Assumed		The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 4,125 Transaction costs 270 Fair value of consideration exchanged $ 4,395 Recognized amounts of identifiable assets acquired and liabilities assumed: Intangible asset—dispensary license $ 6,144 Accrued expenses (121 ) Deferred tax liability (1,628 ) Total net assets acquired $ 4,395
Leef Industries LLC [Member]
Summary of Allocation of Consideration Exchanged for Estimated/Final Fair Value of Tangible and Identifiable Intangible Assets Acquired and Liabilities Assumed		The following table summarizes the allocation of consideration exchanged for the estimated fair value of tangible and identifiable intangible assets acquired and liabilities assumed: (dollars in thousands) Consideration: Cash $ 3,250 Balance of Purchase Price Payable 750 Transaction costs 25 Fair value of consideration exchanged $ 4,025 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 7 Inventory 19 Property and equipment, net 8 Intangible assets: Dispensary License 5,470 Tradename 10 Accrued expenses (38 ) Deferred tax liability (1,452 ) Total net assets acquired $ 4,025
Keystone Shops [Member]
Summary of Allocation of Consideration Exchanged for Estimated/Final Fair Value of Tangible and Identifiable Intangible Assets Acquired and Liabilities Assumed	(dollars in thousands) Consideration: Cash $ 20,251 Shares issued upon acquisition 35,385 Fair value of consideration exchanged $ 55,636 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 500 Inventories 1,766 Prepaid expenses and other current assets 240 Property and equipment 1,144 Right of use asset—finance 1,340 Intangible assets Dispensary license 27,000 Tradename 100 Favorable leasehold interests, net 86 Goodwill 40,072 Other assets 40 Accounts payable and accrued liabilities (878 ) Income tax payable (2,892 ) Operating lease liabilities (1,340 ) Other long-term liabilities (2,179 ) Deferred tax liability (9,363 ) Total net assets acquired $ 55,636
Natures Remedy Of Massachusetts Inc [Member]
Summary of Total Consideration Paid was Allocated to Assets and Liabilities Acquired Based on Relative Fair Values	This adjustment resulted in an updated total consideration of $16.2 million consisting of $7.0 million in cash and 237,881 in Trulieve Shares with an updated fair value of $9.1 million and less than $0.1 million in transaction costs. Refer to “ Note 2. Basis of Presentation Revisions of Previously Issued Financial Statements (dollars in thousands) Consideration: Cash $ 7,000 Shares issued upon acquisition 9,139 Transaction costs 23 Fair value of consideration exchanged $ 16,162 Recognized amounts of identifiable assets acquired and liabilities assumed: Prepaid expenses and other current assets $ 12 Property and equipment 1,006 Right of use asset—finance 799 Intangible assets Dispensary license 19,630 Accounts payable and accrued liabilities (335 ) Finance lease liability (594 ) Deferred tax liability (4,356 ) Total net assets acquired $ 16,162
Patient Centric Of Marthas Vineyard [Member]
Summary of Total Consideration Paid was Allocated to Assets and Liabilities Acquired Based on Relative Fair Values	As a result, the acquisition of PCMV has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on relative fair values. (dollars in thousands) Consideration: Shares issued upon acquisition $ 10,012 Transaction costs 18 Fair value of consideration exchanged $ 10,030 Recognized amounts of identifiable assets acquired and liabilities assumed: Right of use asset—finance $ 1,756 Intangible assets Dispensary license 13,298 Finance lease liabilities (2,321 ) Deferred tax liability (2,703 ) Total net assets acquired $ 10,030

Inventory (Tables)

Inventory (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Summary of Inventory	The Company’s inventory includes the following at September 30, 2021 and December 31, 2020: September 30, December 31, (dollars in thousands) Raw material Cannabis plants $ 19,419 $ 10,661 Harvested cannabis and packaging 23,529 11,233 Total raw material 42,948 21,894 Work in process 63,952 54,780 Finished goods-unmedicated 3,473 3,908 Finished goods-medicated 23,501 17,730 Total inventories $ 133,874 $ 98,312	Inventories are comprised of the following items at December 31: 2020 2019 (dollars in thousands) Raw Material Cannabis plants 10,661 $ 10,835 Harvested Cannabis and Packaging 11,233 8,132 Total Raw Material 21,894 18,967 Work in Process 54,781 34,212 Finished Goods-Unmedicated 3,908 5,263 Finished Goods-Medicated 17,730 7,538 Total Inventories 98,312 $ 65,981

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	At September 30, 2021 and December 31, 2020, Property and Equipment consisted of the following: September 30, 2021 December 31, 2020 (dollars in thousands) Land $ 7,468 $ 5,878 Buildings and improvements 288,133 156,372 Construction in progress 162,528 129,588 Furniture and equipment 93,485 51,714 Vehicles 349 351 Total 551,963 343,903 Less: accumulated depreciation (50,854 ) (29,858 ) Total property and equipment, net $ 501,109 $ 314,045	At December 31, 2020 and 2019, Property and Equipment consisted of the following: 2020 2019 (dollars in thousands) Land $ 5,022 $ 4,479 Buildings & Improvements 112,692 89,542 Construction in Progress 182,962 24,732 Furniture & Equipment 46,532 38,659 Vehicles 351 288 Total 347,559 157,701 Less: accumulated depreciation (29,858 ) (12,953 ) Total property and equipment, net $ 317,701 $ 144,748

Intangible Assets & Goodwill (T

Intangible Assets & Goodwill (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Definite-Lived Intangible Assets	At September 30, 2021 and December 31, 2020, definite-lived intangible assets consisted of the following: September 30, 2021 (dollars in thousands) Net Adjustments to Additions Amortization Net Licenses $ 84,517 $ 3,061 $ 68,493 $ (5,593 ) $ 150,478 Internal use software 3,656 — 3,589 (529 ) 6,716 Moxie brand 2,828 — — (740 ) 2,088 Tradenames 2,109 — 100 (741 ) 1,468 Customer relationship 683 — — (151 ) 532 Miscellaneous 7 — 86 (93 ) — $ 93,800 $ 3,061 $ 72,268 $ (7,847 ) $ 161,282 December 31, 2020 (dollars in thousands) Net Acquired Additions Amortization Net Licenses $ 24,538 $ 887 $ 61,400 $ (2,308 ) $ 84,517 Internal use software 3,656 — — — 3,656 Moxie brand — — 2,960 (132 ) 2,828 Tradenames 800 — 1,510 (201 ) 2,109 Customer relationship 883 — — (200 ) 683 Miscellaneous 25 — — (18 ) 7 Trademarks 134 — — (134 ) — $ 30,036 $ 887 $ 65,870 $ (2,993 ) $ 93,800	At December 31, 2020 and 2019, definite-lived intangible assets consisted of the following: December 31, 2020 (dollars in thousands) Net amount Acquired license agreements Additions from acquisitions Amortization expense Net amount Licenses $ 24,538 $ 887 $ 61,400 $ 2,308 84,517 Moxie brand — — 2,960 132 2,828 Tradenames 800 — 1,510 201 2,109 Customer relationship 883 — — 200 683 Non-compete 25 — — 18 7 Trademarks 134 — — 134 — $ 26,380 $ 887 $ 65,870 $ 2,992 90,144 December 31, 2019 (dollars in thousands) Net amount Acquired license agreements Additions from acquisitions Amortization expense Net amount Licenses $ 11,568 $ — $ 14,300 $ 1,330 $ 24,538 Moxie brand — — — — — Tradenames 900 — — 100 800 Customer relationship — — 1,000 117 883 Non-compete — — 35 10 25 Trademarks 9 — 321 196 134 $ 12,477 $ — $ 15,656 $ 1,753 $ 26,380
Summary of Estimated Future Annual Amortization Expense Related to Intangible Assets	The following table outlines the estimated future annual amortization expense related to all intangible assets as of September 30, 2021: Estimated (dollars in thousands) Remaining 2021 $ 3,326 2022 13,887 2023 13,320 2024 12,349 2025 11,895 Thereafter 106,505 $ 161,282	The following table outlines the estimated future annual amortization expense related to intangible assets as of December 31, 2020: Year Ended December 31, Estimated Amortization (dollars in thousands) 2021 $ 7,914 2022 7,823 2023 7,038 2024 6,066 2025 5,982 Thereafter 55,321 $ 90,144
Summary of Goodwill	At September 30, 2021, Goodwill consisted of the following: (dollars in thousands) At January 1, 2020 7,316 Acquisition of PurePenn, LLC and Pioneer Leasing & Consulting, LLC 47,311 Acquisition of Solevo Wellness 19,473 At December 31, 2020 74,100 Measurement period purchase price allocation adjustments of Solevo Wellness (2,639 ) Measurement period purchase price allocation adjustments of PurePenn, LLC and Pioneer Leasing & Consulting, LLC (338 ) At June 30, 2021 71,123 Acquisition of Keystone Shops 40,072 Measurement period purchase price allocation adjustments of Solevo Wellness 1,150 Measurement period purchase price allocation adjustments of PurePenn, LLC and Pioneer Leasing & Consulting, LLC (624 ) At September 30, 2021 $ 111,721	At December 31, 2020, Goodwill consisted of the following: (dollars in thousands) At January 1, 2019 $ — Acquisition of The Healing Corner, Inc. 7,316 At of December 31, 2019 $ 7,316 Acquisition of PurePenn, LLC and Pioneer Leasing & Consulting, LLC 47,311 Acquisition of Solevo Wellness 19,473 At December 31, 2020 $ 74,100

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Notes Payable	At September 30, 2021 and December 31, 2020, notes payable consisted of the following : September 30, December 31, (dollars in thousands) Promissory note dated April 10, 2017, with annual interest at 12%, due between April $ 4,000 $ 4,000 Promissory note dated December 7, 2017, with annual interest at 12%, secured by certain property located in Miami, FL due December 2021 2,000 2,000 Total notes payable 6,000 6,000 Less current portion (6,000 ) (2,000 ) Long-term notes payable $ — $ 4,000	At December 31, 2020 and 2019, 2020 2019 (dollars in thousands) Promissory note dated April 10, 2017, with annual interest at 12%, due between April $ 4,000 $ 4,000 Promissory note dated December 7, 2017, with annual interest at 12%, secured by certain property located in Miami, FL, due December 2021 2,000 2,000 Less current portion (2,000 ) (2,000 ) Long Term Notes Payable $ 4,000 $ 4,000
Schedule of Stated Maturities of Notes Payable	Stated maturities of notes payable are as follows: As of September 30, (dollars in thousands) 2021 $ 2,000 2022 4,000 $ 6,000	Stated maturities of notes payables are as follows: Year Ended December 31, (dollars in thousands) 2020 $ — 2021 2,000 2022 4,000 $ 6,000

Notes Payable Related Party (Ta

Notes Payable Related Party (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Notes Payable Related Party [Abstract]
Summary of Notes Payable Related Party	At September 30, 2021 and December 31, 2020, notes payable related party consisted of the following: September 30, December 31, (dollars in thousands) Notes payable due to related parties, with varying interest rates between 8% to 12% annual, with varying maturity dates $ 12,000 $ 12,011 Less current portion (12,000 ) (12,011 ) Non-current $ — $ —	At December 31, 2020 and 2019, 2020 2019 2018 (dollars in thousands) Notes payable due to related parties, with varying interest rates between 8% to 12% annual, with varying maturity dates $ 12,011 $ 12,952 $ 14,215 Less debt discount — (49 ) (141 ) Less current portion (12,011 ) (924 ) (1,427 ) Non-current $ — $ 11,979 $ 12,647
Summary of Stated Maturities of Notes Payable to Related Parties	Stated maturities of notes payable to related parties are as follows: (dollars in 2022 $ 12,000 $ 12,000	Stated maturities of notes payable to related parties are as follows: Year Ended December 31, (dollars in thousands) 2021 $ 12,011 $ 12,011

Private Placement Notes (Tables

Private Placement Notes (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Instruments [Abstract]
Summary of Scheduled Annual Maturities of Principal Portion of Long-Term Debt Outstanding	Scheduled annual maturities of the principal portion of long-term debt outstanding at September 30, 2021 in the successive five-year period and thereafter are summarized below: Private (dollars in 2021 $ — 2022 — 2023 — 2024 130,000 2025 — Thereafter — Total debt 130,000 Less: unamortized debt issuance costs (10,522 ) Net debt $ 119,478	Scheduled annual maturities of the principal portion of long-term debt outstanding at December 31, 2020 in the successive five-year period and thereafter are summarized below: Year Ended December 31, Other Long-term Liabilities (dollars in thousands) 2021 $ — 2022 — 2023 — 2024 130,000 2025 Thereafter — Total Debt 130,000 Less: Unamortized debt issuance costs (12,835 ) Net Debt $ 117,165

Leases (Tables)

Leases (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Components of Lease Cost	The following table provides the components of lease cost recognized in the condensed consolidated statement of operations and comprehensive income for the three and nine months ended September 30, 2021 and 2020: For the Three Months For the Nine Months Lease Cost 2021 2020 2021 2020 (dollars in thousands) Operating lease cost 2,483 1,545 5,751 4,087 Finance lease cost: Amortization of lease assets 1,990 1,496 5,357 3,688 Interest on lease liabilities 1,177 782 2,914 1,801 Finance lease cost 3,167 2,278 8,271 5,489 Variable lease cost 2,529 28 3,139 310 Total lease cost $ 8,179 $ 3,851 $ 17,161 $ 9,886	The following table provides the components of lease cost recognized in the consolidated statement of operations and comprehensive income for the year ended December 31, 2020 and 2019. Year Ended December 31, Lease Cost 2020 2019 Operating lease cost 5,700 5,542 Finance lease cost: Amortization of lease assets 4,956 1,984 Interest on lease liabilities 2,133 960 Finance lease cost 7,089 2,944 Variable lease cost 222 192 Total lease cost $ 13,010 $ 8,678
Schedule of Weighted Average Discount Rate and Remaining Lease Term	Weighted average discount rate and remaining lease term for the nine months ended September 30, 2021 are as follows: Operating Finance Weighted average discount rate 8.75 % 8.46 % Weighted average remaining lease term (in years) 8.67 8.20	Other information related to operating and finance leases as of and for the year ended December 31, 2020 are as follows: Finance Lease Operating Lease Weighted average discount rate 8.36 % 8.64 % Weighted average remaining lease term (in years) 8.51 7.49
Schedule of Maturity of Contractual Undiscounted Lease Liabilities	The maturity of the contractual undiscounted lease liabilities as of September 30, 2021 is as follows: Operating Finance (dollars in thousands) Remainder of 2021 $ 1,991 $ 2,494 2022 8,173 10,509 2023 7,886 13,246 2024 7,759 9,395 2025 7,800 9,069 Thereafter 35,893 43,875 Total undiscounted lease liabilities 69,502 88,588 Interest on lease liabilities (21,581 ) (26,000 ) Total present value of minimum lease payments 47,921 62,588 Lease liability—current portion (4,264 ) (5,354 ) Lease liability $ 43,657 $ 57,234	The maturity of the contractual undiscounted lease liabilities as of December 31, 2020 is as follows: Year Ended December 31, Finance Lease Operating Lease (dollars in thousands) 2021 $ 6,964 $ 5,480 2022 6,642 5,405 2023 6,257 5,276 2024 5,787 4,921 2025 5,588 4,843 Thereafter 24,669 14,225 Total undiscounted lease liabilities 55,907 40,150 Interest on lease liabilities (16,972 ) (10,545 ) Total present value of minimum lease payments 38,935 29,605 Lease liability—current portion 3,877 3,154 Lease liability $ 35,058 $ 26,450

Share Capital (Tables)

Share Capital (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Summary of Exercisable Warrants Issued and Outstanding to Certain Employees and Director	Number of Warrants Weighted average exercise price ($CAD) Weighted Average Remaining Contractual Life (Yrs) Outstanding and exercisable at December 31, 2017 — — — Granted 535,446 6.00 2.00 Exercised (321,268 ) 6.00 — Outstanding and exercisable at December 31, 2018 214,178 6.00 1.66 Granted — — — Exercised (214,178 ) 6.00 — Outstanding and exercisable at December 31, 2019 — — — Granted — — — Exercised — — — Outstanding and exercisable at December 31, 2020 — — —

Share Based Compensation (Table

Share Based Compensation (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Fair Value of Options Granted with Assumptions	For the Nine Months For the Nine Months Fair value at grant date $10.58-$11.20 $3.11-$3.26 Stock price at grant date $26.88-$33.42 $11.52-$12.50 Exercise price at grant date $26.88-$33.42 $11.52-$12.50 Expected life in years 3.00 - 3.50 1.58 - 2.00 Expected volatility 49.88% - 53.75% 49.10% - 50.15% Expected annual rate of dividends 0% 0% Risk free annual interest rate 0.16% - 0.79% 1.40 - 1.58%	Year Ended December 31, 2020 Fair Value at Grant Date $ 3.11 – $3.26 Stock Price at Grant Date $ 11.52 – $12.50 Exercise Price at Grant Date $ 11.52 – $12.50 Expected Life in Years 1.58 – 2.00 Expected Volatility 49.10% –50.15 % Expected Annual Rate of Dividends 0 % Risk Free Annual Interest Rate 1.40% – 1.58 %
Schedule of Number and Weighted-average Exercise Prices and Remaining Contractual Life of Options	The number and weighted-average exercise prices and remaining contractual life of options at September 30, 2021 were as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2021 1,129,774 11.72 4.01 — Granted 877,509 29.32 3.55 — Exercised (36,787 ) 11.52 — — Forfeited — — — — Outstanding, September 30, 2021 1,970,496 $ 19.56 4.52 $ 8.43 Exercisable, September 30, 2021 517,672 $ 11.71 3.34 $ 15.20	The number and weighted-average exercise prices and remaining contractual life of options at December 31, 2020 were as follows: Number of Options Weighted average exercise price Weighted Average Remaining Contractual Life (Yrs) Outstanding at January 1, 2020 — $ — — Granted 1,252,403 11.70 1.93 Exercised (9,180 ) 11.52 — Forfeited (113,444 ) 11.52 — Outstanding, December 31, 2020 1,129,779 11.72 1.92 Exercisable, December 31, 2020 554,456 $ 11.70 —
Schedule of Restricted Stock Units	Number of Weighted average Balance as of January 1, 2021 — — Granted 3,249,319 25.45 Vested (2,904,079 ) 25.28 Forfeited — — Balance as of September 30, 2021 345,240 $ 26.88
Summary of warrants issued and outstanding to certain employees and director	The following table summarizes the warrants issued and outstanding to certain employees and directors of the Company as of December 31, 2020 and the changes during the nine months ended September 30, 2021: Number of Weighted Weighted Outstanding as of January 1, 2021 6,061,561 6.00 0.72 Granted — — — Exercised (2,075,990 ) 6.00 — Exchanged in cashless exercise (413,057 ) — — Cancelled (3,572,514 ) — — Outstanding as of September 30, 2021 — — —	The following table summarizes the warrants issued and outstanding to certain employees and directors of the Company as of December 31, 2020 and 2019 and the changes during the year ended December 31, 2020: Number of Warrants Weighted average exercise price ($CAD) Weighted Average Remaining Contractual Life (Yrs) Outstanding as of December 31, 2018 8,784,872 6.00 2.72 Granted — — — Exercised — — — Outstanding as of December 31, 2019 8,784,872 6.00 1.72 Granted — — — Exercised 2,723,311 — — Outstanding as of December 31, 2020 6,061,561 6.00 0.72
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Fair Value of Options Granted with Assumptions		The following were the assumptions utilized in the model during the year ended December 31, 2020 December 31, 2020 Stock Price ($CAD) $ 6.00 Exercise Price ($CAD) $ 6.00 Expected Life in Years 3.00 Annualized Volatility 51 % Annual Rate of Quarterly Dividends 0 % Discount Rate—Bond Equivalent Yield 3 %

Reverse Takeover Transaction (T

Reverse Takeover Transaction (Tables)	12 Months Ended
	Dec. 31, 2020
Business Combination, Consideration Transferred [Abstract]
Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable	The acquisition costs have been allocated as follows: Fair value of 200,000 shares issued $ 927 Transaction costs 460 Total purchase price $ 1,387

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Schedule of Reconciliation For Calculation of Basic And Diluted Earnings Per Share	The following is a reconciliation for the calculation of basic and diluted earnings per share for the three and nine months ended September 30, 2021 and 2020: For the Three Months Ended For the Nine Months Ended 2021 2020 2021 2020 (dollars in thousands) (dollars in thousands) Net income $ 18,616 $ 17,415 $ 89,574 $ 59,958 Weighted average number of common shares outstanding 128,146,298 112,039,640 122,983,729 111,824,816 Dilutive effect of warrants and options outstanding 8,762,968 5,909,584 7,943,354 4,173,888 Diluted weighted average number of common shares outstanding 136,909,266 117,949,224 130,927,083 115,998,704 Basic earnings per share $ 0.15 $ 0.16 $ 0.73 $ 0.54 Diluted earnings per share $ 0.14 $ 0.15 $ 0.68 $ 0.52	The following is a reconciliation for the calculation of basic and diluted earnings per share for the years ended December 31, 2020, 2019 and 2018: 2020 2019 2018 (dollars in thousands) Net Income $ 62,999 $ 53,094 $ 10,893 Weighted average number of common shares outstanding 113,572,379 110,206,103 101,697,002 Dilutive effect of warrants and options outstanding 4,753,345 5,111,839 1,504,125 Diluted weighted average number of common shares outstanding 118,325,724 115,317,942 103,201,127 Basic earnings per share $ 0.55 $ 0.48 $ 0.11 Diluted earnings per share $ 0.53 $ 0.46 $ 0.11

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Summary of Income Tax Expense and Effective Tax Rate	The following table summarizes the Company’s income tax expense and effective tax rate for the three and nine months ended September 30, 2021 and 2020 For the Three Months For the Nine Months 2021 2020 2021 2020 (dollars in thousands) (dollars in thousands) Income before provision for income taxes $ 60,219 $ 43,363 $ 194,828 $ 127,074 Provision for income taxes 41,603 25,948 105,254 67,116 Effective tax rate 69 % 60 % 54 % 53 %
Schedule of Components of Income Tax Expense (Benefit)		The components of the income tax provision include: Year Ended December 31, 2020 2019 2018 (dollars in thousands) Current $ 99,338 $ 51,494 $ 22,697 Deferred (4,887 ) (908 ) (546 ) $ 94,451 $ 50,586 $ 22,151
Schedule of Effective Income Tax Rate Reconciliation		Year Ended December 31, 2020 2019 2018 (dollars in thousands) Income before income taxes $ 157,450 $ 103,680 $ 33,044 Federal statutory rate 21.0 % 21.0 % 21.0 % Theoretical tax expense 33,064 21,773 6,939 State taxes 12,406 9,477 4,366 Other (1,666 ) 1,310 1,176 Tax effect of non-deductible Nondeductible share based compensation — — 3,154 Section 280E permanent differences 50,646 18,026 6,517 61,386 28,813 15,212 Tax expense $ 94,451 $ 50,586 $ 22,151
Schedule of Deferred Tax Assets and Liabilities		Deferred income taxes consist of the following at December 31, 2020 and 2019, and 2018: Year Ended December 31, 2020 2019 2018 (dollars in thousands) Deferred tax assets Lease liability $ 1,219 $ 1,020 $ — Other deferred tax assets 7,025 969 570 Deferred tax liabilities Right of use assets (1,210 ) (1,099 ) — Intangible assets (26,446 ) (6,144 ) (3,080 ) Property and equipment (3,153 ) (233 ) (534 ) Lease payments (1,010 ) — — Net deferred tax liability $ (23,575 ) $ (5,486 ) $ (3,044 )

Related Parties (Tables)

Related Parties (Tables)	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Right of Use Assets and Lease Liabilities under ASC 842	As of September 30, 2021 and December 31, 2020, under ASC 842, the Company had the following in the condensed consolidated balance sheet: As of September 30, 2021 As of December 31, 2020 Operating Finance Operating Finance (dollars in thousands) (dollars in thousands) Right-of-use $ 6,116 $ 2,080 $ 12,003 $ 3,425 Lease liabilities: Lease liabilities—current portion 725 207 1,539 281 Lease liabilities 5,790 2,184 11,083 3,500 Total related parties lease liabilities $ 6,515 $ 2,391 $ 12,622 $ 3,781

Financial Instruments and Fin_2

Financial Instruments and Financial Risk Management (Tables)	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Summary Of Fair Value Measurements	The following tables present information about the Company’s financial instruments and their classifications as of December 31, 2020 and 2019 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: Fair Value Measurements at December 31, 2020 using: Level 1 Level 2 Level 3 Total (dollars in thousands) Financial Assets: Money Market Funds(1) $ 65,516 $ — $ — $ 65,516 Financial Liabilities: Warrant Liability(3) $ — $ — $ — $ — Fair Value Measurements at December 31, 2019 using: Level 1 Level 2 Level 3 Total (dollars in thousands) Financial Assets: Money Market Funds(1) $ 77,993 $ — $ — $ 77,993 Financial Liabilities: Warrant Liability(2) $ — $ 9,892 $ — $ 9,892 (1) Money market funds are included within cash and cash equivalents in the Company’s consolidated balance sheets. As a short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that is fair value. (2) During the year ended December 31, 2020, the Company converted subordinate voting purchase warrants for the June and November debt to equity. (3) During the year ended December 31, 2019, the Company issued subordinate voting purchase warrants with the June and November debt see “Note 9—Debt”
Summary Of Contractual Cash Flows	The following table summarizes the Company’s contractual cash flows: <1 Year 1 to 3 Years 3 to 5 Years >5 Years Total Accounts Payable and Accrued Liabilities $ 41,902 $ — $ — $ — $ 41,902 Notes Payable 2,000 4,000 — — 6,000 Notes Payable—Related Party 12,011 — — — 12,011 Other Long-Term Liabilities — — 130,000 — 130,000 Operating Lease Liability 5,480 10,681 9,764 14,225 40,150 Finance Lease Liability 6,964 12,899 11,375 24,669 55,907 Construction Finance Liability $ — $ — $ 61,071 $ 20,977 $ 82,047

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2021
Basis Of Presentation [Line Items]
Change in accounting principle, accounting standards update, adopted [true false]	true	true
Change in accounting principle, accounting standards update, adoption date	Jan. 1, 2021	Jan. 1, 2021
Change in accounting principle, accounting standards update, immaterial effect [true false]	true	true
Accounting Standards Update [Extensible Enumeration]		us-gaap:AccountingStandardsUpdate201912Member
Operating lease expense, depreciation, and interest expense	$ 0.3

Basis of Presentation - Impact

Basis of Presentation - Impact of Revision on Interim Unaudited Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Basis Of Presentation [Line Items]
Prepaid expenses and other current assets	$ 25,791	$ 24,064	$ 21,452	$ 16,119				$ 7,678
Total current assets	385,704	437,841	290,429	261,452				165,471
Property and equipment, net	501,109	427,924		314,045				144,748
Right of use assets—operating, net	45,753	40,022	32,881	30,076				22,045
Right of use assets—finance, net	58,393	47,892	40,218	36,904				19,088
Intangible assets, net	161,282	122,485		93,800				30,036	$ 12,477
Other assets	12,077	13,793	11,242	7,528				949
TOTAL ASSETS	1,276,039	1,161,080	902,088	817,905				385,996
Operating lease liabilities—current portion	4,264	4,015	3,497	3,277				2,541
Finance lease liabilities - current portion	5,354	5,004	4,414	3,877				2,272
Total current liabilities	94,469	77,451	101,143	76,121				52,667
Operating lease liabilities	43,657	37,777	30,907	28,120				20,601
Finance lease liabilities	57,234	45,516	38,103	35,058				17,168
Deferred tax liability	40,099	27,632		23,575				5,486
TOTAL LIABILITIES	453,396	402,790	416,504	370,001				253,114
Additional paid-in-capital	613,379	524,953		328,214				76,192
TOTAL SHAREHOLDERS' EQUITY	$ 822,643	758,290	485,584	447,904	$ 289,735	$ 188,568	$ 157,710	132,883	$ 78,814	$ 4,160
As Previously Reported
Basis Of Presentation [Line Items]
Prepaid expenses and other current assets		28,313	25,180	19,815
Total current assets		442,090	294,157	265,148
Property and equipment, net		427,666		317,701
Right of use assets—operating, net		31,254	30,051	28,171
Right of use assets—finance, net		41,521	38,380
Intangible assets, net		123,106		90,144				$ 26,380
Other assets		9,547	7,549	3,944
TOTAL ASSETS		1,146,307	897,455	816,112
Operating lease liabilities—current portion		3,583	3,324	3,154
Finance lease liabilities - current portion		4,723	4,344
Total current liabilities		76,738	100,900	75,998
Operating lease liabilities		29,381	28,326	26,450
Finance lease liabilities		39,694	36,294
Deferred tax liability		29,845
TOTAL LIABILITIES		390,072	411,871	368,208
Additional paid-in-capital		522,898		275,644
TOTAL SHAREHOLDERS' EQUITY		756,235
Adjustment
Basis Of Presentation [Line Items]
Prepaid expenses and other current assets		(4,249)	(3,728)	(3,696)
Total current assets		(4,249)	(3,728)	(3,696)
Property and equipment, net		258
Right of use assets—operating, net		8,768	2,830	1,905
Right of use assets—finance, net		6,371	1,838
Intangible assets, net		(621)
Other assets		4,246	3,693	3,584
TOTAL ASSETS		14,773	4,633	1,793
Operating lease liabilities—current portion		432	173	123
Finance lease liabilities - current portion		281	70
Total current liabilities		713	243	123
Operating lease liabilities		8,396	2,581	1,670
Finance lease liabilities		5,822	1,809
Deferred tax liability		(2,213)
TOTAL LIABILITIES		12,718	$ 4,633	$ 1,793
Additional paid-in-capital		2,055
TOTAL SHAREHOLDERS' EQUITY		$ 2,055

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment Useful Life (Detail)	12 Months Ended
	Dec. 31, 2020
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	The lesser of the life of the lease or the estimated useful life of the asset
Minimum [Member] | Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Minimum [Member] | Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Minimum [Member] | Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Maximum [Member] | Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	40 years
Maximum [Member] | Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	10 years
Maximum [Member] | Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Intangible Assets are Amortized using Straight Line Method Over Estimated Useful Lives (Detail)	12 Months Ended
	Dec. 31, 2020
Dispensary License [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	15 years
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	5 years
Moxie Brand [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	3 years
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	2 years
Minimum [Member] | Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	2 years
Minimum [Member] | Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	6 months
Maximum [Member] | Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	10 years
Maximum [Member] | Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets,Amortized Estimated Useful Lives	1 year

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary Of Accounts Payable and Accrued Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Trade Accounts Payable		$ 9,247	$ 9,954
Trade Accounts Payable—Related Party		10,403	6,463
Accrued Payroll		11,030	5,822
Other Payables and Accrued Liabilities		11,222	2,069
Total Accounts Payable and Accrued Liabilities	$ 62,769	41,903	$ 24,308
Previously Reported [Member]
Total Accounts Payable and Accrued Liabilities		$ 41,902

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 10, 2020
Inventory reserves	$ 0	$ 0
Impairment charges on long lived assets	0	0
Impairment of intangible assets	0	0
Impairment of goodwill	0	0
Contract assets on unsatisfied performance obligations	$ 0	0
Uncertain income tax position will not be recognised when estimated range not reach suatained percentage	50.00%
Advertising costs	$ 2,100	1,900	$ 300
Subordinate Voting Share Purchase Warrants [Member]
Warrants exercise price	$ 17.25
Warrants Converted exercise price				$ 13.47
Deferred Revenue [Member]
Total Loyalty liability	$ 5,300	$ 2,400

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details)	Jul. 08, 2021USD ($)shares	Jul. 02, 2021USD ($)shares	Jun. 30, 2021USD ($)shares	Jun. 08, 2021USD ($)	May 06, 2021USD ($)	Nov. 12, 2020USD ($)Dispensaryshares	Oct. 31, 2020USD ($)shares	Sep. 30, 2021USD ($)shares	Jun. 30, 2021USD ($)	Mar. 31, 2021USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Nov. 30, 2018
Business Combination And Asset Acquisition [Line Items]
Cash											$ 119,600,000	$ 65,000,000	$ 96,700,000	$ 46,400,000	$ 12,100,000
Transaction costs related to acquisition													460,000
Business combination, total consideration													1,387,000
PurePenn, LLC and Pioneer Leasing & Consulting, LLC
Business Combination And Asset Acquisition [Line Items]
Acquired membership interests percentage						100.00%
Upfront payment						$ 48,700,000
Equity interests acquired, fair value						$ 29,700,000
Equity interests acquired, number of shares | shares						1,298,964
Payment of cash						$ 19,000,000							19,000,000
Business acquisition potential earn-out payment maximum shares to be issued on achievement of EBITDA milestone | shares						2,405,488
Transaction costs related to acquisition						$ 1,800,000		$ 1,800,000			1,800,000
Business combination, increase (decrease) in contingent consideration payable						(3,000,000)			$ 2,700,000
Goodwill, period increase (decrease)						(3,000,000)			2,700,000
Business combination, total consideration						95,662,000							96,000,000
Adjustment to the deferred tax liability to Increase (decrease) of goodwill								600,000
PurePenn, LLC and Pioneer Leasing & Consulting, LLC | Pennsylvania
Business Combination And Asset Acquisition [Line Items]
Upfront payment						46,000,000
Equity interests acquired, fair value						$ 27,000,000
Equity interests acquired, number of shares | shares						1,780,061
Keystone Relief Centers LLC
Business Combination And Asset Acquisition [Line Items]
Acquired membership interests percentage						100.00%
Equity interests acquired, fair value			$ 1,000,000			$ 11,000,000			1,000,000
Equity interests acquired, number of shares | shares						481,097
Payment of cash						$ 10,000,000							10,000,000
Business acquisition potential earn-out payment maximum shares to be issued on achievement of EBITDA milestone | shares						721,647
Transaction costs related to acquisition						$ 900,000		900,000			$ 900,000
Business combination, increase (decrease) in contingent consideration payable									200,000
Goodwill, period increase (decrease)									200,000	$ (3,800,000)
Number of medical marijuana dispensaries | Dispensary						3
Upfront purchase price						$ 21,000,000
Business combination, increase in contingent consideration intangible assets										$ 3,800,000
Goodwill, period increase (decrease) initial valuation									1,000,000
Business combination, total consideration						36,877,000							35,715,000
Adjustment to the deferred tax liability to Increase (decrease) of goodwill								1,200,000
Keystone Relief Centers LLC | Pennsylvania
Business Combination And Asset Acquisition [Line Items]
Equity interests acquired, fair value						$ 10,000,000
Number of medical marijuana dispensaries | Dispensary						3
Upfront purchase price						$ 20,000,000
PurePenn and Solevo Wellness [Member]
Business Combination And Asset Acquisition [Line Items]
Business Acquisitions,Unaudited proforma revenue													575,200,000
Business Acquisitions,Unaudited Net Income													75,700,000
The Healing Corner, Inc [Member]
Business Combination And Asset Acquisition [Line Items]
Payment of cash													19,900,000
Transaction costs related to acquisition													300,000
Business combination, total consideration													19,900,000
Leef Industries LLC [Member]
Business Combination And Asset Acquisition [Line Items]
Percentage of membership interests acquired																80.00%
Percentage of payment occurred in 2019																19.00%
Percentage of payment for remaining balance made in 2020																1.00%
Transaction costs													25,000
Payment of cash													3,250,000
Business combination, total consideration													$ 4,025,000
PCMV
Business Combination And Asset Acquisition [Line Items]
Equity interests acquired, number of shares holdback as security for indemnity claims | shares		10,879					10,881
Equity interests acquired, number of shares holdback period as security for indemnity claims		6 months					6 months
Equity interests acquired, fair value		$ 10,000,000					$ 4,700,000
Equity interests acquired, number of shares | shares		258,383					258,383
Anna Holdings, LLC
Business Combination And Asset Acquisition [Line Items]
Acquired membership interests percentage	100.00%
Equity interests acquired, fair value	$ 35,400,000
Equity interests acquired, number of shares | shares	1,009,336
Payment of cash	$ 20,300,000
Business combination, total consideration	55,600,000
Business combination, contingent consideration on enactment, adoption or approval	5,000,000
Business combination, contingent consideration liability	$ 0
Dispensary License
Business Combination And Asset Acquisition [Line Items]
Definite-lived intangible assets, useful life													15 years
Dispensary License | PCMV
Business Combination And Asset Acquisition [Line Items]
Definite-lived intangible assets, useful life		15 years
Dispensary License | Anna Holdings, LLC
Business Combination And Asset Acquisition [Line Items]
Definite-lived intangible assets, useful life	15 years
Nature's Remedy of Massachusetts, Inc.
Business Combination And Asset Acquisition [Line Items]
Total consideration			16,162,000
Cash			$ 7,000,000
Number of shares issued | shares			237,881
Transaction costs			$ 23,000
Deferred tax liability			4,356,000						4,356,000
Asset acquisition, increase (decrease) in fair value of equity consideration								2,600,000
Equity interest consideration, fair value			9,100,000
Nature's Remedy of Massachusetts, Inc. | Maximum
Business Combination And Asset Acquisition [Line Items]
Transaction costs			$ 100,000
Nature's Remedy of Massachusetts, Inc. | Dispensary License
Business Combination And Asset Acquisition [Line Items]
Definite-lived intangible assets, useful life			15 years
Definite lived intangible assets			$ 19,630,000						$ 19,630,000
Solevo Wellness West Virginia, LLC
Business Combination And Asset Acquisition [Line Items]
Percentage of membership interests acquired				100.00%
Total consideration								800,000
Cash								$ 200,000
Number of shares issued | shares								11,658
Debt forgiveness				$ 100,000
Asset acquisition, increase (decrease) in fair value of equity consideration								$ (100,000)
Equity interest consideration, fair value								400,000
Solevo Wellness West Virginia, LLC | Maximum
Business Combination And Asset Acquisition [Line Items]
Transaction costs				100,000
Solevo Wellness West Virginia, LLC | Dispensary License
Business Combination And Asset Acquisition [Line Items]
Total consideration				$ 800,000
Definite-lived intangible assets, useful life				15 years
Definite lived intangible assets				$ 1,000,000
Deferred tax liability				$ 200,000
Mountaineer Holding, LLC
Business Combination And Asset Acquisition [Line Items]
Percentage of membership interests acquired					100.00%
Total consideration								5,500,000
Cash								$ 3,000,000
Number of shares issued | shares								60,342
Asset acquisition, increase (decrease) in fair value of equity consideration								$ (500,000)
Equity interest consideration, fair value								$ 2,500,000
Mountaineer Holding, LLC | Cultivation Permit and Dispensary Permits
Business Combination And Asset Acquisition [Line Items]
Total consideration					$ 5,500,000
Definite-lived intangible assets, useful life					15 years
Definite lived intangible assets					$ 7,000,000
Deferred tax liability					$ 1,500,000

Acquisitions - Summary of Total

Acquisitions - Summary of Total Consideration Paid was Allocated to Assets and Liabilities Acquired Based on Relative Fair Values (Details) - USD ($) $ in Thousands	Jul. 08, 2021	Jul. 02, 2021	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Consideration:
Cash				$ 119,600	$ 65,000	$ 96,700	$ 46,400	$ 12,100
Nature's Remedy of Massachusetts, Inc.
Consideration:
Cash			$ 7,000
Shares issued upon acquisition			9,139
Transaction costs			23
Fair value of consideration exchanged			16,162
Recognized amounts of identifiable assets acquired and liabilities assumed:
Prepaid expenses and other current assets			12
Property and equipment			1,006
Right of use asset - finance			799
Intangible assets
Accounts payable and accrued liabilities			(335)
Finance lease liability			(594)
Deferred tax liability			(4,356)
Total net assets acquired			16,162
Nature's Remedy of Massachusetts, Inc. | Dispensary License
Intangible assets
Intangible assets, net			$ 19,630
Keystone Shops [Member]
Consideration:
Cash	$ 20,251
Shares issued upon acquisition	35,385
Fair value of consideration exchanged	55,636
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash	500
Inventories	1,766
Prepaid expenses and other current assets	240
Property and equipment	1,144
Right of use asset - finance	1,340
Intangible assets
Goodwill	40,072
Other assets	40
Accounts payable and accrued liabilities	(878)
Income tax payable	(2,892)
Operating lease liabilities	(1,340)
Other long-term liabilities	(2,179)
Deferred tax liability	(9,363)
Total net assets acquired	55,636
Keystone Shops [Member] | Dispensary License
Intangible assets
Intangible assets, net	27,000
Keystone Shops [Member] | Trademarks [Member]
Intangible assets
Intangible assets, net	100
Keystone Shops [Member] | Favorable Leasehold Interests
Intangible assets
Intangible assets, net	$ 86
PCMV
Consideration:
Shares issued upon acquisition		$ 10,012
Transaction costs		18
Fair value of consideration exchanged		10,030
Recognized amounts of identifiable assets acquired and liabilities assumed:
Right of use asset - finance		1,756
Intangible assets
Finance lease liability		(2,321)
Deferred tax liability		(2,703)
Total net assets acquired		10,030
PCMV | Dispensary License
Intangible assets
Intangible assets, net		$ 13,298

Acquisitions - Summary of Alloc

Acquisitions - Summary of Allocation of Consideration Exchanged for Estimated/Final Fair Value of Tangible and Identifiable Intangible Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Nov. 12, 2020	Dec. 31, 2020	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2019	Dec. 31, 2018
Consideration:
Fair value of consideration exchanged		$ 1,387
Recognized amounts of identifiable assets acquired and liabilities assumed:
Right of Use Asset		30,076	$ 45,753	$ 40,022	$ 32,881	$ 22,045
Intangible assets, net:
Goodwill		74,100	$ 111,721	$ 71,123		$ 7,316	$ 0
PurePenn, LLC and Pioneer Leasing & Consulting, LLC
Consideration:
Cash	$ 19,000	19,000
Shares issued upon issuance	29,711	27,000
Contingent consideration payable in shares	46,951	50,000
Fair value of consideration exchanged	95,662	96,000
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash	563	563
Accounts receivable	1,300	1,300
Prepaid expenses and other current assets	376	376
Inventories	7,461	7,461
Property and equipment, net	26,233	26,233
Intangible assets, net:
Goodwill	46,349	47,311
Other assets	478	478
Accounts payable and accrued liabilities	(2,189)	(2,189)
Construction finance liability	(17,413)	(17,413)
Deferred tax liability	(16,346)	(16,970)
Total net assets acquired	95,662	96,000
PurePenn, LLC and Pioneer Leasing & Consulting, LLC | Tradename
Intangible assets, net:
Intangible Assets, Net	580	580
PurePenn, LLC and Pioneer Leasing & Consulting, LLC | Moxie License
Intangible assets, net:
Intangible Assets, Net	2,960	2,960
PurePenn, LLC and Pioneer Leasing & Consulting, LLC | State License
Intangible assets, net:
Intangible Assets, Net	45,310	45,310
Keystone Relief Centers LLC
Consideration:
Cash	10,000	10,000
Shares issued upon issuance	11,004	10,000
Contingent consideration payable in shares	15,249	15,000
Net Working Capital Adjustment	624	715
Fair value of consideration exchanged	36,877	35,715
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash	1,229	1,229
Accounts receivable	117	117
Prepaid expenses and other current assets	91	91
Inventories	2,337	2,337
Property and equipment, net	2,245	2,245
Right of Use Asset	2,156	2,156
Intangible assets, net:
Goodwill	17,985	19,473
Accounts payable and accrued liabilities	(790)	(790)
Lease Liability	(2,156)	(2,156)
Deferred tax liability	(7,157)	(6,007)
Total net assets acquired	36,877	35,715
Keystone Relief Centers LLC | Tradename
Intangible assets, net:
Intangible Assets, Net	930	930
Keystone Relief Centers LLC | Dispensary License
Intangible assets, net:
Intangible Assets, Net	$ 19,890	16,090
The Healing Corner, Inc [Member]
Consideration:
Cash		19,900
Fair value of consideration exchanged		19,900
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash		2
Prepaid expenses and other current assets		4
Inventories		73
Property and equipment, net		203
Intangible assets, net:
Goodwill		7,316
Accrued expenses		(4)
Deferred tax liability		(3,350)
Total net assets acquired		19,900
The Healing Corner, Inc [Member] | Tradename
Intangible assets, net:
Intangible Assets, Net		321
The Healing Corner, Inc [Member] | Dispensary License
Intangible assets, net:
Intangible Assets, Net		14,300
The Healing Corner, Inc [Member] | Customer Relationship
Intangible assets, net:
Intangible Assets, Net		1,000
The Healing Corner, Inc [Member] | Non-compete
Intangible assets, net:
Intangible Assets, Net		35
Life Essence Inc [Member]
Consideration:
Cash		4,125
Transaction costs		270
Fair value of consideration exchanged		4,395
Intangible assets, net:
Accrued expenses		(121)
Deferred tax liability		(1,628)
Total net assets acquired		4,395
Life Essence Inc [Member] | Dispensary License
Intangible assets, net:
Intangible Assets, Net		6,144
Leef Industries LLC [Member]
Consideration:
Cash		3,250
Balance of Purchase Price Payable		750
Transaction costs		25
Fair value of consideration exchanged		4,025
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash		7
Inventories		19
Property and equipment, net		8
Intangible assets, net:
Accrued expenses		(38)
Deferred tax liability		(1,452)
Total net assets acquired		4,025
Leef Industries LLC [Member] | Tradename
Intangible assets, net:
Intangible Assets, Net		10
Leef Industries LLC [Member] | Dispensary License
Intangible assets, net:
Intangible Assets, Net		$ 5,470

Inventory - Summary of Inventor

Inventory - Summary of Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Inventory [Line Items]
Total Raw Material	$ 42,948	$ 21,894	$ 18,967
Work in process	63,952	54,780	34,212
Total inventories	133,874	98,312	65,981
Previously Reported [Member]
Inventory [Line Items]
Work in process		54,781
Cannabis Plants
Inventory [Line Items]
Total Raw Material	19,419	10,661	10,835
Harvested Cannabis and Packaging
Inventory [Line Items]
Total Raw Material	23,529	11,233	8,132
Unmedicated
Inventory [Line Items]
Finished Goods	3,473	3,908	5,263
Medicated
Inventory [Line Items]
Finished Goods	$ 23,501	$ 17,730	$ 7,538

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	$ 551,963		$ 343,903	$ 157,701
Less: accumulated depreciation	(50,854)		(29,858)	(12,953)
Total property and equipment, net	501,109	$ 427,924	314,045	144,748
Previously Reported [Member]
Property Plant And Equipment [Line Items]
Property and Equipment, Gross			347,559
Total property and equipment, net		$ 427,666	317,701
Land
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	7,468		5,878	4,479
Land | Previously Reported [Member]
Property Plant And Equipment [Line Items]
Property and Equipment, Gross			5,022
Buildings and Improvements
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	288,133		156,372	89,542
Buildings and Improvements | Previously Reported [Member]
Property Plant And Equipment [Line Items]
Property and Equipment, Gross			112,692
Construction In Progress
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	162,528		129,588	24,732
Construction In Progress | Previously Reported [Member]
Property Plant And Equipment [Line Items]
Property and Equipment, Gross			182,962
Furniture and Equipment
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	93,485		51,714	38,659
Furniture and Equipment | Previously Reported [Member]
Property Plant And Equipment [Line Items]
Property and Equipment, Gross			46,532
Vehicles
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	$ 349		$ 351	$ 288

Property and Equipment - Additi

Property and Equipment - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2021
Property, Plant and Equipment [Line Items]
Interest capitalized	$ 2,200	$ 1,300	$ 4,400	$ 2,100	$ 4,800	$ 500	$ 1,000
Depreciation	8,100	$ 3,900	21,000	10,700	16,900	9,300	3,000
Property and equipment purchases			119,600	$ 65,000	96,700	46,400	12,100
Intangible assets, net	161,282		161,282		93,800	30,036	12,477	$ 122,485
Property and equipment, net	501,109		501,109		314,045	144,748		$ 427,924
Land Buildings And Improvements And Furniture And Equipment [Member] | Scenario, Adjustment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, net					50,000
Internal Use Software [Member]
Property, Plant and Equipment [Line Items]
Intangible assets, net	$ 6,716		6,716		3,656	3,656
Accounts Payable [Member]
Property, Plant and Equipment [Line Items]
Property and equipment purchases			$ 14,700		10,400	6,500
J.T. Burnette [Member] | Chief Executive Officer and Chair of the Board of Directors [Member]
Property, Plant and Equipment [Line Items]
Property and equipment purchases					96,700	46,400	$ 12,100
J.T. Burnette [Member] | Accounts Payable [Member] | Chief Executive Officer and Chair of the Board of Directors [Member]
Property, Plant and Equipment [Line Items]
Property and equipment purchases					$ 10,400	$ 6,500

Intangible Assets & Goodwill -

Intangible Assets & Goodwill - Summary of Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance	$ 122,485		$ 93,800	$ 30,036	$ 30,036	$ 12,477
Adjustments to purchase price allocation			3,061
Acquired license agreements					887
Additions			72,268		65,870	15,656
Amortization expense	(3,300)	$ (500)	(7,847)	(1,700)	(2,993)	(1,753)
Net amount, ending balance	161,282		161,282		93,800	30,036
Previously Reported [Member]
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance	123,106		90,144	26,380	26,380
Amortization expense					(2,992)
Net amount, ending balance					90,144	26,380
Licenses
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance			84,517	24,538	24,538	11,568
Adjustments to purchase price allocation			3,061
Acquired license agreements					887
Additions			68,493		61,400	14,300
Amortization expense			(5,593)		(2,308)	1,330
Net amount, ending balance	150,478		150,478		84,517	24,538
Moxie Brand
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance			2,828
Additions					2,960
Amortization expense			(740)		(132)
Net amount, ending balance	2,088		2,088		2,828
Tradenames
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance			2,109	800	800	900
Additions			100		1,510
Amortization expense			(741)		(201)	100
Net amount, ending balance	1,468		1,468		2,109	800
Customer Relationship
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance			683	883	883
Additions						1,000
Amortization expense			(151)		(200)	117
Net amount, ending balance	532		532		683	883
Non-compete
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance			7	25	25
Additions			86			35
Amortization expense			(93)		(18)	10
Net amount, ending balance					7	25
Trademarks
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance				134	134	9
Additions						321
Amortization expense					(134)	196
Net amount, ending balance						134
Internal Use Software
Finite Lived Intangible Assets [Line Items]
Net amount, beginning balance			3,656	$ 3,656	3,656
Additions			3,589
Amortization expense			(529)
Net amount, ending balance	$ 6,716		$ 6,716		$ 3,656	$ 3,656

Intangible Assets & Goodwill _2

Intangible Assets & Goodwill - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 3,300	$ 500	$ 7,847	$ 1,700	$ 2,993	$ 1,753

Intangible Assets & Goodwill _3

Intangible Assets & Goodwill - Summary of Estimated Future Annual Amortization Expense Related to Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Indefinite-lived Intangible Assets [Line Items]
Remaining 2021	$ 3,326
2022	13,887		$ 7,914
2023	13,320		7,823
2024	12,349		7,038
2025	11,895		6,066
2025			5,982
Thereafter	106,505
Thereafter			55,321
Estimated amortization	$ 161,282	$ 122,485	93,800	$ 30,036	$ 12,477
Previously Reported [Member]
Indefinite-lived Intangible Assets [Line Items]
Estimated amortization		$ 123,106	$ 90,144	$ 26,380

Intangible Assets & Goodwill _4

Intangible Assets & Goodwill - Summary of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill, Beginning Balance	$ 71,123	$ 74,100	$ 7,316	$ 0
Goodwill, Ending Balance	111,721	71,123	74,100	7,316
PurePenn, LLC and Pioneer Leasing & Consulting, LLC
Goodwill [Line Items]
Goodwill, Beginning Balance		47,311
Acquisition			47,311
Adjustment to Purchase Price Allocation	(624)	(338)
Goodwill, Ending Balance			47,311
Solevo Wellness
Goodwill [Line Items]
Acquisition			$ 19,473
Adjustment to Purchase Price Allocation	1,150	$ (2,639)
Healing Corner Inc [Member]
Goodwill [Line Items]
Acquisition				$ 7,316
Key Stone Shops [Member]
Goodwill [Line Items]
Acquisition	$ 40,072

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Notes Payable [Line Items]
Total notes payable	$ 6,000	$ 6,000		$ 6,000
Less current portion	(6,000)	(2,000)	$ (2,000)
Long-term notes payable	0	4,000	4,000
Promissory Note Dated April10, 2017 with Annual Interest at 12%, Due Between April and July 2022
Notes Payable [Line Items]
Total notes payable	4,000	4,000	4,000
Promissory Note Dated December 7, 2017 with Annual Interest at 12%, Due December 2021
Notes Payable [Line Items]
Total notes payable	$ 2,000	$ 2,000	$ 2,000

Notes Payable - Schedule of N_2

Notes Payable - Schedule of Notes Payable (Parenthetical) (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Promissory Note Dated April10, 2017 with Annual Interest at 12%, Due Between April and July 2022
Notes Payable [Line Items]
Notes payable, commencement date	Apr. 10, 2017	Apr. 10, 2017
Notes payable, annual interest rate	12.00%	12.00%
Notes payable, maturity description	due between April and July 2022	due between April and July 2022
Notes payable, maturity month and year range, start	2022-04	2022-04
Notes payable, maturity month and year range, end	2022-07	2022-07
Promissory Note Dated December 7, 2017 with Annual Interest at 12%, Due December 2021
Notes Payable [Line Items]
Notes payable, commencement date	Dec. 7, 2017	Dec. 7, 2017
Notes payable, annual interest rate	12.00%	12.00%
Notes payable, maturity month and year	2021-12	2021-12

Notes Payable - Schedule of Sta

Notes Payable - Schedule of Stated Maturities of Notes Payable (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2018
Debt Disclosure [Abstract]
2021	$ 2,000
2022	4,000	$ 2,000
2022		4,000
Total notes payable	$ 6,000	$ 6,000	$ 6,000

Notes Payable - Additional Info

Notes Payable - Additional Information (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)
Amended Unsecured Promissory Note [Member]
Notes Payable [Line Items]
Debt instrument extended maturity term	3 years
Debt instrument maturity period	2022-05
Promissory Note [Member]
Notes Payable [Line Items]
Threshold limit for prepayment of note	$ 24

Notes Payable Related Party - S

Notes Payable Related Party - Summary of Notes Payable Related Party (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Notes Payable Related Party [Abstract]
Notes payable due to related parties, with varying interest rates between 8% to 12% annual, with varying maturity dates	$ 12,000	$ 12,011	$ 12,952	$ 14,215
Less debt discount			(49)	(141)
Less current portion	$ (12,000)	$ (12,011)	(924)	(1,427)
Non-current portion			$ 11,979	$ 12,647

Notes Payable Related Party -_2

Notes Payable Related Party - Summary of Notes Payable Related Party (Parenthetical) (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Minimum
Notes Payable Related Party [Line Items]
Notes payable due to related parties, interest rate	8.00%	8.00%
Maximum
Notes Payable Related Party [Line Items]
Notes payable due to related parties, interest rate	12.00%	12.00%

Notes Payable Related Party -_3

Notes Payable Related Party - Summary of Stated Maturities of Notes Payable to Related Parties (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Notes Payable Related Party [Abstract]
2022/2021	$ 12,000	$ 12,011
Notes payable due to related parties	$ 12,000	$ 12,011	$ 12,952	$ 14,215

Notes Payable Related Party - A

Notes Payable Related Party - Additional Information (Details)	1 Months Ended			12 Months Ended
	Mar. 31, 2021PromissoryNote	Sep. 30, 2018USD ($)	Apr. 30, 2018USD ($)	Dec. 31, 2019USD ($)PromissoryNote	Dec. 31, 2018USD ($)PromissoryNote	Mar. 31, 2019USD ($)	Jun. 30, 2018USD ($)	May 31, 2018USD ($)
Notes Payable Related Party [Line Items]
Number of unsecured promissory notes | PromissoryNote	2
Unamortized debt discount amount related party				$ (49,000)	$ (141,000)
Repayment of related party debt					6,000,000
Property plant and equipment financed through notes payable related party				$ 300,000	$ 3,100,000
C To C Lines Of Credit
Notes Payable Related Party [Line Items]
Repayment of long term line of credit			$ 1,500,000
Former Shareholder And Director | March Two Thousand And Nineteen Unsecured Notes | Benjamin Atkins
Notes Payable Related Party [Line Items]
Long term debt term				24 months
Related party transaction interest rate				8.00%
Debt instrument face value						$ 300,000
Unamortized debt discount amount related party				$ 10,092
Former Shareholder And Director | March Two Thousand And Nineteen Unsecured Notes | Benjamin Atkins | Discount Rate
Notes Payable Related Party [Line Items]
Debt instrument measurement input				0.12
Former Shareholder And Director | April Two Thousand And Eighteen Unsecured Notes | Benjamin Atkins
Notes Payable Related Party [Line Items]
Long term debt term					24 months
Related party transaction interest rate					8.00%
Debt instrument face value			200,000
Unamortized debt discount amount related party					$ 6,232
Former Shareholder And Director | April Two Thousand And Eighteen Unsecured Notes | Benjamin Atkins | Discount Rate
Notes Payable Related Party [Line Items]
Debt instrument measurement input					0.12
Former Shareholder And Director | June Two Thousand And Eighteen Unsecured Notes | Benjamin Atkins
Notes Payable Related Party [Line Items]
Long term debt term					24 months
Related party transaction interest rate					8.00%
Debt instrument face value							$ 300,000
Unamortized debt discount amount related party					$ 10,276
Former Shareholder And Director | June Two Thousand And Eighteen Unsecured Notes | Benjamin Atkins | Discount Rate
Notes Payable Related Party [Line Items]
Debt instrument measurement input					0.12
Former Shareholder And Director | November Two Thousand And Eighteen Unsecured Notes | Benjamin Atkins
Notes Payable Related Party [Line Items]
Number of unsecured promissory notes | PromissoryNote					2
Long term debt term					24 months
Related party transaction interest rate					8.00%
Debt instrument face value					$ 500,000
Unamortized debt discount amount related party					$ 18,624
Former Shareholder And Director | November Two Thousand And Eighteen Unsecured Notes | Benjamin Atkins | Discount Rate
Notes Payable Related Party [Line Items]
Debt instrument measurement input					0.12
Clearwater GPC | April Two Thousand And Eighteen Unsecured Notes
Notes Payable Related Party [Line Items]
Long term debt term					24 months
Related party transaction interest rate					12.00%
Debt instrument face value			$ 6,000,000
Repayment of related party debt		$ 6,000,000
Tranch Four LLC And Kim River | May Two Thousand And Eighteen Unsecured Notes
Notes Payable Related Party [Line Items]
Number of unsecured promissory notes | PromissoryNote				2
Debt instrument extended maturity term				1 year
Debt instrument maturity period				2021-05
Long term debt term								24 months
Related party transaction interest rate					12.00%
Debt instrument face value								$ 12,000,000
Unsecured Promissory Notes
Notes Payable Related Party [Line Items]
Debt instrument extended maturity term	1 year
Debt instrument maturity period	2022-05			2021-05

Private Placement Notes - Addit

Private Placement Notes - Additional Information (Details)	Dec. 10, 2020USD ($)	Nov. 07, 2019USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2019USD ($)$ / sharesshares	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2020USD ($)yr	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2018USD ($)shares	Dec. 10, 2020$ / shares	Dec. 10, 2020$ / shares	Dec. 09, 2020	Dec. 31, 2019$ / shares	Aug. 31, 2019shares	Jun. 18, 2019USD ($)	May 16, 2019USD ($)	Oct. 31, 2018shares
Debt Instrument [Line Items]
Class of warrants or rights number of share called by the warrants or rights | shares											8,784,872					214,178			321,268
Derivative liabilities fair value			$ 9,892,000			$ 9,892,000			$ 0	$ 9,892,000
Notes payable carrying amount				$ 6,000,000			$ 6,000,000		6,000,000		$ 6,000,000
Interest expense				6,145,000	$ 5,352,000		20,693,000	$ 16,566,000	20,237,000	9,050,000	$ 2,103,000
Long term debt gross carrying amount				130,000,000			130,000,000
Net debt									117,200,000
November two thousand and nineteen units
Debt Instrument [Line Items]
Amortization of debt issuance costs										2,100,000
Number of units issued during the period | shares		60,000
Other Noncurrent Liabilities
Debt Instrument [Line Items]
Long term debt gross carrying amount									$ 130,000,000
Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Notes payable carrying amount		$ 54,700,000
Warrants and secured debt
Debt Instrument [Line Items]
Amortization of debt issuance costs						3,100,000
Stock Price
Debt Instrument [Line Items]
Warrants measurement input									6
Exercise Price
Debt Instrument [Line Items]
Warrants measurement input									6
Expected Life in Years
Debt Instrument [Line Items]
Warrants measurement input | yr									3
Annualized Volatility
Debt Instrument [Line Items]
Warrants measurement input									51
Dividend Yield
Debt Instrument [Line Items]
Warrants measurement input									0
Discount Rate
Debt Instrument [Line Items]
Warrants measurement input									3
Warrants to purchase subordinate voting shares
Debt Instrument [Line Items]
Amortization of debt issuance costs						2,900,000
November two thousand and nineteen warrants to purchase subordinate voting shares | November two thousand and nineteen units
Debt Instrument [Line Items]
Amortization of debt issuance costs										200,000
November two thousand and nineteen warrants to purchase subordinate voting shares | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Derivative liabilities fair value			$ 4,400,000			$ 4,400,000				$ 4,400,000
Class of warrants or rights issued during the period units | shares		1,560,000
Debt attached warrants issue price per unit | $ / shares		$ 980
November two thousand and nineteen warrants to purchase subordinate voting shares | Other Noncurrent Liabilities | Supplement warrant indenture agreement | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants exercise price | (per share)												$ 17.25	$ 13.47
Foreign exchange rate														0.781
November two thousand and nineteen warrants to purchase subordinate voting shares | Stock Price | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Share price | $ / shares															$ 14.29
November two thousand and nineteen warrants to purchase subordinate voting shares | Exercise Price | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants exercise price | $ / shares															17.25
November two thousand and nineteen warrants to purchase subordinate voting shares | Expected Life in Years | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants expected life			2 years 7 months 6 days			2 years 7 months 6 days				2 years 7 months 6 days
November two thousand and nineteen warrants to purchase subordinate voting shares | Annualized Volatility | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants measurement input			48.57			48.57				48.57
November two thousand and nineteen warrants to purchase subordinate voting shares | Dividend Yield | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants measurement input			0			0				0
November two thousand and nineteen warrants to purchase subordinate voting shares | Discount Rate | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants measurement input			1.92			1.92				1.92
November two thousand and nineteen warrants to purchase subordinate voting shares | Exchange Rate | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants exchange rate			1.32			1.32				1.32
Warrants
Debt Instrument [Line Items]
Warrants exercise price | $ / shares															17.25
Warrants expected life			3 years			3 years				3 years
Warrants fair value			$ 4,700,000			$ 4,700,000				$ 4,700,000
Share price | $ / shares															14.48
Warrants exchange rate			1.34			1.34				1.34
Warrants | Annualized Volatility
Debt Instrument [Line Items]
Warrants measurement input			49.96			49.96				49.96
Warrants | Dividend Yield
Debt Instrument [Line Items]
Warrants measurement input			0			0				0
Warrants | Discount Rate
Debt Instrument [Line Items]
Warrants measurement input			1.92			1.92				1.92
November Warrant
Debt Instrument [Line Items]
Warrants exercise price | $ / shares															17.25
Warrants expected life			2 years 7 months 6 days			2 years 7 months 6 days				2 years 7 months 6 days
Warrants fair value			$ 4,400,000			$ 4,400,000				$ 4,400,000
Share price | $ / shares															14.29
Warrants exchange rate			1.32			1.32				1.32
November Warrant | Annualized Volatility
Debt Instrument [Line Items]
Warrants measurement input			48.57			48.57				48.57
November Warrant | Dividend Yield
Debt Instrument [Line Items]
Warrants measurement input			0			0				0
November Warrant | Discount Rate
Debt Instrument [Line Items]
Warrants measurement input			1.92			1.92				1.92
June Notes
Debt Instrument [Line Items]
Debt instrument face amount			$ 70,000,000			$ 70,000,000				$ 70,000,000
Debt instrument, interest rate			13.32%			13.32%				13.32%
Warrants to purchase of shares | shares			1,470,000			1,470,000				1,470,000
Debt instrument, fair value			$ 63,900,000			$ 63,900,000				$ 63,900,000
June Notes | Supplemental Warrant Indenture | Odyssey Trust Company
Debt Instrument [Line Items]
Warrants exercise price | (per share)												17.25	13.47
Conversion of convertible warrants to equity expense	$ 25,500,000
Exchange rate per Canadian dollar														0.781
June Notes | Other Noncurrent Liabilities | Supplement warrant indenture agreement
Debt Instrument [Line Items]
Warrants exercise price | (per share)												$ 17.25	$ 13.47
Foreign exchange rate														0.781
Conversion of convertible warrants to equity expense									$ 25,500,000
June Notes | General and Administrative Expenses
Debt Instrument [Line Items]
Accretion expense				800,000	$ 700,000		2,300,000	$ 2,100,000
June Notes | Secured debt
Debt Instrument [Line Items]
Debt instrument face amount																	$ 70,000,000
Long term debt term			5 years			5 years				5 years
Long term debt bearing fixed interest rate percentage			9.75%			9.75%			9.75%	9.75%
Notes payable fair value disclosure			$ 63,900,000			$ 63,900,000				$ 63,900,000
Amortization of debt issuance costs						$ 200,000
June Notes | Secured debt | Other Noncurrent Liabilities
Debt Instrument [Line Items]
Notes payable carrying amount																	60,100,000
Notes payable carrying amount at maturity due to accretion of coupon interest																	$ 70,000,000
June Notes | Secured debt | General and Administrative Expenses | Other Noncurrent Liabilities
Debt Instrument [Line Items]
Interest expense									$ 1,500,000	$ 700,000
June Notes | Secured debt | Debt instrument effective interest rate
Debt Instrument [Line Items]
Warrants expected life																	5 years
Warrants measurement input																	13.32
June Notes | Warrants to purchase subordinate voting shares | Secured debt
Debt Instrument [Line Items]
Class of warrants or rights number of share called by the warrants or rights | shares			1,470,000			1,470,000				1,470,000
Warrants exercise price | $ / shares			$ 13.47			$ 13.47				$ 13.47
Warrants expected life			3 years			3 years				3 years
Long term debt terms						semi-annually
Debt instrument maturity date range start						Dec. 18, 2019
Derivative liabilities fair value			$ 4,700,000			$ 4,700,000				$ 4,700,000
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Measurement input, risk free interest rate
Debt Instrument [Line Items]
Warrants measurement input			13.32			13.32				13.32
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Stock Price
Debt Instrument [Line Items]
Share price | $ / shares															14.48
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Exercise Price
Debt Instrument [Line Items]
Warrants exercise price | $ / shares															$ 17.25
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Expected Life in Years
Debt Instrument [Line Items]
Warrants expected life			3 years			3 years				3 years
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Annualized Volatility
Debt Instrument [Line Items]
Warrants measurement input			49.96			49.96				49.96
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Dividend Yield
Debt Instrument [Line Items]
Warrants measurement input			0			0				0
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Discount Rate
Debt Instrument [Line Items]
Warrants measurement input			1.92			1.92				1.92
June Notes | Warrants to purchase subordinate voting shares | Secured debt | Measurement Input Exchange Rate
Debt Instrument [Line Items]
Warrants exchange rate			1.34			1.34				1.34
June and November Notes
Debt Instrument [Line Items]
Debt instrument term										5 years
Debt instrument face amount				$ 130,000,000			$ 130,000,000
Debt instrument, frequency of payment							payable semi-annually, in equal installments, in arrears on June 18 and December 18 of each year.		payable semi-annually, in equal installments, in arrears on June 18 and December 18 of each year
Debt instrument, interest rate			9.75%			9.75%				9.75%
Debt instrument exercised period										3 years
Debt instrument maturity year							2024
June and November Notes | Secured and unsecured debt | Other Noncurrent Liabilities
Debt Instrument [Line Items]
Long term debt gross carrying amount									$ 130,000,000
November Notes
Debt Instrument [Line Items]
Debt instrument face amount			$ 60,000,000			$ 60,000,000				$ 60,000,000
Debt instrument, interest rate			13.43%			13.43%				13.43%
Warrants to purchase of shares | shares			1,560,000			1,560,000				1,560,000
Debt instrument, fair value			$ 54,500,000			$ 54,500,000				$ 54,500,000
November Notes | Supplemental Warrant Indenture | Odyssey Trust Company
Debt Instrument [Line Items]
Conversion of convertible warrants to equity expense	$ 27,100,000
November Notes | Secured debt | November two thousand and nineteen units
Debt Instrument [Line Items]
Warrants expected life		4 years 7 months 6 days
November Notes | Secured debt | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Debt instrument face amount		$ 60,000,000
Long term debt bearing fixed interest rate percentage			9.75%			9.75%				9.75%
Notes payable fair value disclosure			$ 56,700,000			$ 56,700,000				$ 56,700,000
Amortization of debt issuance costs										2,000,000
Notes payable carrying amount at maturity due to accretion of coupon interest		$ 60,000,000
Notes issued issue price per unit | $ / shares		$ 1,000
Debt instrument maturity year			2024
November Notes | Secured debt | Other Noncurrent Liabilities | Supplement warrant indenture agreement | November two thousand and nineteen units
Debt Instrument [Line Items]
Conversion of convertible warrants to equity expense									27,100,000
November Notes | Secured debt | General and Administrative Expenses | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Interest expense									$ 1,300,000	$ 100,000
November Notes | Secured debt | Debt instrument effective interest rate | November two thousand and nineteen units
Debt Instrument [Line Items]
Debt instrument measurement input		0.1343	0.1343			0.1343				0.1343
November Notes | November two thousand and nineteen warrants to purchase subordinate voting shares | Other Noncurrent Liabilities | November two thousand and nineteen units
Debt Instrument [Line Items]
Number of warrants per note		26
Proceeds from the issuance of long term notes payable			$ 61,100,000
Private offering | Unsecured Debt | Bridge Loan
Debt Instrument [Line Items]
Debt instrument face amount																		$ 17,800,000
Short term debt bearing fixed interest rate percentage																		9.75%

Private Placement Notes - Summa

Private Placement Notes - Summary of Scheduled Annual Maturities of Principal Portion of Long-Term Debt Outstanding (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
2024	$ 130,000
Total debt	130,000
Less: Unamortized debt issuance costs	(10,522)
Net Debt	$ 119,478
Other Noncurrent Liabilities
Debt Instrument [Line Items]
2024		$ 130,000
Total debt		130,000
Less: Unamortized debt issuance costs		(12,835)
Net Debt		$ 117,165

Leases - Components of Lease Co

Leases - Components of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease cost	$ 2,483	$ 1,545	$ 5,751	$ 4,087	$ 5,700	$ 5,542
Finance lease cost:
Amortization of lease assets	1,990	1,496	5,357	3,688	4,956	1,984
Interest on lease liabilities	1,177	782	2,914	1,801	2,133	960
Finance lease cost	3,167	2,278	8,271	5,489	7,089	2,944
Variable lease cost	2,529	28	3,139	310	222	192
Total lease cost	$ 8,179	$ 3,851	$ 17,161	$ 9,886	$ 13,010	$ 8,678

Leases - Schedule of Weighted A

Leases - Schedule of Weighted Average Discount Rate and Remaining Lease Term (Details)	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Finance lease, weighted average discount rate	8.46%	8.36%
Operating lease, weighted average discount rate	8.75%	8.64%
Finance lease, weighted average remaining lease term (in years)	8 years 2 months 12 days	8 years 6 months 3 days
Operating lease, weighted average remaining lease term (in years)	8 years 8 months 1 day	7 years 5 months 26 days

Leases - Schedule of Maturity o

Leases - Schedule of Maturity of Contractual Undiscounted Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finance Lease
Remainder of 2021	$ 2,494			$ 6,964
2022	10,509			6,642
2023	13,246			6,257
2024	9,395			5,787
2025	9,069			5,588
Thereafter	43,875			24,669
Total undiscounted lease liabilities	88,588			55,907
Interest on lease liabilities	(26,000)			(16,972)
Total present value of minimum lease payments	62,588			38,935
Finance lease liability - current portion	(5,354)			3,877
Finance lease liability	57,234	$ 45,516	$ 38,103	35,058	$ 17,168
Operating Lease
Remainder of 2021	1,991			5,480
2022	8,173			5,405
2023	7,886			5,276
2024	7,759			4,921
2025	7,800			4,843
Thereafter	35,893			14,225
Total undiscounted lease liabilities	69,502			40,150
Interest on lease liabilities	(21,581)			(10,545)
Total present value of minimum lease payments	47,921			29,605
Operating lease liability - current portion	(4,264)			3,154
Operating lease liability	$ 43,657	37,777	30,907	28,120	$ 20,601
Previously Reported [Member]
Finance Lease
Finance lease liability		39,694	36,294
Operating Lease
Operating lease liability		$ 29,381	$ 28,326	$ 26,450

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 01, 2019
Lessee, Lease, Description [Line Items]
Operating lease right of use assets	$ 45,753	$ 40,022	$ 32,881	$ 30,076	$ 22,045
Operating lease liabilities	47,921			29,605
Finance lease right of use assets	58,393	$ 47,892	$ 40,218	36,904	$ 19,088
Finance lease liabilities	$ 62,588			$ 38,935
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease right of use assets						$ 21,700
Operating lease liabilities						22,400
Finance lease right of use assets						1,200
Finance lease liabilities						$ 1,200
Real Estate Used For Dispensaries Production And Corporate Offices | Minimum
Lessee, Lease, Description [Line Items]
Operating lease term lessee					5 years
Real Estate Used For Dispensaries Production And Corporate Offices | Maximum
Lessee, Lease, Description [Line Items]
Operating lease term lessee					10 years
Passenger Vehicles Trucks And Equipment | Minimum
Lessee, Lease, Description [Line Items]
Operating lease term lessee					3 years
Passenger Vehicles Trucks And Equipment | Maximum
Lessee, Lease, Description [Line Items]
Operating lease term lessee					5 years

Construction Finance Liabilit_2

Construction Finance Liabilities - Additional Information (Details) $ in Thousands	Mar. 08, 2021USD ($)	Oct. 31, 2019USD ($)	Oct. 31, 2019USD ($)Option	Oct. 31, 2019USD ($)	Jul. 31, 2019USD ($)	Jul. 31, 2019USD ($)Option	Jul. 31, 2019USD ($)	Sep. 30, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Construction Finance Liability [Line Items]
Tenant improvements allowance									$ 16,700
Construction finance liability								$ 92,021	82,047	$ 22,956
Percentage at which one twelfth of tenant improvement allowance dispersed for first 5.0 million				12.75%
Percentage at which one twelfth of tenant improvement allowance dispersed after 5.0 million up to 21.0 million				13.75%
Massachusetts
Construction Finance Liability [Line Items]
Proceeds from sale of property					$ 3,500
Tenant improvements allowance					$ 40,000	$ 40,000	$ 40,000		40,000	2,500
Finance lease liability, initial term					10 years	10 years	10 years
Finance lease liability, extended term					5 years	5 years	5 years
Number of options to extend finance lease						2	2
Percentage of purchase price of property as initial payment for finance lease							11.00%
Percentage increase in finance lease liability payment							3.00%
Construction finance liability								44,400	43,900	6,100
Florida
Construction Finance Liability [Line Items]
Proceeds from sale of property		$ 17,000
Finance lease liability, initial term		10 years	10 years	10 years
Finance lease liability, extended term		5 years	5 years	5 years
Number of options to extend finance lease			2	2
Percentage of purchase price of property as initial payment for finance lease				11.00%
Percentage increase in finance lease liability payment				3.00%
Construction finance liability								17,400	17,200	$ 16,900
Sale and lease back transaction amount payable after year four									23,000
Pennsylvania
Construction Finance Liability [Line Items]
Proceeds from sale of property		$ 5,000
Tenant improvements allowance	$ 36,500	$ 21,000	$ 21,000	$ 21,000					36,500
Tenant improvements allowance received								25,600
Finance lease liability, initial term		15 years	15 years	15 years
Finance lease liability, extended term		5 years	5 years	5 years
Number of options to extend finance lease			2	2
Construction finance liability								$ 30,200
Threshold minimum tenant improvement allowance for calculating interest rate									$ 21,000
Percentage at which one twelfth of tenant improvement allowance dispersed for first 5.0 million				12.75%
Percentage at which one twelfth of tenant improvement allowance dispersed after 5.0 million up to 21.0 million				13.75%
Percentage at which one twelfth of tenant improvement allowance dispersed in excess 21.0 million	10.75%								10.75%

Share Capital - Summary of War

Share Capital - Summary of Warrants Issued and Outstanding To Certain Employees and Director (Details) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Warrants, Granted		535,446
Number of Warrants, Exercised	(214,178)	(321,268)
Number of shares/warrants, Outstanding, Ending Balance		214,178
Weighted average exercise price, Granted		$ 6
Weighted average exercise price, Exercised	$ 6	6
Weighted average price, Ending Balance		$ 6
Weighted Average Remaining Contractual Life (Yrs), Outstanding		1 year 7 months 28 days	2 years

Share Capital - Additional Info

Share Capital - Additional Information (Details)	Aug. 27, 2018USD ($)shares	Aug. 31, 2019USD ($)shares	Oct. 31, 2018USD ($)shares	Sep. 30, 2021USD ($)Vote$ / sharesshares	Sep. 30, 2020USD ($)shares	Dec. 31, 2020USD ($)Dispensaryshares	Dec. 31, 2019USD ($)shares	Dec. 31, 2018USD ($)shares
Class Of Stock [Line Items]
Common stock, shares issued				129,531,207		119,573,998	110,346,346
Common stock, shares outstanding				129,531,207		119,573,998	110,346,346
Common stock, shares authorized, unlimited				Unlimited		Unlimited	Unlimited
Promissory notes | $				$ 6,000,000		$ 6,000,000		$ 6,000,000
Stock issued during the period, conversion of debt | $								200,000
debt discount | $								$ 50,000
Common stock, value, subscriptions | $	$ 50,600,000
Proceeds from issuance of common stock | $	$ 47,500,000
Percentage of cash fee paid on gross proceeds of warrants issued	6.00%
Percentage of cash fee payable on gross proceeds of warrants issued	3.00%
Warrants outstanding	535,446
Number of warrants exercised		214,178	321,268					8,784,872
Proceeds from warrant exercised | $		$ 964,000,000	$ 1,500,000	$ 7,672,000	$ 11,459,000	$ 11,459,000	$ 964,000	$ 1,289,000
Subordinate Voting Shares
Class Of Stock [Line Items]
Voting rights				At each such meeting holders of Subordinate Voting Shares shall be entitled to one vote in respect of each Subordinate Voting Share held.		At each such meeting holders of Subordinate Voting Shares shall be entitled to one vote in respect of each Subordinate Voting Share held.
Number of votes entitled by each share of common stockholder				1		1
Dividend declared | $ / shares				$ 0
Dividend paid | $ / shares				$ 0
Common stock, shares issued				74,611,611	58,134,478	59,952,461	35,871,672	11,135,117
Common stock, shares outstanding				74,611,611	58,134,478	59,952,461	35,871,672	11,135,117
Common stock, shares authorized, unlimited				Unlimited	Unlimited	Unlimited
Conversion of stock, shares issued	3,573,450						7,089,077
Common stock, shares converted	10,927,500			54,919,596	1,476,959		17,433,300
Multiple Voting Shares
Class Of Stock [Line Items]
Voting rights				At each such meeting, holders of Multiple Voting Shares are entitled to one vote in respect of each Subordinate Voting Share into which such Multiple Voting Share could ultimately then be converted (initially, 100 votes per Multiple Voting Share). The initial “Conversation Ratio” for Multiple Voting Shares is 100 Subordinate Voting shares for each Multiple Voting Share,		At each such meeting, holders of Multiple Voting Shares are entitled to one vote in respect of each Subordinate Voting Share into which such Multiple Voting Share could ultimately then be converted (initially, 100 votes per Multiple Voting Share)
Number of votes entitled by each share of common stockholder				1		1
Dividend declared | $ / shares				$ 0
Dividend paid | $ / shares				$ 0
Common stock, shares issued				549,196	14,770	14,390	66,614	137,505
Common stock, shares outstanding				549,196	14,770	14,390	66,614	137,505
Common stock, shares authorized, unlimited				Unlimited	Unlimited	Unlimited
Common stock, conversion basis				100 Subordinate Voting shares for each Multiple Voting Share		100 Subordinate Voting shares for each Multiple Voting Share
Common stock, conversion ratio				100		100
Conversion of stock, shares issued							70,891
Common stock, shares converted	35,734.50					1,439,037	6,661,374	13,750,451
Super Voting Shares
Class Of Stock [Line Items]
Voting rights				At each such meeting, holders of Super Voting Shares are be entitled to two votes in respect of each Subordinate Voting Share into which such Super Voting Share could ultimately then be converted (initially, 200 votes per Super Voting Share).		At each such meeting, holders of Super Voting Shares are be entitled to two votes in respect of each Subordinate Voting Share into which such Super Voting Share could ultimately then be converted (initially, 200 votes per Super Voting Share).
Number of votes entitled by each share of common stockholder				2		2
Common stock, shares issued				0	581,825	581,825	678,133	852,466
Common stock, shares outstanding				0	581,825	581,825	678,133	852,466
Common stock, shares authorized, unlimited				Unlimited	Unlimited
Common stock, conversion basis				one Multiple Voting Share for each Super Voting Share		one Multiple Voting Share for each Super Voting Share
Common stock, conversion ratio				200		200
Conversion of stock, shares issued							174,333
Common stock, shares converted				58,182,500	58,182,500	58,182,500	67,813,300	85,246,600
Subscription Receipts [Member]
Class Of Stock [Line Items]
Common stock, shares issued	10,927,500
Common stock, shares outstanding	10,927,500
Common stock, shares subscribed but unissued	10,927,500

Share Based Compensation - Addi

Share Based Compensation - Additional Information (Details)

Sep. 29, 2021

Jan. 04, 2021

Jan. 03, 2020

Sep. 30, 2021USD ($)Officers$ / sharesshares

Sep. 30, 2021USD ($)$ / sharesshares

Sep. 30, 2021USD ($)$ / sharesshares

Sep. 30, 2021USD ($)Officers$ / sharesshares

Sep. 30, 2020shares

Dec. 31, 2020USD ($)$ / sharesshares

Dec. 31, 2019shares

Dec. 31, 2018USD ($)

Aug. 31, 2019shares

Dec. 31, 2018$ / sharesshares

Oct. 31, 2018shares

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares

$ 6

Share based compensation awards granted | shares

877,509

1,252,403

Share based compensation, contractual term

4 years 6 months 7 days

4 years 3 days

Share-based compensation | $

$ 2,200,000

$ 2,800,000

$ 15,000,000

Share based compensation unvested options, aggregate unrecognized compensation expense | $

$ 8,500,000

$ 8,500,000

$ 8,500,000

$ 8,500,000

Share based compensation unvested options, unrecognized compensation expense weighted average recognition period

2 years 1 month 2 days

Number of warrants issued | shares

214,178

8,784,872

321,268

Class of warrant or right, vesting | shares

0

Class of warrant or right, exercisable term

3 years

Class of warrant or right may not be exercised term

18 months

Warrant or right, for issuance, description

(i) the warrants may not be exercised for 18 months following the Issue Date; (ii) 50% of the warrants may be exercised between months 19-24 following the Issue Date; and (iii) the remaining 50% of the warrants may be exercised at any time thereafter until expiration.

(i) the warrants may not be exercised for 18 months following the Issue Date; (ii) 50% of the warrants may be exercised between months 19-24 following the Issue Date; and (iii) the remaining 50% of the warrants may be exercised at any time thereafter until expiration.

Warrants related to share-based compensation issued | shares

0

0

0

0

Restricted Stock Units

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares

$ 26.88

$ 26.88

$ 26.88

$ 26.88

Share-based compensation | $

$ 0

Number of executive officers | Officers

2

2

Number of officers awarded premium | Officers

2

Share based compensation arrangement awarded premium | $

$ 3,100,000

Number of officers allocated to incentivize cancellation and replacement | Officers

2

Share-based compensation expense recorded related to cancellation and replacement | $

$ 0

Restricted Stock Units | Maximum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share based compensation options, vesting period

3 years

Restricted Stock Units | Minimum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share based compensation options, vesting period

2 years

Cost of Goods Sold

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation | $

$ 200,000

$ 200,000

General and Administrative Expenses

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation | $

1,600,000

2,100,000

Sales and Marketing

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation | $

$ 400,000

$ 500,000

2021 Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Common Stock, reserved for future issuance | shares

4,000,000

4,000,000

4,000,000

4,000,000

Share based compensation awards granted | shares

895,877

2021 Plan | Officers and Other Select Employees

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share based compensation options, vesting period

3 years

2021 Plan | Officers and Other Select Employees | Maximum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share based compensation, contractual term

7 years

2021 Plan | Officers and Other Select Employees | Minimum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share based compensation, contractual term

6 years

2021 Plan | Officers and Other Select Employees | Restricted Stock Units | Maximum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share based compensation options, vesting period

3 years

2021 Plan | Officers and Other Select Employees | Restricted Stock Units | Minimum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share based compensation options, vesting period

2 years

2021 Plan | Directors and Officers | Vest on December 31, 2021

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

33.33%

2021 Plan | Directors and Officers | Vest on December 31, 2022

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

33.33%

2021 Plan | Directors and Officers | Vest on December 31, 2023

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

33.33%

Prior Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares

$ 1.71

Share based compensation, number of further awards granted | shares

0

0

0

0

Expected term of bond yield rate

3 years

3 years

Share based compensation unvested options | shares

1,452,824

1,452,824

1,452,824

1,452,824

Prior Plan | Employees | Vest on December 31, 2021

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

15.00%

15.00%

Prior Plan | Employees | Vest on December 31, 2022

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

25.00%

25.00%

Prior Plan | Employees | Vest on December 31, 2023

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

60.00%

60.00%

Prior Plan | Founding and Non-founding Members of Board of Directors | Vest on December 31, 2021

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

50.00%

50.00%

Prior Plan | Founding and Non-founding Members of Board of Directors | Vest on December 31, 2022

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Share-based compensation option vesting rights, percentage

50.00%

50.00%

Share Based Compensation - Sche

Share Based Compensation - Schedule of Fair Value of Options Granted with Assumptions (Details)	9 Months Ended		12 Months Ended
	Sep. 30, 2021$ / shares	Sep. 30, 2020$ / shares	Dec. 31, 2020yr$ / shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected annual rate of dividends	0.00%	0.00%	0.00%
Expected volatility rate, minimum	49.88%	49.10%
Expected volatility rate, maximum	53.75%	50.15%
Risk free annual interest rate, minimum	0.16%	1.40%	1.40%
Risk free annual interest rate, maximum	0.79%	1.58%	1.58%
Stock Price
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants measurement input			6
Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants measurement input			6
Expected Life in Years
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants measurement input | yr			3
Annualized Volatility
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants measurement input			51
Dividend Yield
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants measurement input			0
Discount Rate
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants measurement input			3
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Fair value at grant date	$ 10.58	$ 3.11	$ 3.11
Stock price at grant date	26.88	11.52	11.52
Exercise price at grant date	$ 26.88	$ 11.52	$ 11.52
Expected life in years	3 years	1 year 6 months 29 days	1 year 6 months 29 days
Expected volatility			49.10%
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Fair value at grant date	$ 11.20	$ 3.26	$ 3.26
Stock price at grant date	33.42	12.50	12.50
Exercise price at grant date	$ 33.42	$ 12.50	$ 12.50
Expected life in years	3 years 6 months	2 years	2 years
Expected volatility			50.15%

Share Based Compensation - Sc_2

Share Based Compensation - Schedule of Number and Weighted-average Exercise Prices and Remaining Contractual Life of Options (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of Options Outstanding, beginning balance	1,129,774
Number of Options, Granted	877,509	1,252,403
Number of Options, Exercised	(36,787)	(9,180)
Number of Options, forfeited		(113,444)
Number of Options Outstanding, Ending balance	1,970,496	1,129,774
Number of Options, Exercisable, Ending balance	517,672	554,456
Weighted average exercise price Outstanding, beginning balance	$ 11.72
Weighted average exercise price, Granted	29.32	$ 11.70
Weighted average exercise price, Exercised	11.52	11.52
Weighted average exercise price, Forfeited		11.52
Weighted average exercise price Outstanding, Ending balance	19.56	11.72
Weighted average exercise price, Exercisable, Ending balance	$ 11.71	$ 11.70
Weighted Average Remaining Contractual Life (Yrs) Outstanding	4 years 6 months 7 days	4 years 3 days
Weighted Average Remaining Contractual Life (Yrs), Granted	3 years 6 months 18 days	1 year 11 months 4 days
Weighted Average Remaining Contractual Life (Yrs), Exercisable, Ending balance	3 years 4 months 2 days
Aggregate intrinsic value Outstanding	$ 8,430
Aggregate intrinsic value Exercisable	$ 15,200
Previously Reported [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of Options Outstanding, beginning balance	1,129,779
Number of Options Outstanding, Ending balance		1,129,779
Weighted Average Remaining Contractual Life (Yrs) Outstanding		1 year 11 months 1 day

Share Based Compensation - Sc_3

Share Based Compensation - Schedule of Restricted Stock Units (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2021$ / sharesshares	Dec. 31, 2018$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares/warrants, Granted | shares		535,446
Number of shares/warrants, Outstanding, Ending Balance | shares		214,178
Weighted average price, Granted | $ / shares		$ 6
Weighted average price, Ending Balance | $ / shares		$ 6
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares/warrants, Granted | shares	3,249,319
Number of shares/warrants, Vested | shares	(2,904,079)
Number of shares/warrants, Outstanding, Ending Balance | shares	345,240
Weighted average price, Granted | $ / shares	$ 25.45
Weighted average price, Vested | $ / shares	25.28
Weighted average price, Ending Balance | $ / shares	$ 26.88

Share Based Compensation - Summ

Share Based Compensation - Summary of Warrants Issued and Outstanding To Certain Employees and Director (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2021$ / sharesshares	Dec. 31, 2020$ / sharesshares	Dec. 31, 2019$ / sharesshares	Dec. 31, 2019$ / sharesshares	Dec. 31, 2018$ / sharesshares	Dec. 31, 2018$ / sharesshares	Dec. 31, 2017
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares/warrants, Outstanding, Beginning Balance			214,178	214,178
Number of Warrants, Exercised			(214,178)	(214,178)	(321,268)	(321,268)
Number of shares/warrants, Outstanding, Ending Balance					214,178	214,178
Weighted average price, Beginning Balance | $ / shares				$ 6
Weighted average exercise price, Exercised | $ / shares				$ 6		$ 6
Weighted average price, Ending Balance | $ / shares						$ 6
Weighted Average Remaining Contractual Life (Yrs), Outstanding					1 year 7 months 28 days	1 year 7 months 28 days	2 years
Warrants | Certain Employees and Directors
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares/warrants, Outstanding, Beginning Balance	6,061,561	8,784,872	8,784,872	8,784,872
Number of Warrants, Exercised	(2,075,990)	2,723,311
Number of shares/warrants, Exchanged in cashless exercise	(413,057)
Number of shares/warrants, Cancelled	(3,572,514)
Number of shares/warrants, Outstanding, Ending Balance		6,061,561	8,784,872	8,784,872	8,784,872	8,784,872
Weighted average price, Beginning Balance | $ / shares	$ 6	$ 6	$ 6
Weighted average exercise price, Exercised | $ / shares	$ 6
Weighted average price, Ending Balance | $ / shares		$ 6	$ 6		$ 6
Weighted Average Remaining Contractual Life (Yrs), Outstanding		8 months 19 days	1 year 8 months 19 days	1 year 8 months 19 days	2 years 8 months 19 days	2 years 8 months 19 days

Reverse Takeover Transaction -

Reverse Takeover Transaction - Summary of Acquisition Costs (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)
Business Combination, Consideration Transferred [Abstract]
Fair value of 200,000 shares issued	$ 927
Transaction costs	460
Total purchase price	$ 1,387

Reverse Takeover Transaction _2

Reverse Takeover Transaction - Summary of Acquisition Costs (Parenthetical) (Details)	12 Months Ended
	Dec. 31, 2020shares
Schyan Exploration, Inc [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	200,000

Reverse Takeover Transaction _3

Reverse Takeover Transaction - Additional Information (Detail) - Schyan Exploration, Inc [Member] $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares	200,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable | $	$ 0.1
Concurrent financing subscription price | $ / shares	$ 4.6328
Stockholders' Equity Note, Stock Split, Conversion Ratio	0.01235

Prospectus Offering - Additiona

Prospectus Offering - Additional Information (Detail) - Subordinate Voting Shares [Member] - Canaccord Genuity Corp [Member] $ / shares in Units, $ in Millions	Sep. 21, 2020USD ($)$ / sharesshares
Sale of Stock, Number of Shares Issued in Transaction | shares	4,715,000
Sale of Stock, Price Per Share | $ / shares	$ 18.56
Payments for Underwriting Expense	$ 4.1
Payments of Stock Issuance Costs	0.1
Proceeds from Issuance Initial Public Offering	$ 83.2

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Reconciliation For Calculation Of Basic And Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Earnings Per Share [Abstract]
Net income	$ 18,616	$ 40,880	$ 30,078	$ 17,415	$ 18,938	$ 23,605	$ 89,574	$ 59,958	$ 62,999	$ 53,094	$ 10,893
Weighted average number of common shares outstanding	128,146,298			112,039,640			122,983,729	111,824,816	113,572,379	110,206,103	101,697,002
Dilutive effect of warrants and options outstanding	8,762,968			5,909,584			7,943,354	4,173,888	4,753,345	5,111,839	1,504,125
Diluted weighted average number of common shares outstanding	136,909,266			117,949,224			130,927,083	115,998,704	118,325,724	115,317,942	103,201,127
Basic earnings per share	$ 0.15			$ 0.16			$ 0.73	$ 0.54	$ 0.55	$ 0.48	$ 0.11
Diluted earnings per share	$ 0.14			$ 0.15			$ 0.68	$ 0.52	$ 0.53	$ 0.46	$ 0.11

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Expense and Effective Tax Rate (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income before provision for income taxes	$ 60,219	$ 43,363	$ 194,828	$ 127,074	$ 157,450	$ 103,680	$ 33,044
Provision for income taxes	$ 41,603	$ 25,948	$ 105,254	$ 67,116	$ 94,451	$ 50,586	$ 22,151
Effective tax rate	69.00%	60.00%	54.00%	53.00%

Income Taxes - Summary of compo

Income Taxes - Summary of components of the income tax provision (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Current					$ 99,338	$ 51,494	$ 22,697
Deferred			$ (2,111)	$ (2,324)	(4,887)	(908)	(546)
Income Tax Expense (Benefit)	$ 41,603	$ 25,948	$ 105,254	$ 67,116	$ 94,451	$ 50,586	$ 22,151

Income Taxes - Summary of Feder

Income Taxes - Summary of Federal statutory income tax rate percentage (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income before income taxes					$ 157,450	$ 103,680	$ 33,044
Federal statutory rate					21.00%	21.00%	21.00%
Theoretical tax expense					$ 33,064	$ 21,773	$ 6,939
State taxes					12,406	9,477	4,366
Other					(1,666)	1,310	1,176
Tax effect of non-deductible expenses:
Nondeductible share based compensation							3,154
Section 280E permanent differences					50,646	18,026	6,517
Income Tax Reconciliation Total Amount					61,386	28,813	15,212
Income Tax Expense (Benefit)	$ 41,603	$ 25,948	$ 105,254	$ 67,116	$ 94,451	$ 50,586	$ 22,151

Income Taxes - Summary of Defer

Income Taxes - Summary of Deferred income taxes (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Deferred tax assets
Lease liability	$ 1,219	$ 1,020	$ 0
Other deferred tax assets	7,025	969	570
Deferred tax liabilities
Right of use assets	(1,210)	(1,099)	0
Intangible assets	(26,446)	(6,144)	(3,080)
Property and equipment	(3,153)	(233)	(534)
Lease payments	(1,010)	0	0
Net deferred tax liability	$ (23,575)	$ (5,486)	$ (3,044)

Income Taxes - Additional infor

Income Taxes - Additional information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Undistributed Earnings of Foreign Subsidiaries	$ 0
Uncertain tax positions	3,900,000	$ 3,900,000	$ 0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	$ 0

Related Parties - Additional In

Related Parties - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2021	Mar. 31, 2021
Related Party Transaction [Line Items]
Notes issued, related parties	$ 12,000		$ 12,000		$ 12,000	$ 13,000
Property and equipment purchases			119,600	$ 65,000	96,700	46,400	$ 12,100
Operating lease right of use assets	45,753		45,753		30,076	22,045		$ 40,022	$ 32,881
Expenses recognized for related party leases	$ 900	$ 900	2,400	$ 2,600
Property, Plant and Equipment [Member]
Related Party Transaction [Line Items]
Operating lease right of use assets					15,400	18,900
Lease Liabilities [Member]
Related Party Transaction [Line Items]
Operating lease right of use assets					1,800	1,800
Accounts Payable
Related Party Transaction [Line Items]
Property and equipment purchases			$ 14,700		$ 10,400	$ 6,500

Related Parties - Right of Use

Related Parties - Right of Use Assets and Lease Liability under ASC 842 (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finance
Right-of-use asset, net	$ 58,393	$ 47,892	$ 40,218	$ 36,904	$ 19,088
Lease liabilities - current portion	5,354	5,004	4,414	3,877	2,272
Lease liabilities	57,234	45,516	38,103	35,058	17,168
Total present value of minimum lease payments	62,588			38,935
Operating
Right-of-use asset, net	45,753	40,022	32,881	30,076	22,045
Lease liabilities - current portion	4,264	4,015	3,497	3,277	2,541
Lease Liabilities	43,657	$ 37,777	$ 30,907	28,120	$ 20,601
Total present value of minimum lease payments	47,921			29,605
Various Related Parties and Benjamin Atkins
Finance
Right-of-use asset, net	2,080			3,425
Lease liabilities - current portion	207			281
Lease liabilities	2,184			3,500
Total present value of minimum lease payments	2,391			3,781
Operating
Right-of-use asset, net	6,116			12,003
Lease liabilities - current portion	725			1,539
Lease Liabilities	5,790			11,083
Total present value of minimum lease payments	$ 6,515			$ 12,622

Financial Instruments and Fin_3

Financial Instruments and Financial Risk Management - Summary Of Fair Value Measurements (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Assets, Fair Value Disclosure [Abstract]
Money Market Funds	$ 65,516	$ 77,993
Financial Liabilities Fair Value Disclosure [Abstract]
Warrant Liability	0	9,892
Fair Value, Inputs, Level 1 [Member]
Assets, Fair Value Disclosure [Abstract]
Money Market Funds	65,516	77,993
Financial Liabilities Fair Value Disclosure [Abstract]
Warrant Liability	0	0
Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure [Abstract]
Money Market Funds	0	0
Financial Liabilities Fair Value Disclosure [Abstract]
Warrant Liability	0	9,892
Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure [Abstract]
Money Market Funds	0	0
Financial Liabilities Fair Value Disclosure [Abstract]
Warrant Liability	$ 0	$ 0

Financial Instruments and Fin_4

Financial Instruments and Financial Risk Management - Summary Of Contractual Cash Flows (Details) $ in Thousands	Dec. 31, 2020USD ($)
Accounts Payable and Accrued Liabilities [Member]
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	$ 41,902
Accounts Payable and Accrued Liabilities [Member] | 1 Year
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	41,902
Accounts Payable and Accrued Liabilities [Member] | 1 to 3 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	0
Notes Payable, Other Payables [Member]
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	6,000
Notes Payable, Other Payables [Member] | 1 Year
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	2,000
Notes Payable, Other Payables [Member] | 1 to 3 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	4,000
Notes Payable Related Party [Member]
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	12,011
Notes Payable Related Party [Member] | 1 Year
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	12,011
Other Noncurrent Liabilities [Member]
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	130,000
Other Noncurrent Liabilities [Member] | 1 Year
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	0
Other Noncurrent Liabilities [Member] | 3 to 5 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	130,000
Operating Lease Liability [Member]
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	40,150
Operating Lease Liability [Member] | 1 Year
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	5,480
Operating Lease Liability [Member] | 1 to 3 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	10,681
Operating Lease Liability [Member] | 3 to 5 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	9,764
Operating Lease Liability [Member] | 5 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	14,225
Finance Lease Liability [Member]
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	55,907
Finance Lease Liability [Member] | 1 Year
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	6,964
Finance Lease Liability [Member] | 1 to 3 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	12,899
Finance Lease Liability [Member] | 3 to 5 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	11,375
Finance Lease Liability [Member] | 5 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	24,669
Construction Finance Liability [Member]
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	82,047
Construction Finance Liability [Member] | 1 Year
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	0
Construction Finance Liability [Member] | 1 to 3 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	0
Construction Finance Liability [Member] | 3 to 5 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	61,071
Construction Finance Liability [Member] | 5 Years
Disclosure Of Contractual Cash Flows [Line Items]
Contractual Obligation	$ 20,977

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) $ in Thousands	Oct. 06, 2021USD ($)	Oct. 01, 2021USD ($)shares	Mar. 21, 2021shares	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2018USD ($)
Subsequent Event [Line Items]
Net proceeds from private placement				$ 217,896	$ 83,228	$ 83,228	$ 47,467
Subsequent Event | Senior Secured Notes Due 2026
Subsequent Event [Line Items]
Debt instrument, interest rate	8.00%
Gross proceeds from private placement	$ 350,000
Net proceeds from private placement	$ 342,600
Notes issued, percentage of face value	100.00%
Redemption description	The Notes will mature on October 6, 2026 and may be redeemed in whole or in part, at any time from time to time, on or after October 6, 2023 at the application redemption price set forth in the Indenture
Debt instrument, frequency of payment	payable semi-annually in equal installments until the maturity date
Debt instrument, maturity date	Oct. 6, 2026
Subsequent Event | Super Voting Shares [Member]
Subsequent Event [Line Items]
Conversion of Outstanding Super Voting Shares into Multiple voting shares, Shares | shares			551,614
Subsequent Event | Multiple Voting Shares [Member]
Subsequent Event [Line Items]
Conversion of Outstanding Super Voting Shares into Multiple voting shares, Shares | shares			551,614
Subsequent Event | Harvest Health & Recreation, Inc | Arrangement Agreement
Subsequent Event [Line Items]
Aggregate number of shares issued | shares		50,874,175
Shares issued for acquisition		$ 1,400,000
Subsequent Event | Harvest Health & Recreation, Inc | Arrangement Agreement | Subordinate Voting Shares
Subsequent Event [Line Items]
Business acquisition shares exchange ratio		0.1170